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Summary 
 
Macrophages (mφ) are one the most numerous leukocytes present in the 
healthy gut and contribute to both harmful and beneficial immune reactions. 
In the colon, mφ are exposed continuously to large amounts of material from 
the environment, including harmful agents such as invasive bacteria, viruses 
and parasites, as well as harmless materials such as food proteins and the 
commensal bacteria which inhabit the healthy intestine. As a result, mφ play 
an important role in helping defend the intestine against harmful invaders. 
However if these cells make similar reactions to harmless food proteins or 
commensal bacteria, it would be both wasteful and detrimental, likely 
leading to inflammatory diseases such as coeliac disease and Crohn’s disease. 
Several genes, which underlie susceptibility to Crohn’s disease are involved in 
controlling how macrophages respond to the microbiota, with considerable 
evidence indicating that this reflects a loss of the normal unresponsiveness 
that characterises intestinal macrophages in the healthy intestine. One of the 
most significant aspects of the epidemiology of Crohn’s disease is a 
particularly rapid increase in its incidence in childhood, suggesting that the 
first encounters between the microbiota and intestinal macrophages may be 
of critical importance in determining disease susceptibility. Given this link, it 
is essential that we elucidate the processes controlling macrophage seeding 
and development in the intestine and this was an aim of this thesis. 
 
In the adult healthy colon, two main mφ subsets can be identified: A 
dominant and homogenous one, made up of mature mφ, which express high 
levels of F4/80, MHC II, CX3CR1, are CD11bint/+, highly phagocytic and 
produce high amounts of IL10. The second mφ group is relatively smaller and 
is much more heterogeneous. These cells express intermediate levels of 
F4/80 and CX3CR1, are CD11b+ and can be divided into 3 subsets based on 
their levels of Ly6C and MHC II. These subsets represent a maturation 
continuum towards the mature mφ phenotype. Recent reports have suggested 
that resident macrophages in healthy tissues may be derived from yolk-sac 
and/or foetal liver precursors that seed tissues during development and 
subsequently self-renew locally. In contrast, it is proposed that macrophages 
in inflammation are generated by recruitment of blood monocytes, raising 
the possibility that these different origins could be exploited in therapy. 
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However none of these studies have examined macrophages in the intestine 
and recent work in our laboratory has suggested that monocytes may be the 
precursors of macrophages in both healthy and inflamed gut of adult mice.  
 
Therefore, the aims of this thesis were to investigate the development of 
murine colonic mφ from birth until adulthood, examining the relative roles of 
the yolk sac, foetal liver and bone marrow monocytes, exploring their 
functions and comparing them with the well-characterised adult mφ. In 
addition, I also examined how mφ phenotype and functions are influenced by 
the microbiota using broad-spectrum antibiotics and germ free mice. Lastly, I 
examined the role of fractalkine and its receptor CX3CR1 in defining the 
development and functions of intestinal macrophages. 
 
Development of macrophages in early life 
 
The initial characterisation and comparison of colonic mφ subsets is included 
in Chapter 3. In this chapter, I describe a series of experiments adapting 
existing protocols and techniques used for examining the adult murine 
intestine in order to analyse the origin, phenotype and functions of murine 
colonic macrophages from late foetal life through to adulthood. These studies 
found that intestinal mφ are present before birth, with similar levels of 
phagocytic ability and IL10, TNFα and CD163 mRNA expression to the adult. 
However, the numbers and phenotype of mφ in the intestine do not reach the 
adult level until the 3rd week of postnatal life. This phenomenon appears to 
reflect the de novo recruitment of blood monocytes in a CCR2-dependent 
fashion at this time and throughout adult life, but not at early stages of life. 
 
In the colon of newborn mice, two macrophage populations can be observed 
and are clearly differentiated based on their F4/80 and CD11b expression: 
F4/80hi CD11bint/+ and F4/80lo CD11b+. Interestingly, unlike adult colonic 
F4/80hi mφ, the majority of F4/80hi neonatal cells do not express MHC II, 
however they gradually express this molecule as they age. In addition to 
acquiring MHC II expression, the two populations in the newborn colon 
gradually merge and from the 3rd week of life it is difficult to discriminate 
them reliably. My experiments show that both mφ subsets proliferate actively 
during the first 2 weeks of life, but this is later reduced and maintained at 
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low levels indicating that there is no self-renewal of mature mφ. Moreover, 
fate-mapping analysis carried out in collaboration with Professor Frederic 
Geissmann, showed that yolk sac-derived precursors contribute only 
minimally to the pool of colonic mφ, even at early life stages. Conversely, 
additional fate mapping studies suggested that most intestinal macrophages 
are derived from Flt3+ progenitors. Taken together, the results in this chapter 
demonstrate that blood monocytes are vital in replenishing the intestinal 
macrophage pool in the steady state, setting them apart from other tissue 
macrophages, which derive from primitive progenitors.  
 
Investigating the effect of the microbiota on intestinal macrophage 
subsets 
 
In Chapter 4, I assessed the effects of the commensal microbiota on intestinal 
mφ, using two different approaches: First, I assessed the function and gene 
expression of colonic macrophages following administration of broad-
spectrum antibiotics. My results showed that this did not alter the numbers, 
phenotype, intracellular cytokine production or mRNA expression by 
macrophages. Several reasons may account for this, including dose/nature of 
antibiotics, length of administration or lifespan of macrophages. To overcome 
these issues, I compared the phenotype of colonic mφ in germ free (GF) and 
conventionally (CNV) reared mice of different ages in collaboration with Dr 
David Artis. Absolute absence of microbiota in GF mice severely impacted 
Ly6Chi monocyte recruitment to the colon, suggesting that constant 
recruitment of monocytes to the gut is at least in part due to the microbial 
burden. The biggest differences between GF and CNV mice were evident at 3 
weeks of age, when GF mice had a much lower number and frequency of 
monocyte-derived cells than their CNV counterparts. By 12 weeks of age, 
Ly6Chi mφ populations from GF mice were partially restored, although the 
expression of MHC II by F4/80hi mφ remained reduced. Additionally, I FACS-
purified F4/80hi cells from GF and CNV adults and sent RNA for microarray 
analysis, the results of which we are waiting to receive. This data will 
provide further information regarding how GF intestinal mφ differ from those 
found in conventional animals. 
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Role of the CX3CL1-CX3CR1 axis in mφ development and function 
 
As mature colonic mφ express high levels of the chemokine receptor CX3CR1 
(fractalkine), finally, in Chapter 5 I went on to investigate the role of 
CX3CL1-CX3CR1 axis in colonic lamina propria. In addition to the high 
expression of CX3CR1 by colonic mφ, its ligand, CX3CL1 has been reported to 
be expressed at high levels by the intestinal epithelium. Furthermore, as 
there is strong evidence that the CX3CL1-CX3CR1 axis may be involved in 
inflammation in several tissues, we hypothesised this axis might play a role in 
mφ function in the gut. To this end, I examined mφ phenotype, activation 
status and survival following in vitro co-culture of WT or CX3CR1-deficient 
bone marrow-derived mφ with an epithelial cell line modified to express 
either the soluble or membrane-bound forms of CX3CL1. I also examined the 
development of chemically induced colitis in CX3CR1-deficient mice. Finally, 
since it has been reported by the lab of Oliver Pabst, that the lack of CX3CR1 
results in reduced IL10 production by intestinal mφ, I compared the ability of 
WT and CX3CR1-deficient mice to prime T cells after being fed with 
ovalbumin together with an adjuvant. The results from this chapter failed to 
show any definitive role of the CX3CL1-CX3CR1 axis in mφ function in either 
the steady state or in the setting of inflammation. 
 
My in vitro studies did not show any significant difference between WT and 
CX3CR1 deficient intestinal mφ in terms of survival, or co-stimulatory 
molecule expression, nor did bone marrow mφ (BMM) from CX3CR1 KO mice 
show differences in co-stimulatory molecules and pro-inflammatory cytokine 
production with or without stimulation by LPS. Moreover, the responses of 
wild type BMM were not altered by exposure to exogenous CX3CL1 either in 
soluble form, or when expressed as a transmembrane form by epithelial cells. 
 
The in vivo assessment of CX3CR1 during inflammation, Ly6Chi CX3CR1int cells 
increased after 4 days on DSS, however, the lack of CX3CR1 failed to confer 
protection from colitis in a consistent manner, suggesting that there may be 
more factors responsible for colonic inflammation apart from the CX3CL1-
CX3CR1 axis.  
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Taken together, the results of this thesis highlight that important cellular 
changes take place during the development of mφ in the intestine. In 
addition, the presence or absence of microbiota plays a crucial role in this 
development with acquisition of MHC II depending at least in part on the 
presence of microbes. Microarray data obtained from purified F4/80hi mφ 
populations of GF and CNV mice may reveal interesting differences and 
suggest how mφ phenotype and function may be regulated by the microbiota. 
Finally, I have shown that the CX3CL1-CX3CR1 axis plays a redundant role in 
the regulation of intestinal mφ phenotype and function with mφ from CX3CR1-
deficient animals appearing to function normally in both health and disease.  
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Chapter 1 
General introduction 
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1.1 The intestinal immune system 
 
The mucosal surfaces that comprise the gastrointestinal, reproductive and 
respiratory tracts have a unique immune system whose properties are 
determined by their anatomical location and function they execute 
(Maldonado-Contreras and McCormick, 2011). The intestine has a massive 
surface area and is in intimate contact with a vast array of foreign antigens 
such as bacteria, food proteins and potential pathogens. As a result, the 
intestine is the largest compartment of the immune system and it has to 
discriminate between harmless and harmful antigens (Artis, 2008; Mowat, 
2003). While adaptive immunity has to be induced against pathogens, similar 
responses against harmless materials such as commensal bacteria or foods are 
dangerous, as they can lead to inflammatory bowel disease (IBD) or coeliac 
disease, respectively (Bain and Mowat, 2011; Gujral et al., 2012). Thus, a 
complex and sophisticated series of processes have evolved to ensure 
appropriate immune responses in the intestine. 
 
1.2 Adaptive immune responses in the intestine 
 
The intestinal immune system comprises both organised lymphoid tissues and 
populations of scattered effector cells. The organised lymphoid tissues are 
the sites where immune responses are initiated and they comprise the 
Peyer’s patches and isolated lymphoid follicles (ILF) found in the intestinal 
wall, together with the draining mesenteric lymph nodes (MLN) (Bailey and 
Haverson, 2006; Mowat, 2003). 
 
Peyer’s patches are macroscopic structures located along the small intestine 
containing several large B cell follicles with germinal centres and smaller T 
cell areas between the follicles. The scattered ILFs are similar in structure to 
PP, but are much smaller and are found throughout the small and large 
intestines (Jung et al., 2010). They are mainly composed of B cells, with a 
low proportion of T cells and only develop after birth in response to bacterial 
colonisation (Bouskra et al., 2008). Both the PP and ILFs also contain DCs and 
macrophages (mφ). The PP are covered by a single layer of follicle associated 
epithelium (FAE), containing specialised epithelial cells known as microfold 
(M) cells that take up bacteria and other antigens from the lumen and pass 
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them on to DCs in the dome region underlying the FAE. DCs can then present 
the antigen either to T and B lymphocytes in the PP themselves, or migrate 
through lymphatics to the MLN to interact with lymphocytes there. The MLNs 
are the largest lymph nodes in the body and are essential for all immune 
responses in the intestine. Lymphocytes which are primed in the PP or MLN 
acquire homing molecules which ensure the activated lymphocytes return 
specifically to the intestinal mucosa as effector cells via the efferent lymph 
and bloodstream. These molecules are α4β7 integrin, that binds to MADCAM-1 
on the vascular endothelium of mucosal blood vessels and in the small 
intestine, CCR9, the receptor for the CCL25 chemokine produced selectively 
by epithelial cells in the small intestine. The mechanisms responsible for 
driving lymphocyte recirculation to the large intestine are not yet known, but 
may include CCR10 and its ligand CCL28 (Jung et al., 2010; Mowat, 2003). 
 
The lamina propria (LP) is the layer of loose connective tissue beneath the 
epithelium and contains large numbers of CD4+ and CD8+ T cells, as well as 
IgA producing plasma cells, mφ, DCs, occasional eosinophils and mast cells. 
The majority of T cells in the LP have a memory/effector phenotype, 
consistent with them being the product of primed naïve T cells; CD4+ T cells 
outnumber CD8+ T cells by ~2:1 (MacDonald et al., 2011). CD4+ T cells 
producing IFNγ or IL17 or expressing Foxp3 are all readily detectable in the LP 
even under steady state conditions, emphasising the constant stimulation 
present in this tissue (Shale et al., 2013). The epithelium also contains many 
lymphocytes but these are virtually all CD8+ T cells, which again have a 
memory/effector phenotype and are capable of constitute functions such as 
cytotoxicity and cytokine production. Many intraepithelial lymphocytes (IEL) 
also express the unusual homodimeric α-α form of the CD8 molecule and 
appear to be related to cells of the innate immune system, rather than being 
conventional CD8+ T cells. γδ T cells are also present in the epithelium, 
where they again have an activated phenotype and innate-like properties 
(Mowat, 2003; van Wijk and Cheroutre, 2009). 
 
Humoral immunity in the intestine is characterised by the selective 
production of IgA antibodies that are transported across the epithelial cells 
into the lumen. The production of IgA is dependent on selective switching of 
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B cells under control of TGFβ, and is driven by T cells primed by antigen in 
the PP or MLN (Cerutti and Rescigno, 2008).  
 
1.3 Innate immunity in the intestine 
 
As in other parts of the body, innate immune responses are triggered in a 
very short time, but do not generate memory responses or show antigen-
specificity (Medzhitov and Janeway, 2000). Despite these limitations, the 
local innate immune response can deal efficiently with most challenges and it 
was this aspect of immune function my project focused on.  
 
The first layer of innate immunity comprises physiological factors such as the 
low pH of the stomach, digestive enzymes and the peristaltic movement of 
fluid through the lumen. The epithelium then presents an important 
mechanical barrier, dependent both on passive and active mechanisms that 
contribute to innate defence. The tight junctions between epithelial cells 
prevent influx of materials across the barrier, while the goblet cells within 
the epithelium produce mucus which forms an additional physical barrier and 
has antimicrobial properties (Abreu, 2010; van der Flier and Clevers, 2009). 
Paneth cells are a further kind of epithelial cell found in the crypts of the 
small intestine, which in response to microbial products, secrete 
antimicrobial mediators, such as α-defensins, cryptdins, C-type lectins and 
RegIIIγ. Their production is also enhanced by IL22 produced by local CD4+ T 
cells and innate lymphoid cells (ILC). Together, these small proteins play an 
important part in intestinal defence by disrupting the membranes of 
bacteria, fungi and viral envelopes. Paneth cells also produce phospholipase 
A2, which kills bacteria by hydrolising phospholipids in the cell membrane 
(Clevers and Bevins, 2013; Ganz, 2003; Reddy et al., 2004). A further 
important characteristic of gut epithelial cells is their very high turnover rate 
which means they are replaced every 4-5 days, allowing removal of attached 
or invading organisms (van der Flier and Clevers, 2009).  
 
1.4 TLRs and NLRs 
 
Epithelial cells and many leukocytes found in the intestinal mucosa express 
germline-encoded pattern recognition receptors (PRRs) that recognise 
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conserved features on microbes, which are not found in mammalian cells and 
are known as pathogen-associated molecular patterns (PAMPs). PAMPs are 
carbohydrate, lipid or nucleic acid structures essential for the survival of 
microbes, and thus are ideal targets for the innate immune system (Raetz 
and Whitfield, 2002). 
 
The best known PRRs are the Toll-like receptors (TLRs), of which 13 have 
been described in the mouse and 10 in humans (Bryant and Monie, 2012; 
Oldenburg et al., 2012). As shown in Table 1.1, different TLRs recognise a 
variety of microbial products including nucleic acids, membrane components, 
LPS and flagellin. TLRs are single-pass transmembrane proteins with an 
extracellular region composed of leucine-rich repeats (LRR) creating a 
protein scaffold that forms the basis of ligand binding. Mammalian TLRs are 
activated when binding of a ligand induces them to form dimers or 
oligodimers and they are found either on the cell surface, in endosomes or in 
the cytoplasm (Bryant and Monie, 2012; Murphy, 2012; Testro and 
Visvanathan, 2009). 
 
TLR ligation triggers a signalling cascade of NF-κB and interferon regulatory 
factor (IRF) mediated intracellular responses, which result in the production 
of proinflammatory mediators such as TNFα, IL6, chemokines, antimicrobial 
peptides, as well as interferons (Cario, 2010). These mediators also attract 
and activate innate effector cells such as neutrophils, monocytes, eosinophils 
and DCs. Additionally, TLR signalling involves a number of adaptor molecules 
such as myeloid differentiation factor 88 (MyD88), which is a universal 
adaptor used by almost all the TLRs except for TLR3 (Gay et al., 2011). TIR 
domain-containing adaptor-inducing IFN-β (TRIF) and TRIF-related adaptor 
molecule (TRAM) on the other hand are responsible for activation of MyD88-
independent genes after stimulation with TLR4 and TLR3 ligands (Brasier, 
2006; Paun and Pitha, 2007; Yamamoto et al., 2003). 
 
Other innate sensors displayed by epithelial and haematopoietic cells are the 
nucleotide-binding oligomerisation domain proteins NOD1 and NOD2. These 
PRRs are related to TLRs, but are exclusively intracellular and recognise 
components of the peptidoglycans found in bacterial cell walls (Cario, 2010; 
Franchi et al., 2009). 
	   26	  
 
TLR Ligand that binds to Cellular distribution 
TLR1:TLR2 
heterodimer 
TLR2:TLR6 
heteromdimer 
Lipomannans (Diacyl/triacyl 
lipopeptides) 
Lipoteichoic acids 
Cell wall β-glucans 
Zymosan 
 
Monocytes, DCs, mφ, 
mast cells, 
neutrophils, 
eosinophils, basophils 
TLR3 Double-stranded RNA NK cells, CD8+ DCs, 
CD103+ DCs, mφ 
 
TLR4 (plus MD-2 
and CD14) 
Bacterial LPS 
Lipoteichoic acids 
CD103- CD11b+ DCs, 
mφ, mast cells, 
neutrophils, 
eosinophils 
 
TLR5 Flagellin DCs, mφ, neutrophils, 
intestinal epithelium 
 
TLR7 Single-stranded RNA  NK cells, mφ 
plasmacytoid DCs, 
neutrophils, 
eosinophils, B cells 
 
TLR8 Single-stranded RNA NK cells, mφ, DCs, 
neutrophils 
 
TLR9 DNA with unmethylated CpG NK cells, mφ, 
plasmacytoid DCs, 
neutrophils, 
eosinophils, B cells, 
basophils 
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TLR10 Unknown Plasmacytoid DCs, 
neutrophils, 
eosinophils, B cells, 
basophils 
 
TLR11 (mouse 
only) 
Flagellin 
Profilin 
 
CD8+ DCs, mφ 
TLR12 Profilin  CD8+ DCs, mφ, neurons 
 
TLR13 Bacterial ribosomal RNA 
sequence “CGGAAAGACC” 
CD8+ DCs, mφ and 
monocytes 
 
Table 1.1. Innate immune recognition by Toll-like receptors. Adapted 
from Mishra 2008, Murphy, 2012 and Rosenberg, 2003. 
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1.5 Effector cells of the intestinal innate immune system 
 
The cellular arm of the innate immune system is found mostly in the LP and 
comprises natural killer (NK) cells, innate lymphoid cells, granulocytes 
(basophils and eosinophils), DCs, monocytes and mφ. 
 
Natural killer (NK) cells. Are cytotoxic non-B, non-T lymphocytes that are 
not antigen specific, but are stimulated by cytokines and molecules present 
on stressed cells, tumour cells or infected cells. In addition, they express 
inhibitory receptors that recognise MHC I and which prevent their activation, 
unless MHC I has been downregulated. NK cells act through the release of 
cytotoxic granules containing perforin and granzymes, and by producing 
cytokines such as IFNγ (Vivier et al., 2011; Vivier et al., 2008). Currently, NK 
cells are seen as part of a wider range of innate lymphoid cells and classified 
amongst Group 1 ILCs (Hwang and McKenzie, 2013).  
 
Innate lymphoid cells (ILC). These newly identified members of the lymphoid 
lineage comprise a number of non-antigen specific, non-T, non-B cells that 
are related to lymphoid tissue inducer (LTI) cells. So far, 3 groups of ILCs 
have been identified based on their signature cytokines and their dependence 
on different growth factors and transcription factors. As mentioned above, 
ILC1 include NK cells and are characterised by their production of IFNγ and 
TNFα in response to IL15. They are dependent on the Th1 cell-associated 
transcription factor T-bet. ILC2, previously known as natural helper cells and 
“nuocytes”, produce IL5, IL9 and IL13 in response to IL25 and IL33 and are 
controlled by the retinoic acid receptor-related orphan receptorα (RORα) and 
GATA-binding protein 3 (GATA3). ILC3 produce IL17 and IL22 in response to 
IL23 and are dependent on the transcription factor RORγt. A subset of ILC3 
produces both IFNγ and IL17 and has been associated with intestinal 
inflammation. These subsets of ILCs are believed to be the innate equivalent 
of the various subsets of effector T cells that play distinct roles in immunity 
against viruses and intracellular bacteria (ILC1), parasites and allergens 
(ILC2) and extracellular bacteria and fungi (ILC3) (Pearson et al., 2012; Spits 
et al., 2013; Walker et al., 2013). 
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Granulocytes. Despite their usual association with parasite infections, 
allergic reactions and asthma, eosinophils are found at surprisingly high 
frequencies in the steady state LP, where they may play a role in tissue 
repair and remodelling of the epithelial barrier (Mowat, 2010; Rothenberg 
and Hogan, 2006). Eosinophils also make important contributions to defence 
against helminths in the intestine and express several TLRs, such as TLR1, 
TLR2, TLR4, TLR6, TLR7, TLR9 and TLR10. Finally, basophils are rare in the 
normal intestine, but increase in numbers during helminth infections 
(Anthony et al., 2007; Kvarnhammar and Cardell, 2012; Suurmond et al., 
2013). Granulocytes can be divided into neutrophils, eosinophils and 
basophils based on the content of their granules and their staining with 
haematoxylin and eosin. Although they are rare in the steady state LP, 
neutrophils are the first cells to accumulate during acute inflammation of the 
intestine, where they are phagocytic, have a microbicidal role and produce 
proinflammatory cytokines (Rosenberg, 2003).  
 
Dendritic cells (DCs). These myeloid cells received their name from Ralph 
Steinman in the early 1970s and form a crucial link between the innate and 
adaptive immune systems (Steinman and Cohn, 1973). They are defined by 
their morphology and by their ability to sample antigens in tissues, before 
migrating in afferent lymph to draining lymph nodes, where they have a 
unique ability to prime naïve T cells and initiate adaptive immune responses 
(Banchereau and Steinman, 1998). These properties are dependent on the 
ability of DCs to respond to TLR ligands and their PAMPs in the tissues, which 
stimulate locomotor activity, antigen processing, expression of the LN homing 
chemokine receptor CCR7 and of the costimulatory molecules CD40, CD80 
and CD86 needed for T cell priming (Hammer and Ma, 2013).  
 
DC development is dependent on Fms-like kinase 3 (Flt3) and these cells 
begin as committed DC precursors in the BM, before migrating via the 
bloodstream into lymphoid and non-lymphoid tissues, where they divide and 
differentiate into mature DCs (Bogunovic et al., 2009; McKenna et al., 2000; 
Onai et al., 2007). Two major families of conventional DCs have been defined 
in humans and mice, which can be defined by their mutually exclusive 
expression of SIRPα and XCR1. In mice, the former population expresses 
CD11b, but not CD8α, whereas the latter is C11b- CD8α+ (Turnbull et al., 
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2005). CD8α+ (XCR1+) DCs have a specialised ability to cross-present 
exogenous antigens to CD8+ T cells and they are found particularly in the T 
cell dependent areas of secondary lymphoid tissues (Bachem et al., 2012). 
However like SIRPα+ DCs, they can also be found in non-lymphoid tissues and 
can migrate to lymph nodes to prime CD4+ T cells (Cerovic et al., 2013). 
Plasmacytoid DCs are a further lineage of DCs, but these do not migrate from 
tissues to LN and their ability to present antigen to T cells is controversial. 
Their main role in the immune system is the production of type 1 interferons 
in response to virus infections (Yrlid et al., 2006).  
 
DCs are abundant both in the organised lymphoid tissues of the intestine such 
as the PP and MLN, as well as in the LP. Recent studies in our own and other 
laboratories have identified 4 main subsets of DCs in intestinal LP that can 
migrate in lymph to the MLN, based on their expression of CD103 and CD11b 
(Cerovic et al., 2013). These are CD103+ CD11b-, CD103+ CD11b+, CD103- 
CD11b+ and CD103- CD11b-. All are bona fide DCs as shown by their 
dependency on Flt3 and expression of the DC specific transcription factor 
zbtb46 (Satpathy et al., 2012) (Scott, unpublished data). The exact functions 
of these individual subsets are still being defined, but previous work has 
shown that CD103+ DCs from the intestine are characterised by a unique 
ability to imprint the expression of the gut markers CCR9 and α4β7 on 
interacting naïve T and B cells and may selectively generate FoxP3 expressing 
regulatory T cells; these properties reflect the production of retinoic acid 
from dietary vitamin A (Engberg et al., 2010; Johansson-Lindbom et al., 2005; 
Scott et al., 2011). In addition, CD103+ DCs express the TGFβ activating 
integrin αvβ8 and indoleamine 2-3 dioxygenase (IDO), which collectively 
inhibit the generation of effector T cells and favour the differentiation of 
Treg cells (Paidassi et al., 2012). For these reasons, it is proposed that 
CD103+ DCs play the critical role in the development of tolerance to food 
proteins and commensals in the intestine (Pabst and Mowat, 2012; Persson et 
al., 2013). Conversely, it is thought that CD103- CD11b+ DCs may be 
responsible for Th17 cell differentiation through production of pro-
inflammatory mediators such as IL6 or IL23 (Cerovic et al., 2013; Siddiqui et 
al., 2010). However it has to be noted that TLR activated CD103+ DCs can 
produce IL12 and drive Th1 differentiation (Fujimoto et al., 2012) and that 
CD103+ DCs are the principal cells carrying Salmonella to MLN (Farache et al., 
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2013). Furthermore, recent work shows that loss of IRF4 or Notch 2 leads to a 
selective defect in CD103- CD11b+ DC which is associated with absence of 
Th17 cells in the LP (Schlitzer et al., 2013). Therefore there may be 
functional plasticity within the individual DC subsets. 
 
1.6 Intestinal macrophages  
 
1.6.1 What is an intestinal macrophage and why are they important? 
 
Phagocytosis was first reported in starfish over a century ago by the zoologist 
Elie Metchnikoff (Gordon, 2007; Metchnikoff, 1989). This early discovery led 
to the description of the cells later known to comprise the 
reticuloendothelial system and they were eventually classified as 
macrophages (mφ) in the early 1970’s by van Furth (Lichanska and Hume, 
2000; van Furth R, 1972). Mφ are found throughout the body, with the single 
largest population being in the intestine and they act as innate effector cells 
ingesting and killing microbes, as well as having important homeostatic 
functions, such as the clearance of debris and apoptotic cells, and the 
production of growth factors. At the same time however, activated mφ 
produce a wide variety of proinflammatory mediators which can contribute to 
tissue damage (Wynn et al., 2013). 
 
Intestinal mφ are found in the lamina propria, just underneath the epithelial 
surface all along the length of the intestinal tract. There are more mφ in the 
colon than the small intestine, which correlates with the microbial load in 
these sites. Being adjacent to the epithelium puts mφ in an ideal position to 
clear away dying epithelial cells and to assist the tissue remodelling needed 
in such a rapidly dividing tissue (Hopkinson-Woolley et al., 1994; Hume et al., 
1995; Mantovani et al., 2013; van der Flier and Clevers, 2009). Additionally, 
they can act as sentinels for any microbes that may have breached the 
epithelium. Mφ can express a wide range of TLRs and normally, the 
interaction between TLRs and PAMPs would trigger the synthesis of mediators 
of inflammation such as nitric oxide (NO), reactive oxygen species, IL6 and 
TNFα (Medzhitov and Janeway, 2000; Raetz and Whitfield, 2002). However 
this is not the case with intestinal mφ, which even though they express TLRs, 
they do not respond to TLR ligation or other stimuli in a classical manner by 
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producing such mediators. Instead they produce high levels of IL10 
constitutively. However, intestinal mφ are not entirely inert, as in addition to 
producing IL10, they are highly phagocytic, express high levels of MHC II and 
produce some TNFα constitutively (Bain et al., 2013; Platt and Mowat, 2008; 
Smith et al., 2011; Ueda et al., 2010). This suggests that mφ are partially 
activated in situ, but are held in check by IL10.  
 
Intestinal mφ have several unusual phenotypic features. As well as expressing 
classical mφ markers such as F4/80, CD68, CD64 and CD11b, they also express 
intermediate to high levels of CD11c and most express very high levels of the 
fractalkine receptor CX3CR1 (Bain and Mowat, 2011; Platt and Mowat, 2008; 
Smythies et al., 2005; Tamoutounour et al., 2012). Consistent with their 
position and functions, they also express receptors that assist the 
phagocytosis of microbes and cells, such as the scavenger receptor CD163 and 
the mannose receptor CD206 (Bain and Mowat, 2011; Bain et al., 2013; Platt 
et al., 2010). Interestingly, the realisation that CX3CR1 is a mφ marker has 
revised opinion on the nature of the MHC II+ CX3CR1+ cells that form 
transepithelial dendrites (TEDs) and capture bacteria from the lumen. 
Originally believed to be DCs, it seems likely that they are resident mφ 
(Niess, 2010; Niess and Adler, 2010; Niess et al., 2005; Zigmond and Jung, 
2013). 
 
1.6.2 Origins and development of intestinal macrophages 
 
Mφ first appear early in embryogenesis, when they develop from primitive 
mesenchymal precursors in the yolk sac (YS), around day 8 in mice. The 
purpose of this primitive production of CSF1R+ cells is to facilitate tissue 
oxygenation in the rapidly growing embryo (Ginhoux et al., 2010; Hume et 
al., 1995; Orkin and Zon, 2008; Schulz et al., 2012) and is quickly replaced by 
CSF1R+ cells that have seeded the FL from the aorta gonad mesonephros 
(AGM) around embryonic day 10.5. Finally, the BM takes over haematopoiesis 
during the perinatal period (Gekas et al., 2005; Muller et al., 1994; Pixley 
and Stanley, 2004).  
 
In the adult BM, haematopoietic stem cells (HSC) give rise to common 
myeloid progenitors (CMP), which then differentiate into the myeloid, 
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megakaryocytic or erythroid lineages (Figure 1.1). Next, 
granulocyte/macrophage progenitors (GMP) give rise to granulocytes and to 
the mφ and DC precursor (MDP), which then generates the common DC 
precursors (CDP) of conventional and plasmacytoid DCs, as well as the 
monoblasts that are the precursors of pro-monocytes that give rise to 
monocytes that are released into the bloodstream and mature into mφ after 
entry into tissues (Geissmann et al., 2010; Hettinger et al., 2013; 
Mouchemore and Pixley, 2012). All these stages of mφ differentiation are 
controlled by a range of growth factors and transcription factors (Figure 1.1), 
such as Notch homolog 1 (Notch1) and runt related transcription factor 1 
(Runx1), which regulate the earliest phase of HSC differentiation in the AGM, 
while the transcription factor PU.1 is required for the earliest steps of 
myeloid lineage commitment and regulates the genes encoding the 
macrophage colony-stimulating factor (M-CSF or CSF-1) (Anderson et al., 
1998; Lichanska et al., 1999; Orkin and Zon, 2008). The CSF1R, (also known 
as c-fms, M-CSFR and CD115), along with the stem cell factor (c-kit ligand) 
and IL3 are critical for the survival and early differentiation of myeloid cells. 
CSF1 deficient mice (op/op) lack virtually all mφ including intestinal mφ 
(Bartelmez et al., 1989; Cecchini et al., 1994; Mouchemore and Pixley, 2012; 
Pixley and Stanley, 2004; Yoshida et al., 1990).  
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Figure 1.1. Schematic differentiation of macrophages from 
haematopoietic stem cells (HSC) in the adult bone marrow. CMP, common 
myeloid progenitor; GMP, granulocyte-macrophage progenitor; MEP, 
megakaryocyte-erythroid progenitor; MDP, macrophage-dendritic cell 
progenitor; DC, dendritic cell; CDP, common dendritic cell progenitor; 
Runx1, runt related transcription factor 1; SCF, stem cell factor; Flt3 L, 
Flt3 ligand; GM-CSF, granulocyte/macrophage colony stimulation factor; 
CSF-1, colony stimulation factor. Adapted from Mouchemore and Pixley, 
2012, Orkin and Zon, 2008. 
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Until recently, it was believed that tissue mφ were derived from blood 
monocytes and two populations of CD115+ blood monocytes have been 
described in mice and humans. In mice, one of these groups expresses high 
levels of Ly6C, GR1 and CCR2, together with low levels of CX3CR1, while the 
other is GR1lo Ly6Clo CCR2- and CX3CR1+ (Auffray et al., 2009; van Furth and 
Cohn, 1968; Varol et al., 2009b). Initially, it was suggested that Ly6Chi 
monocytes only gave rise to mφ in inflamed tissues, whereas the Ly6Clo subset 
was thought to generate mφ in steady state tissues. Although supported by 
some studies on lung parenchyma (Landsman et al., 2007; Yona, 2009), this 
idea has gone out of fashion in recent years, as it has been very difficult to 
show Ly6Clo monocytes migrating into tissues. Rather, it is now believed that 
these are a more mature form of Ly6Chi monocytes and that they have a 
specialised role in patrolling the vasculature by crawling along the 
endothelium (Auffray et al., 2007; Auffray et al., 2009; Geissmann et al., 
2003; Gordon and Taylor, 2005; Varol et al., 2009b).  
 
After circulating in the bloodstream, monocytes extravasate into tissues using 
adhesion molecules such as L-selectin (CD62L), P-selectin glycoprotein ligand 
1 (PSGL1), lymphocyte function-associated antigen 1 (LFA1) and platelet 
endothelial cell adhesion molecule (PECAM1) (Ley et al., 2007; Shi and 
Pamer, 2011), together with chemotactic factors such as CSF1 and the 
chemokines CX3CL1 and CXCL12. Once in tissues, monocytes differentiate 
into mφ under control of CSF1 (Auffray et al., 2009; Fong et al., 1998; Pixley 
and Stanley, 2004). 
 
This view of mφ development has been challenged recently by the idea that 
conventional haematopoiesis in the bone marrow may not be the principal 
source of the resident mφ pool and that they may be derived from precursors 
that enter the tissues in foetal life, before self-renewing throughout adult 
life (Chorro et al., 2009; Ginhoux et al., 2010; Schulz et al., 2012). Using 
Csf1rmer-iCre-mer reporter gene mice, Schulz and collaborators proposed that 
mφ in skin, brain, lung, liver and pancreas are derived exclusively from YS-
derived precursors that self renew in tissues under control of the CSF1R 
ligands IL34 or CSF1 (Greter et al., 2012). In this model, pregnant dams 
receive a low dose of tamoxifen at 8.5 days post coitus (dpc) and only those 
cells expressing the CSF1R at that time will react to tamoxifen, due to their 
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expression of the mammalian oestrogen receptor (mer) under control of the 
CSF1R promoter. The mer in turn is linked to cre recombinase and after 
crossing to ROSA-STOP reporter mice, in which YFP has been inserted into the 
ROSA locus, with its expression normally prevented by an upstream lox P-
flanked (floxed) STOP codon. Therefore, by driving excision of the STOP 
codon, tamoxifen induces irreversible YFP expression by CSF1R bearing cells 
in the progeny of these mice. Although these findings have been challenged 
by evidence that the Langerhans cell precursors are derived from foetal liver 
(FL) rather than the yolk sac (YS), the overall conclusion remains that blood 
monocytes do not appear to contribute to the ontogeny of many tissue mφ 
such as Kupffer cells in the liver, microglia of the CNS and alveolar mφ 
(Geissmann et al., 2010; Ginhoux et al., 2010; Hoeffel et al., 2012; Schulz et 
al., 2012; Wang et al., 2012). Importantly however, none of these studies 
have examined intestinal mφ and indeed very little is known about their 
development or precursors.  
 
When I began my project, a PhD student in the laboratory had found that 
steady state mφ in mouse colon were derived via local differentiation of BM 
derived Ly6Chi monocytes (Bain et al., 2013). This process can be followed 
phenotypically, revealing individual stages based on their expression of 
CX3CR1, Ly6C and MHC II. When they first arrive in the intestine, the cells are 
identical to blood monocytes, being Ly6Chi MHC II- CX3CR1int and are referred 
to as P1. These then acquire MHC II expression (P2), before losing MHC II (P3) 
and finally becoming CX3CR1hi Ly6C- MHC II+ resident mφ (P4). Importantly, 
these phenotypic changes are accompanied by functional maturation. 
Recently arrived cells in P1 and P2 are fully responsive to TLR stimulation and 
produce TNFα, but have very little IL10 production or phagocytic activity. 
However these properties are acquired progressively as the mφ differentiate, 
together with expression of CD163 and CD206 and loss of TLR responsiveness 
(Bain et al., 2013). That this process needs to be maintained throughout life 
is suggested by the fact that there are reduced numbers of intestinal mφ in 
mice lacking CCR2, the chemokine receptors needed for egress of Ly6Chi 
monocytes from BM to tissues (Serbina and Pamer, 2006; Si et al., 2010). 
Together those findings have suggested that intestinal mφ may differ from 
those in other tissues by being derived from continuous replenishment by 
blood borne monocytes. However when and how this process becomes 
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established, or whether foetal precursors make any contribution to the 
intestinal mφ pool is unknown. Exploring these ideas were major aims of my 
project.  
 
1.6.3 Monocytes and macrophages in intestinal inflammation 
 
Intestinal mφ populations alter dramatically during infection or inflammation, 
such as that found in IBD (Serbina et al., 2008; Shi and Pamer, 2011; Si et al., 
2010). Under these conditions, there is an accumulation of proinflammatory 
monocytes and immature mφ, which retain TLR responsiveness and produce 
mediators such as IL1, IL6 and TNFα, as well as iNOS (Smith et al., 2011). 
These cells are crucial for killing microbes and for causing damage, as is 
shown by the success of targeting mφ products like TNFα and IL6 in human 
Crohn’s disease (Bain et al., 2013; Kaser et al., 2010; Maloy and Powrie, 
2011). Thus it would be important to understand the factors responsible for 
driving the steady state differentiation of monocytes into non-inflammatory 
mφ and how these processes are disrupted in inflammation. 
 
1.6.4 Is it a macrophage or a DC? 
 
A topic of much recent debate in the field of myeloid cell biology has been 
the relationship between mφ and DCs. This is particularly the case in the 
intestine due to the shared expression of several surface markers such as 
CD11b, CD11c and MHC II (Bain et al., 2013; Shortman and Liu, 2002). Initial 
studies assumed that all MHC II+ CD11c+ mononuclear phagocytes (MPs) were 
DCs, leading to considerable confusion about the relative roles of these cells 
in intestinal immune responses, as well as to the idea that Ly6Chi monocytes 
may give rise to both intestinal DCs and mφ (Bogunovic et al., 2009; Persson 
et al., 2013; Varol et al., 2007; Varol et al., 2009a). 
 
Distinguishing between mφ and DCs is important, as despite their phenotypic 
similarities, they play quite different roles in the intestinal immune response. 
Whereas DCs migrate to LN and prime T cells, LP mφ are sessile and cannot 
prime T cells, with their main role being as local scavenger cells (Johansson-
Lindbom et al., 2005; Schulz et al., 2009). For a time it was proposed that 
the mutually exclusive expression of CD103 and CX3CR1 could be used to 
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identify intestinal DCs and mφ respectively (Schulz et al., 2009). However as 
discussed above, it is now known that there is a populations of CD103- DCs 
that are CX3CR1int, meaning that additional markers are needed to be used 
(Cerovic et al., 2013). As part of ongoing work in our and other laboratories, 
a multiparametric strategy has been developed to do this, which is based on 
the expression of F4/80 and CD64 by mφ but not DCs (Bain et al., 2013; De 
Calisto et al., 2012; Persson et al., 2013; Tamoutounour et al., 2012). By 
allowing these cells to be identified precisely, this approach can be applied 
to characterising mononuclear phagocytes in new models and different mouse 
strains, as I will do here in neonatal and germ free mice.  
 
1.7 The intestinal microbiota 
 
Prenatal development takes place in a sterile environment, but at birth the 
newborn animal comes into direct contact with the maternal flora. This leads 
to the progressive establishment of a complex intestinal microbiota and to a 
host-bacterial mutualism (Kosiewicz et al., 2011; Macpherson and Harris, 
2004; Reading and Kasper, 2011; Round and Mazmanian, 2009). The density of 
bacteria increases going down the length of the gastrointestinal tract, with 
the stomach and proximal small intestine containing few organisms (101-103 
CFU/ml), whereas the colon contains up to 1012 microbes/ml of luminal 
contents (Figure 1.2) (Langhendries, 2005; Sartor, 2008). The exact number 
of intestinal bacteria and their species are not yet clear, as most are non-
culturable, but modern molecular biological techniques estimate that there 
may be 10 times more commensal bacteria as the number of cells in the 
human body, comprising of several hundred species. The majority of these 
are obligate anaerobes, with the Bacteriodetes phylum dominating, followed 
by Firmicutes (Figure 1.2) (Kosiewicz et al., 2011; Kuwahara et al., 2011; 
Langhendries, 2005).  
 
The result of this enormous colonisation is a symbiotic mutualism which 
benefits both the host and the bacteria (Inman et al., 2010a; Molloy et al., 
2012; Mulder et al., 2011). In addition to metabolising indigestible food 
compounds such as complex carbohydrates and producing vitamins (Hooper 
and Gordon, 2001; Round and Mazmanian, 2009), the commensal bacteria 
provide an important defence against pathogens by competing for nutrients, 
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space and surface receptors (Atarashi et al., 2011; Ewaschuk et al., 2008; 
Fagundes et al., 2011; Hans et al., 2000; Lamouse-Smith et al., 2011; 
Macpherson and Harris, 2004; Mazmanian et al., 2008; Ochoa-Reparaz et al., 
2010; Reading and Kasper, 2011; Seth et al., 2008; Smith et al., 2007). 
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Figure 1.2. Composition of dominant microbial species in various regions 
of the human gastrointestinal tract. Adapted from Sartor, 2008. 
	   41	  
 
As well as being beneficial for normal health, commensal bacteria are also 
potentially harmful, producing sepsis if they gain access to the mucosa and 
systemic tissues (Madan et al., 2012). Furthermore, all experimental models 
of IBD are entirely dependent on the presence of the microbiota (Elson et al., 
2005). Because so many bacteria are separated from the intestinal 
environment by only a single layer of epithelium, the host has evolved a 
sophisticated array of mechanisms to maintain the microbiota at arm’s length 
and prevent inappropriate immune responses (Artis, 2008; Dahan et al., 2007; 
Sonnenberg et al., 2012). These include many of the innate immune 
mechanisms discussed above, such as mucus production, epithelial tight 
junctions and antimicrobial peptides, as well as antigen specific mechanisms 
involving regulatory T cells and IL10, and immunity mediated by IL22 and 
Th17 cells (Atarashi et al., 2011; Hadis et al., 2011; Ivanov et al., 2009; 
Natividad et al., 2012; Ostman et al., 2006; Pearson and Brownlee, 2010; 
Ueda et al., 2010; Wu et al., 2010). Importantly, defects in all these 
processes have been associated with susceptibility to IBD under experimental 
conditions. 
 
1.8 Tonic effects of the microbiota on intestinal function 
 
Although germ free (GF) animals can be maintained for long periods, this has 
severe effects on many aspects of metabolism and immune function (Sartor, 
2008; Tlaskalova-Hogenova et al., 2011). GF mice have decreased cellularity 
in Peyer’s patches, delayed or absent maturation of isolated lymphoid 
follicles (ILFs), immaturity of epithelial cells and slower epithelial turnover 
rates (Abrams et al., 1963; Bouskra et al., 2008; Macpherson and Harris, 
2004). Additionally, the normal maturation of the mucosal immune system is 
dependent on the presence of microbiota and colostrum, with germ free mice 
showing a general paucity of lymphocytes, with fewer IgA producing plasma 
cells in both systemic and intestinal lymphoid tissues, as well as low serum 
immunoglobulins (Atarashi et al., 2008; Bauer et al., 1963; Benveniste et al., 
1971; Macpherson and Harris, 2004). 
 
Administration of broad-spectrum antibiotics reproduces many of the effects 
of the GF state, including amelioration of colitis (Cummings et al., 2003; 
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Guarner and Malagelada, 2003; Hans et al., 2000; Videla et al., 1994), 
impairment of IFN dependent mφ activation, NK cell priming and mφ 
activation during virus infection (Abt et al., 2012; Ganal et al., 2012). There 
are also decreased numbers of Th17 cells in the LP and a concomitant 
increase in Foxp3+ Treg cells. Antibiotic treatment also decreases Paneth cell 
function and MHC II expression in the small intestine (Ivanov et al., 2008; 
Schumann et al., 2005). Interestingly, a recent report has suggested that 
modulation of the intestinal microbiota by antibiotic treatment of pregnant 
mice can have longterm effects on the offspring, impairing their antibody 
production (Lamouse-Smith et al., 2011). 
 
Interestingly it has also been reported that colonic CD11b+ CD11c- MPs from 
GF mice produce less IL10 than their conventional counterparts and are fully 
responsive to LPS stimulation, although the exact nature of these cells was 
not defined precisely (Ueda et al., 2010). Furthermore, these effects are only 
partial and subsequent work suggested that they were not dependent on the 
TLR signalling adapter MyD88, making these effects difficult to interpret 
mechanistically (Rivollier et al., 2012). Although all those defects caused by 
lack of the microbiota can be reversed by colonisation with normal 
commensal bacteria, it has been suggested that this must occur within a 
narrow time window after birth, as reconstitution of GF mice can restore 
innate immune responses when given during the first week of age, but not at 
5 weeks of age.  
 
1.9 Modulation of immune responses by the microbiota 
 
The wider impact of commensal microbes in health and disease is highlighted 
by the hygiene hypothesis. First put forward by Strachan, this proposes that 
the reduced number of microbes found in the cleaner environment of 
industrialised countries, together with the wider use of antibiotics has led to 
an over-reactive immune system (Strachan, 1989). This theory is supported by 
evidence that the incidence of allergy, IBD and autoimmune diseases has 
increased dramatically in industrialised countries in the last 50 years. The 
immune response of newborns is characterised by a bias towards a T-helper-2 
(Th2) cytokine profile (Rowe et al., 2000), the kind of response which causes 
allergic diseases, such as asthma and atopic dermatitis. However, once the 
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newborn gut has been colonised with commensals and has been in contact 
with bacterial and food antigens, the cytokine profile normally reaches a 
more balanced Th1/Th2 state (Romagnani, 2004; Strachan, 1989). Consistent 
with the hygiene hypothesis, a number of reports highlight the 
proinflammatory effect of being brought up in a clean environment, as shown 
by delayed epithelial maturation, accumulation of DCs, Th17 cells and CD4+ 
CD25+ T cells, along with a concomitant decrease in Foxp3+ Tregs. 
Additionally, animals reared in high hygiene conditions produced more type I 
IFN, IL22, and IL23 (Inman et al., 2010a; Lewis et al., 2012; Mulder et al., 
2011). It is for this reason that abnormal microbial colonisation (dysbiosis) 
has been proposed to be a predisposing factor in atopic disease and it is 
assumed that analogous processes may be involved in susceptibility to 
Th1/Th17 driven inflammatory diseases such as IBD, rheumatoid arthritis and 
others (Seiderer et al., 2008; Siddiqui et al., 2010; Wu et al., 2010). 
 
Not surprisingly, many of the immunomodulatory effects of the microbiota 
have been described in the intestine itself. These include decreased 
responsiveness to TLR ligands in LP mφ, increased regulatory T cell 
development and skewed production of antibodies towards secretory IgA 
rather than IgG antibodies. More distally, it is now clear that the microbiota 
can impact on the immune response throughout the body, influencing the 
outcome of diabetes, atherosclerosis and viral infections (Abraham and 
Medzhitov, 2011; Abt et al., 2012; Sartor, 2008; Tlaskalova-Hogenova et al., 
2011). Although the precise mechanisms that link individual bacterial species 
to different aspects of health and disease are mostly unclear, a well-known 
example is segmented filamentous bacteria (SFB). These were first 
discovered in studies of IgA production in mouse intestine (Jiang et al., 
2004), but have received attention recently after studies showing that the 
numbers of Th17 cells in the intestine between mice from different suppliers 
correlated with the presence or absence of SFB (Denning et al., 2011; Ivanov 
et al., 2009). In accordance with this, monocolonisation of GF mice with SFB 
was then shown to produce an expansion of IL17 and IL22 producing CD4+ T 
cells in the LP, as well as stimulating the production of secretory IgA. SFB 
driven expansion of Th17 cells and auto-antibodies has also been related to 
autoimmune arthritis (Chappert et al., 2013; Gaboriau-Routhiau et al., 2009; 
Wu et al., 2010). The specific mechanisms involved in these effects of SFB 
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are still to be defined, but have been associated with the production of 
serum amyloid A, which in turn may induce intestinal DCs to promote a Th17 
cell environment (Ivanov et al., 2009). On the other hand, the administration 
of capsular polysaccharide A (PSA) derived from Bacteroides fragilis induces 
IL10 production together with reduction of IL17 and TNFα production by CD4+ 
T cells (Mazmanian et al., 2008). Other studies have also shown that certain 
Clostridia species can induce the development of Foxp3+ cells in mouse 
intestine (Atarashi et al., 2011) and more recently, similar organisms have 
been isolated from human intestine, generating Treg, IL10 production 
through TGFβ dependent mechanisms (Atarashi et al., 2013). 
 
Other examples of organisms of this kind remain to be identified and 
although there are now several diseases which have been associated with 
dysbiosis of the microbiota, the role of individual organisms remains mostly 
unproven. There is evidence that patients with active IBD have imbalances in 
their commensal bacterial populations, with increased proportions of 
Proteobacteria and Actinobacteria and decreases in Firmicutes and 
Bacteroidetes (Frank et al., 2007). Whether these changes are cause or effect 
remains to be established. Some specific organisms that have been associated 
with Crohn’s disease include Mycobacterium paratuberculosis and more 
recently, enteroadhesive E. coli, which has been shown to colonise the ileum 
of Crohn’s disease patients (Barnich and Darfeuille-Michaud, 2007; Chiodini, 
1989; Frank et al., 2007; Sartor, 2005). Additionally, deficiency of a member 
of the Firmicutes family Faecalibacterium prautsnitzii has been associated 
with higher risk of recurrence of ileal CD and this is consistent with F. 
prautsnitzii normally favouring IL10 production and reducing IL12 and IFNγ 
production by blood mononuclear cells. Finally, oral adiminstration of F. 
prautsnitzii reduces severity of TNBS (2,4,6-tinitrobenzene sulfonic acid) 
colitis (Sokol et al., 2008). 
 
In all these cases, it has been difficult to prove whether the relevant 
organisms are acting as pathogens or simply reflect altered balance within 
the overall microbiota, or if their presence is a cause or an effect of the 
disease. 
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In summary, colonisation of the intestine is initiated at birth and has a 
profound influence on intestinal and systemic immune responses. However, 
the cellular mechanisms are still being explored and interestingly, little is 
known about how the microbiota affects intestinal mφ behaviour, despite the 
proximity of these cells to the lumen and their clear role in dealing with local 
bacteria. Therefore one aim of my project was to use our refined analysis 
protocols to explore the influence of microbiota on mφ development. 
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1.10 Chemokines 
 
Chemokines are a family of small proteins (8-14 kDa) that coordinate 
leukocyte trafficking, adhesion and homing (Zimmerman et al., 2008; Zlotnik 
and Yoshie, 2000). Even though all chemokines share structural similarities, 
they can be classified into four subgroups according to the number and 
spacing of the first two cysteines in a conserved cysteine structural motif (C, 
CC, CXC and CX3C). They signal through G-protein-coupled receptors to 
stimulate a number of cellular responses, but are best known for their ability 
to induce migration of cells, which may be directional if a gradient is present 
(D'Haese et al., 2010). Originally, chemokines were described as attractants 
for leukocytes, therefore regarded as proinflammatory. However other 
chemokines were constitutively expressed in lymphoid and mucosal tissues 
and increasing evidence suggests chemokines may also be important in 
development and homeostasis (Kunkel et al., 2003; Nishimura et al., 2009). 
 
Homeostatic chemokines are expressed constitutively in normal tissues and 
mediate migration of leukocytes in steady state, whilst inflammatory 
chemokines are upregulated in response to inflammation. In practice 
however, there may be overlap between these groups, with some chemokines 
having both homeostatic and inflammatory roles (Le et al., 2004). 
Chemokines play two roles in the extravasation of leukocytes from the 
bloodstream. First, chemokines presented on the surface of vascular 
endothelial cells induce increased affinity of leukocyte integrins on 
leukocytes, allowing them to bind more strongly to endothelial adhesion 
molecules inducing the cells to stop. Secondly, chemokines present in the 
tissue parenchyma attract leukocytes to move through the vascular 
endothelium into the tissues (Butcher and Picker, 1996; Johnson et al., 2005; 
MacDermott et al., 1998; Zlotnik and Yoshie, 2000).  
 
Apart from the functions mentioned above, chemokines and their receptors 
can play an important role in mucosal immunity, influencing particularly the 
cell migration, or homing of effector/memory cells from regional lymph 
nodes to the mucosal-associated sites (Bono et al., 2007; Forster et al., 2008; 
Le et al., 2004). Several chemokines and their receptors have been 
associated with the promotion/regulation of homing mechanisms, examples 
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being CCR9-CCL25 (Rivera-Nieves et al., 2006), CCR10-CCL28 (Pan et al., 
2000) and less gut homing specific, such as CCL5 and CCR7 (Thomas and 
Baumgart, 2011; Zimmerman et al., 2008). Amongst the chemokine receptors 
studied, it has been previously reported that CCR2 (CCL2 receptor) plays a 
key role in monocyte recruitment during inflammation and work from our lab 
has confirmed that this also happens in the intestine (Bain et al., 2013; 
Serbina and Pamer, 2006). Additionally it has been described that colonic mφ 
express high levels of CX3CR1 (the CX3CL1 receptor), although more detailed 
information about the specific role of these chemokines in the intestine is 
required. Therefore my project focused on these two particular chemokine 
receptors 
 
1.10.1 CCR2 
 
CCR2 is a member of the CC chemokine family that is expressed as a cell 
surface G-protein linked receptor. The known ligands for CCR2 are CCL2 
(MCP1), CCL7 (MCP3), CCL8 and CCL12, which can be produced by epithelial 
cells, endothelial cells and mesenchymal cells in response to activation by 
proinflammatory cytokines or stimulation via innate immune receptors 
(Rollins and Pober, 1991; Serbina et al., 2012; Struyf et al., 1998; Tsou et al., 
2007; Tsuboi et al., 2002). The best known role for CCR2 is in the 
accumulation of the Ly6Chi subset of monocytes at sites of inflammation, 
although the exact role of CCR2 in the entry of monocytes into tissues can be 
difficult to determine because CCR2 plays a crucial role in the egress of these 
monocytes from BM (Boring et al., 1997; Engel et al., 2008; Serbina et al., 
2008; Si et al., 2010). CCR2 has also been shown to be required for 
recruitment of inflammatory monocytes to the intestine during T. gondii, 
Listeria monocytogenes infection and experimental colitis (Platt et al., 2010; 
Serbina et al., 2008; Serbina and Pamer, 2006). As noted above, the idea that 
CCR2 dependent accumulation of monocytes is only important in intestinal 
inflammation has been challenged by the recent work in our laboratory which 
indicates that CCR2+ Ly6Chi monocytes appear to replenish steady state 
intestinal mφ (Bain et al., 2013). This is supported by other work showing 
that the accumulation of IL10 producing intestinal mφ in normal intestine is 
dependent on CCR2 and its ligand CCL2 (Feterowski et al., 2004). More 
recently it has also been suggested that CCR2 dependent monocytes actually 
	   48	  
play a protective role in the intestinal inflammation associated with T. gondii 
infection, by encouraging tissue repair and inhibiting pathogenic neutrophil 
activity (Grainger et al., 2013). Thus the role of CCR2 in regulating intestinal 
mφ recruitment and function remains uncertain. Furthermore it is unknown if 
CCR2 plays a role throughout life, or if the possible involvement of non BM-
derived precursors in early tissue mφ development might overcome a need for 
CCR2. Finally other receptors such as CCR1 and CCR5 have been implicated in 
monocyte recruitment (Lebre et al., 2011; Tokuyama et al., 2005). The 
effects of CCR2 or other mechanisms have never been examined in neonatal 
intestine and this was one of the aims of my project. 
 
1.10.2 CX3CR1 
 
The CX3CL1/CX3CR1 axis has been implicated in a number of models of 
inflammation, pain, cancer, neurodegenerative diseases, pancreatic disease, 
fibrogenesis and even mood disorders (D'Haese et al., 2010; D'Haese et al., 
2012).  
 
CX3CR1 is the only member of the CX3CR family and its ligand is CX3CL1 
(fractalkine). CX3CL1 can be produced as a membrane-bound chemokine, in 
which a chemokine/mucin hybrid domain is linked to a transmembrane 
domain, or as a soluble molecule following its cleavage from the cell surface 
by ADAM10 and ADAM17/TACE (tumour-necrosis factor alpha converting 
enzyme) during inflammation (Andrzejewski et al., 2010; Bazan et al., 1997; 
Garton et al., 2001; Hundhausen et al., 2003; Pan et al., 1997; Tsou et al., 
2001). The membrane-bound form of CX3CL1 is expressed by epithelial cells 
in the lung, bronchus and intestine, as well as by tubular and glomerular 
epithelial cells in the kidney and by vascular endothelial cells (Durkan et al., 
2007). Its production by epithelia can be increased by stimulation with pro-
inflammatory cytokines, such as TNFα (D'Haese et al., 2010; Fong et al., 
1998; Sans et al., 2007).  
 
Regarding mucosal immunity, it is believed that membrane-bound CX3CL1 
acts as an adhesion molecule, promoting the local retention of receptor 
bearing leukocytes and the formation of TEDs by intestinal mφ (Ancuta et al., 
2003; Imaizumi et al., 2004; Muehlhoefer et al., 2000; Niess et al., 2005; 
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Owlasiuk et al., 2009). Additionally, reports suggest that inflammation can 
enhance the expression of the membrane bound form of CX3CL1. In vitro 
stimulation of human intestinal microvascular endothelial cells with TNFα 
and IFNγ enhances CX3CL1 expression and clinical studies have shown that 
increased CX3CL1 mRNA expression in inflamed lesions of Crohn´s disease 
(Nishimura et al., 2009; Sans et al., 2007) and IL8 induces increased 
expression of mRNA for CX3CL1 by a colonic epithelial cell line (Brand et al., 
2006). 
 
Conversely, the functions of the shed isoform of CX3CL1 remain poorly 
defined, especially in regard to mφ or its role in mucosal immunity. However 
it is thought to induce chemotaxis of CX3CR1+ leukocytes and is also 
associated with myositis (Suzuki et al., 2012). It may promote survival of 
Ly6Clo blood monocytes (Kim, 2011; Landsman et al., 2009) and it has 
recently been reported to be necessary for neuroprotection in a model of 
Parkinson’s disease, while its presence has been associated with mild to 
moderate Alzheimer’s disease (Kim, 2011; Kim et al., 2008; Morganti et al., 
2012).  
 
CX3CR1 is considered to be a myeloid specific marker, being present no only 
on monocytes or intestinal macrophages, but also in microglia in the central 
nervous system, some DCs and NK cells (Fong et al., 1998; Imai et al., 1997; 
Kim, 2011). Very interestingly, one of the most characteristic features of 
mature intestinal mφ is their expression of very high levels of CX3CR1 (Bain et 
al., 2013; Cerovic et al., 2013; Hamann et al., 2011; Kim, 2011; Mionnet et 
al., 2010), although its precise role in the intestine has yet to be defined. 
The presence of CX3CR1+ cells correlates with increased risk of relapse in 
breast cancer patients (Andre et al., 2006) and expression of CX3CL1 by local 
vascular cells may promote tumour development by inducing angiogenesis via 
a VEGF-A/KDR (kinase insert domain receptor)- dependent pathway (D'Haese 
et al., 2010; Ryu et al., 2008). 
 
Despite the high expression of CX3CR1 by steady state intestinal LP mφ, little 
is known about its role in the function of these cells. Most evidence from 
models of colitis suggests that the CX3CL1-CX3CR1 axis plays a 
proinflammatory role in the intestine (Kayama et al., 2012; Kostadinova et 
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al., 2010; Niess and Adler, 2010). However, conflicting data has shown that 
CX3CR1 KO mice are actually more susceptible to colitis (Kim, 2011; Medina-
Contreras et al., 2011), and these mice are also resistant to the induction of 
oral tolerance secondary to a failure of LP mφ to produce IL10, needed for 
the secondary expansion of Foxp3+ Tregs in the mucosa (Hadis et al., 2011).  
In view of this lack of information and contradictory findings, one of my 
project aims was to examine how CX3CR1 influenced mφ populations in the 
intestine and to investigate the effects of CX3CL1 on mφ function. 
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1.11 Thesis aims 
 
It is clear that although the development and functions of intestinal 
macrophages depend on a wide array of local factors, much remains to be 
determined about their origin and the regulatory mechanisms involved. 
 
Thus, the central aim of this thesis was to gain knowledge about colonic 
macrophage development, by following their numbers, phenotype and 
functions from just before birth until adulthood. In order to do this, the 
experiments shown in Chapter 3 adapted techniques which had been 
established in the laboratory for isolating and characterising mφ from adult 
intestine and analysed neonatal mφ using multi parametric flow cytometry 
and real time quantitative PCR. In addition, I examined the relative 
contributions of foetal precursors and classical monocytes to the origin of 
intestinal mφ, using fate mapping models and CCR2 deficient mice. In 
Chapter 4, I then explored how colonic macrophages were influenced by the 
microbiota, first by treating adult mice with broad-spectrum antibiotics, and 
then using germ free mice. Finally in Chapter 5, I investigated the role of 
CX3CL1 and its receptor on macrophage function during steady state and 
inflammatory conditions. I also performed in vitro analysis of bone marrow-
derived macrophages co-cultured with cell lines expressing either the soluble 
or membrane bound form of CX3CL1 to assess how the chemokine influenced 
the activation status of macrophages. 
  
 
 
 
 
 
 
 
Chapter 2 
Materials and methods 
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2.1 Mice 
 
All the mice used were on C57/Bl6 background unless stated otherwise. All 
experiments were carried out according to UK Home Office regulations. 
 
CX3CR1GFP/GFP mice (Jung et al., 2000) were originally obtained from 
Professor William Agace (Lund University, Sweden), bred and kept at the 
University of Glasgow Veterinary Research Facility or the Central Research 
Facility and maintained on conventional diet until use.  
 
CCR2 null mice (Boring et al., 1997) were kindly provided by Dr Robert Nibbs 
(University of Glasgow) and originally obtained from Jackson Laboratories 
(Maine, USA). 6-8-week-old WT mice for the oral priming experiments were 
purchased from Harlan UK (Bicester, Oxfordshire).  
 
For studies on foetal or neonate animals, CX3CR1GFP/+ litters were obtained 
after mating a CX3CR1GFP/GFP male with C57/Bl6 females. For timed 
pregnancies, mice were mated in harem system and presence of vaginal plug 
was considered as gestation day 0.5. 
 
Csf1rmer-iCre-Mer; RosaLSL-YFP and Flt3-Cre; Rosa26-YFP mice were kindly provided 
by Professor Frederic Geissmann’s lab (King’s College London, UK). 
 
Germ free mice and their conventional counterparts were all in the C57/Bl6 
background with the exception of one set of 3-week-old mice, which were on 
a Rag-deficient background. All animals were kindly provided by Dr David 
Artis’ lab (University of Pennsylvania, USA). 
 
2.2 Treatment of mice with antibiotics 
 
For the simple antibiotics scheme mice received 50mg/kg Meropenem and 
Vancomycin (both from Hospira, UK Limited) plus artificial sweetener 
(Sweetex, Reckitt Benckiser Household, UK) in drinking water for different 
periods of between 10 and 22 days. For the broader scheme, 500mg/kg 
ampicillin, gentamicin, metronidazole, neomycin (Roche) and vancomycin 
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(250mg/kg) were administered to mice for either 10 or 21 days. Control mice 
received sweetened water only. Antibiotic solutions were made up 
immediately before giving use and were replaced every other day. 
 
2.3 Isolation of colonic lamina propria cells 
 
Mice were culled by cervical dislocation (or with CO2 overdose when blood 
was collected), colons were carefully removed and soaked in non-sterile PBS. 
Residual fat and faeces were removed, the colons opened longitudinally and 
washed in Hank’s Balanced Salt Solution (HBSS) 2% FCS (Sigma) and ~5mm 
segments cut. The segments were placed in 10ml of HBSS 2% FCS at 4ºC for 
storage, before being shaken vigorously and supernatants discarded by 
passing them through nitex mesh (Cadisch, London). The pieces of colon were 
then incubated in 10-15ml of HBSS 1mM EDTA in a shaking incubator at 37ºC 
for 15 min. After incubation, the supernatants were discarded, the samples 
were rinsed with pre-warmed HBSS and then incubated further 30 min. Next, 
the colon pieces were rinsed again before being incubated in complete RPMI 
1640 (2mM L-glutamine, 100µg/ml penicillin, 100µg/ml streptomycin, 
1.25µg/ml fungizone, and 10% FCS) containing 0.85mg/ml collagenase V 
(Sigma), 1.25mg/ml collagenase D (Roche), 1mg/ml Dispase (Gibco) and 
30µg/ml Dnase (Roche) for another 25-45 min with constant observation. To 
ensure complete digestion, the samples were shaken vigorously every 5-10 
min and the resulting cells were passed through a 40µm cell strainer (BD, 
Biosciences), centrifuged at 400g at 4ºC for 5 min, resuspended in FACS 
buffer, counted and kept at 4ºC until use. If necessary, the enzymatic 
digestion step was repeated in order to achieve proper tissue disruption. For 
isolation of LP cells from 7-day-old or younger mice, the guts were not 
opened nor emptied before digestion due to their size and fragility.  
 
2.4 Generation of bone marrow-derived macrophages (BMM) 
 
Bone marrow (BM) was flushed out of the femurs and tibiae of healthy adult 
mice in RPMI 1640 (Gibco BRL, Paisley, Scotland) using a syringe and a 26G 
needle. The BM cells were transferred into a sterile 15ml tube and counted 
using a haemocytometer and phase contrast microscope. In some cases, 
erythrocytes were removed using red blood cell lysis buffer (Sigma). Next, 
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1ml of cell suspension containing 3x106 cells was transferred into 90cm Petri 
dishes (Sterilin, UK) and cultured in complete RPMI 1640 medium, plus 10% M-
CSF (supernatant from the L929 fibroblast cell line) at 37ºC in 5% CO2. After 
three days, the medium was supplemented with 5ml of CRPMI plus 2ml of M-
CSF and incubated for 3 more days. On day 6, non-adherent cells were 
discarded and adherent cells were harvested by adding 1mM EDTA/PBS for 5 
min and then displacing them with cell scrapers (Costar). The resulting cells 
were then washed before use and were tested for viability and presence of 
F4/80 and CD11b by flow cytometry. 
 
2.5 CX3CL1-expressing HEK cells 
 
Human embryonic kidney cell lines (HEK293) modified to express either 
membrane-bound or soluble CX3CL1, as well as wild type HEK cells were 
kindly provided by Professor Andreas Ludwig (Aachen University, Germany) 
(Andrzejewski et al., 2010). Due to their original transfection with 
lipofectamin, the presence of 500µg/ml geneticin (Gibco, UK) in DMEM 10% 
FCS selects only cells with stable expression CX3CL1 and cells cultures had to 
be allowed to grow for at least two weeks before working with each newly-
defrosted aliquot.  
 
2.6 Culture of BMM with LPS and FKN 
 
BMM suspensions at 1x105 or 1x106 cells/ml of CRPMI were cultured in ultra-
low attachment 24-well plates (Costar) in the presence of different 
concentrations of recombinant fractalkine (rCX3CL1; R&D Systems) and S. 
tyhpimurium LPS (Sigma), for varying times before being harvested and 
assessed for viability and expression of CD40, CD80, CD86, MHC II and CX3CR1 
by flow cytometry. Culture supernatants were collected and stored at -20ºC 
until used for measurement of cytokines by ELISA. 
 
2.7 Co-culture of BMM with CX3CL1-expressing HEK cells  
 
HEK cells were used at decreasing concentrations, starting at 1x106. 
Conventional or CX3CL1 expressing HEK cells were cultured in 24-well low-
adherence plate overnight before BMM were added and incubated for a 
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further 24h. Next, 100ng/ml of LPS was added to each well for a final period 
of 24h and the BMM analysed for viability, phenotype and cytokine production 
as described above. 
 
2.8 Measurement of antigen-specific proliferative and cytokine 
responses in vitro 
 
Single cell suspensions were obtained by mashing spleen and MLN through 
sterile nitex mesh in RPMI 1640 medium. After washing by centrifugation at 
400g for 5 min at 4ºC, the cells were resuspended in CRPMI, counted, 
adjusted to 1x106 cells/ml and 200µl added in triplicate to 96-well round-
bottomed plates in the presence or absence of 500µg/ml OVA (Sigma) or 
1µg/ml anti-CD3 and anti-CD28 (both from BD, Biosciences). After 48h culture 
at 37ºC, ~200µl supernatant was collected and stored at -20ºC for 
measurement of cytokines by ELISA and the medium was replaced. To 
measure proliferative activity, cells were cultured for a total of 96 hr with 
1µCi tritiated thymidine (3H-TdR) (Western Infirmary radionucleotide 
dispensary) being added for the final 18 hours of culture. Cellular DNA was 
then harvested onto glass fibre filter mats (Wallac, Perkin Elmer, UK) and 
thymidine uptake was measured using a scintillation counter. 
 
2.9 Measurement of cytokines by ELISA 
 
Immulon 4 plates (Corning) were pre-coated with 1µg/ml purified anti-IL-6 or 
2µg/ml anti-TNF-α (both from BD Biosciences, Table 2.1) capture antibodies 
in carbonate-bicarbonate coating buffer (Sigma) and incubated at 4°C 
overnight. The plates were washed three times with PBS/0.05% Tween 20 
(Sigma), 200µl of blocking buffer (PBS/10% FCS) was added to each well and 
the plates incubated for 1h at 37°C. After three more washes, serial dilutions 
of standards and samples were incubated for 2h at 37°C, before the plates 
were washed again and incubated with 50µl of biotinylated anti IL-6 (1µg/ml) 
and anti TNF-α (2µg/ml) detection antibodies (BD Biosciences, Table 2.1) for 
1h at 37°C. The plates were then washed and incubated with 1:1000 dilution 
of extravidin-peroxidase (Sigma) for 40 min. After washing, the plates were 
developed using 50µl of tetramethylbenzidine (TMB) substrate (KPL) and 
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stopped by adding 1N sulphuric acid. Optical densities were then obtained 
using a Dynex MRX TC Microplate reader at 450nm wavelength. 
 
2.10 Measurement of OVA-specific antibodies and total immunoglobulins 
in serum by ELISA 
 
Blood samples were centrifuged at 13000g at 4ºC for 20 min, serum collected 
and stored at -20ºC until use. To measure OVA specific antibodies by ELISA, 
flat-bottomed Immulon 96-well plates were coated with 10µg/ml OVA in 50µl 
PBS coating buffer overnight at 4ºC. For detection of total IgG and IgA, plates 
were coated with appropriate coating antibodies (Table 2.1). The plates were 
then washed with PBS Tween (0.05%) and blocked with PBS 3% BSA for 1 hour, 
before being washed again and doubling dilutions of serum samples added, 
followed by double serial dilutions. After incubating overnight at 4ºC, the 
plates were washed and 75µl biotin-conjugated detection antibodies were 
added at the appropriate concentration (Table 2.1) and incubated at 37ºC for 
one more hour. After washing, 50µl of 1:1000 extravidin peroxidase (Sigma) 
were added to each well for 45-60 min at 37ºC. Finally, plates were washed 
and developed by adding 50µl TMB, followed by 50µl 1N sulphuric to stop the 
reaction and the plates were read at 630nm using the microplate reader 
(Dynex). 
 
2.11 Measurement of OVA-specific and total IgA in faeces 
 
Faeces were removed from colon into ice-cold protease inhibitor cocktail 
(complete mini, Roche Diagnostics, Germany) PBS 50mM EDTA. After 
centrifugation at 1500g for 10 min, the supernatants were transferred to 
fresh 1.5ml tubes and 10µl of 100mM phenylmethylsulfonyl (PMSF; Sigma) in 
95% ethanol was added followed by centrifugation at 14000g for 30min at 
4ºC. Finally, 10µl PMSF solution, 10µl of 1% sodium azide (Sigma) and 50µl FCS 
were added to the resulting supernatants and were stored at -20ºC until 
used. Total and OVA specific IgA levels were measured by ELISA as described 
above. 
	  Table 2.1. Antibodies used for measurement of antibodies in serum and faeces  
 
 
Use Antibody Capture/detection Working 
concentration 
Source 
Total IgG Anti mouse IgG (Fc specific) 
Alkaline phosphatase ab 
 
Capture 1:40000  Sigma 
Total & OVA 
specific IgG 
Anti mouse IgG (Fab specific) 
biotin ab (produced in goat) 
 
Detection 1:200000 Sigma 
Total IgA Purified rat anti mouse IgA 
 
Capture 1:500 BD Biosciences 
Total & OVA 
specific IgA 
Biotin rat anti-mouse IgA 
 
Detection 1:500 BD Biosciences 
OVA specific 
IgG1 
Biotin rat anti mouse IgG1 
 
Detection 1:16000 BD Biosciences 
OVA specific 
IgG2a 
Biotin rat anti mouse IgG2a Detection 1:1000 BD Biosciences 
	       
Use Antibody Capture/detection Working 
concentration 
Source 
IL6 Purified rat anti mouse IL6 Capture 1:25000 BD Pharmigen 
IL6 Biotin rat anti mouse IL6 Detection 1:25000 BD Pharmigen 
TNF α Purified hamster anti mouse Capture 1:12500 BD Biosciences 
TNF α Biotin human anti mouse Detection 1:12500 BD Pharmigen 	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2.12 Induction of DSS colitis 
 
Mice were fed 2% DSS in their drinking water for up to 8 days and the disease 
progression monitored by measuring weight loss, clinical score (Table 2.2) 
and colon length. In accordance with the Home Office regulations, mice were 
sacrificed if they lost >20% of their original body weight.  
	  Table 2.2. Points system for evaluation of DSS induced colitis severity 
 
 
Score % Weight loss 
compared to steady 
state 
Rectal bleeding Stool 
0 
 
No weight loss None Well formed pellets 
1 
 
1-5 Blood traces in faeces Well formed pellets 
2 
 
5-10 Blood stains in bedding 
and cage 
Softer pellets 
3 
 
 
10-15 Blood stains around 
anus 
Pasty faeces adhered to 
anus 
4 15-20 Gross bleeding Diarrhoea  	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2.13 Flow cytometry 
 
Surface staining. 1-5x106 cells were added to FACS tubes and Fc receptors 
blocked by incubating with a 1:200 dilution of purified anti-mouse CD16/CD32 
(Fc block, BD Biosciences) and incubated for 20 min at 4ºC. Next, cells were 
washed with FACS buffer, and the incubated for 20 min at 4ºC with relevant 
fluorochrome-conjugated antibodies, as detailed in Table 2.3. Cells were 
then washed in FACS buffer twice before be acquired on LSRII or AriaI (BD 
Bioscience). 
 
Intracellular staining. For assessment of intracellular cytokine production, 
4x106 cells in 1ml were incubated in sterile FACS tubes with 1µM monensin 
(Biolegend) and 10µg/ml Brefeldin A (Sigma) at 37ºC for 4.5 hrs. After 
washing with PBS, the cells were then incubated with 1:1000 dilution of 
violet viability dye (Molecular Probes; Life Technologies) or fixable viability 
dye eFluor 780 (eBioscience) in PBS in the dark at 4ºC for 30 min, washed in 
FACS buffer, blocked with Fc block and stained for surface markers as above, 
except that PBS was used instead of FACS buffer. After a further wash, the 
cells were fixed with 1% paraformaldehyde (or 4% if cells were obtained from 
CX3CR1gfp/+ reporter mice) for 10 min, washed once in FACS buffer and once 
in Perm wash (PBS 0.1% NaN3 0.1% BSA 0.2% FCS 0.1% saponin). These cells 
were then blocked again with 1:200 Fc block in Perm stain buffer (PBS 0.1% 
NaN3 0.1% BSA 1% FCS 0.1% saponin) for 20 min at 4ºC, washed in Perm wash 
and stained for intracellular cytokines in 1:100 dilution Perm stain buffer. 
Finally, the cells were washed in Perm wash, resuspended in FACS buffer and 
analysed by flow cytometry. 
 
For the assessment of Ki67 expression by colonic isolates, 3-4x106 cell 
suspensions were incubated with fixable viability and stained for the 
appropriate surface markers as described above. Next, cells were 
resuspended in 200µl of Foxp3 fixation/permeabilisation working solution and 
incubated overnight at 4ºC. Next, cells were washed in PermWash, Fc 
blocked for 15 min and then incubated with Ki67 fluorochrome-conjugated 
antibody for further 30min. Finally, cells suspensions were washed and 
resuspended in FACS buffer before acquisition. 
	  Table 2.3. List of antibodies for surface and intracellular FACS analysis. Primary antibodies were conjugated to either FTIC, 
PE, PerCP-Cy5.5, PE-Cy7, APC, APC-Cy7, Alexa Fluor 700, BD Horizon V450, V500 or biotinylated and conjugated to Streptavidin 
Q-dot 605 (Molecular probes, Invitrogen UK). 
 
 
Cellular 
marker 
Working 
concentration 
Isotype Clone Source 
CD3α 1:200 Armenian 
hamster IgG1 
 
15-2C11 BD biosciences 
CD11b 1:200 Rat 
IgG2b 
 
M1/70 BD 
biosciences 
CD11c 1:200 Armenian 
hamster IgG1 
 
HL3 BD biosciences 
CD19 1:200 Rat IgG2a 
 
1D3 BD biosciences 
CD40 1:200 Rat IgG2a 
 
3/23 BD biosciences 
CD45 1:200 Rat IgG2a 
 
30-F11 BD biosciences 
CD45.2 1:200 Mu IgG2a 
 
104 BD biosciences 
     
	  Cellular 
marker 
Working 
concentration 
Isotype Clone Source 
CD49b 1:200 Rat IgM 
 
DX5 BD biosciences 
CD64 1:200 Rat IgG1 
 
X54-5/7.1 Biolegend 
CD80 1:200 Armenian 
hamster IgG2 
16-10A1 BD biosciences 
CD86 1:200 Rat IgG2a 
 
GL1 BD biosciences 
F4/80 1:200 Rat IgG2a 
 
BM8 BD biosciences 
IL-10 
(intracellular) 
1:100 Rat IgG2b 
 
JES5-16E3 BD biosciences 
Ly6C 
 
1:200 Rat IgM AL-21 BD biosciences 
Ly6G 
 
1:200 Rat IgG2a 1A8 BD biosciences 
MHC II  
 
1:600 Rat IgG2b M5/114.15.2 BD biosciences 
Siglec F 1:200 Rat IgG2a E50-2440 BD biosciences 	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2.14 Phagocytosis assay 
 
The phagocytic activity of colonic isolates was assessed using pHrodo E.coli 
bioparticles (Molecular Probes, Life Technologies), with adaptations made to 
the manufacturer’s instructions. Briefly, LP cells from neonate or adult 
CX3CR1GFP/+ mice were stained for surface markers as described above, 
washed in FACS buffer and resuspended in 100µl CRPMI. After 15 min 
incubation on ice, 10µl of pHrodo E. coli bioparticles was added to each 
sample. For each biological replicate there were two conditions: one tube 
was left on ice (negative control), while the other was incubated at 37ºC for 
15 min. Finally all samples were washed, resuspended and acquired in ice 
cold buffer C. 
 
2.15 FACS purification of colonic CX3CR1hi subpopulations  
 
Neonate colonic LP cells were stained as described above in sterile 
conditions. CX3CR1 subsets were sorted using FACSAria I (BD Biosciences) on 
the basis of viable CD45+ Siglec F- Ly6G-, F4/80, CD11b and GFP expression.  
 
2.16 Oral priming of mice 
 
Mice were fed 10mg OVA with or without 10µg Vibrio cholerae toxin (CT; both 
from Sigma) by gavage curved shed tube on three occasions 7 days apart. 
Control mice were fed PBS alone. 7 days after the last feed, the mice were 
killed and blood collected by cardiac puncture and stored in Eppendorf tubes. 
Faecal samples were taken directly from the colon, and MLN and spleen were 
isolated.  
 
2.17 DNA extraction 	  
DNA was obtained from tail tips and extracted using DNeasy blood & tissue kit 
(Qiagen) following manufacturer’s spin-column protocol. Briefly, 0.5cm 
collected tail segments received 180µl ATL buffer, 20µl proteinase K, mixed 
by vortexing and incubated overnight at 56ºC followed by adding 200µl buffer 
AL and further vortexing, samples then received 200µl absolute ethanol, 
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mixed, transferred into the DNeasy mini spin column and washed by 
centrifugation at 6000g. Samples in the column then received 500µl buffer 
AW2 before being centrifuged at 20000g for 3 min to get rid of the ethanol. 
Finally, columns were placed in a 1.5 ml collection tube 200µl elution buffer 
was added and incubated at room temperature for 1 min before centrifuging 
at 6000g. Flow through was then stored at -20ºC until use.  
 
PCR was carried out using T professional thermocycler (Biometra, Denmark), 
adding 1µl 1:2 DNA to 0.4µl 10µM primers mix, 4µl 5X reaction buffer, 0.4µl 
dNTPs, 0.1µl Taq polymerase and 14.1µl nuclease free water (all from New 
England Biolabs). DNA amplification needed 94ºC 5min plus 35 cycles at 94ºC 
30sec, 50ºC 30sec and 72ºC 1min, followed by 72ºC 10min and held at 4ºC.  
 
PCR products were then run on a 2% agarose gel (Gibco) containing 100µg 
ethidium bromide (Sigma) in 1x TBE buffer in a gel tank, gel run for 45 min at 
90V and analysed using the Gel Logic 200 imaging system. 
 
2.18 RNA extraction 
 
RNA was obtained from sorted CX3CR1hi cells using the RNeasy Micro kit 
(Qiagen). Briefly, after cell suspensions were spun, cell pellets were loosened 
by flicking the collection tubes and 75µl of RLT buffer was added, mixed and 
homogenised by passing samples through a Qiashredder column and 
centrifuged for 2 min at full speed. Next, 75µl 70% ethanol was added, mixed 
and transferred to an RNeasy MinElute column placed in a fresh collection 
tube for a further centrifugation at 8000g, followed by washing with 350µl 
buffer RW1 plus further centrifugation at 8000g. Elute columns then received 
10µl DNase I in 70µl buffer RDD and incubated at room temperature for 15min 
and washed with 350µl buffer RW1, centrifuged then washed again with 500µl 
buffer RPE and a final wash with 500µl 80% ethanol. Finally columns were 
dried by 5min centrifugation full speed and RNA eluted by adding 14µl of 
RNase-free water, spun at full speed for 1min and flow-through was 
collected. RNA concentration and purity were measured using Nanodrop 3300 
(Thermo Scientific) and stored at -20ºC until use. 
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2.19 cDNA synthesis 
 
cDNA was reverse transcribed from DNase-treated RNA using Superscript II 
Reverse Transcriptase (RT) (Invitrogen) according to the manufacturer’s 
instructions on the T professional thermocycler. Briefly, RNA was added to 
1µl 10mM dNTP mix, 1µl 10µM primer mix, and DEPC treated water in a 
nuclease-free microcentrifuge tube in a total volume of 10µl. RNA/primer 
mixture was then incubated at 65ºC 5min followed by chilling at 4ºC for at 
least 1 minute before adding a mixture of 2µl 10x RT buffer, 4µl 25mM MgCl2, 
2µl 0.1M DTT and 1µl 40U/µl RNaseOUT to make up to a total of 19µl and 
incubated at 42ºC 2min. Then 1µl of Superscript II RT was added to each 
tube, incubated at 42ºC for 50min, increased to 72ºC for 15min, before 1µl of 
RNase H was added for the final incubation at 37ºC for 20min. Samples were 
stored at -20ºC until use. 
 
2.20 Quantitative real time PCR 
 
Gene expression was measured by quantitative reverse transcription PCR 
using specific primers (Table 2.4) and Brilliant III Ultra Fast SYBR qPCR master 
mix (Agilent Technologies) and run on the 7500HT Real Time Fast system 
(Applied Biosystems). Each assay was performed with technical replicates, 
gene expression was normalised to Cyclophilin A (CPA) and the mean relative 
quantification was calculated using 2-ΔΔCT. Melting curves were estimated to 
confirm the specificity of the amplification. 
 
2.21 Analysis of CSF1r/YFP and Flt3/YFP reporter mice 
 
Sample collection, CLP isolation and cell-surface staining were performed as 
described above at the Centre of Molecular & Cellular Biology of 
Inflammation, King’s College London. FACS analysis was using a BD LSR II and 
a BD LSR Fortessa (both BD Biosciences). Both mice strains were generated 
and kept as described previously (Schulz et al., 2012). 
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2.22 Analysis of germ free mice  
 
All experiments done on germ free mice were performed at David Artis’ lab 
at the Perelman School of Medicine, University of Pennsylvania, USA. In order 
to assess the germ free (GF) status, in-house testing of fecal pellets from GF 
mice for culturable aerobic and anaerobic bacteria was performed every two 
weeks and quarterly testing at Charles River Animal Diagnostics (USA). FACS 
analysis was using a BD FACS Aria II (BD Biosciences). 
 
2.23 Statistical analysis 
 
Results are shown as means ±1 standard deviation (SD) unless stated 
otherwise and groups were compared using a Student’s unpaired two-tailed t 
test. When comparing multiple groups, two-way ANOVA was performed, 
followed by a Bonferroni multiple comparison test. P values <0.05 were 
considered to be statistically significant. 
	  Table 2.4. List of primers used for PCR and qPCR 
 
 
Gene Sense 
 
Anti-sense Reaction 
CCR2 CTT GGG TGG AGA GGC TAT 
TC 
 
AGG TGA GAT GAC AGG AGA 
TC 
End point PCR 
CD163 CCT TGG AAA CAG AGA CAG 
GC 
 
TCC ACA CGT CCA GAA CAG 
TC 
Q PCR 
Cyclophilin A GTG GTC TTT GGG AAG GTG 
AA 
 
TTA CAG GAC ATT GCG AGC 
AG 
Q PCR 
IL-10 GCT CTT ACT GAC TGG CAT 
GAG 
 
CGC AGC TCT AGG AGC ATG 
TG 
Q PCR 
TNF-α ACC CTC ACACTC AGA TCA 
TCT TC 
 
TGG TGGTTT GCT ACG ACG T 
 
Q PCR 
 	  
  
 
 
 
 
 
 
 
Chapter 3 
Development of intestinal 
macrophages in early life 
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3.1 Introduction 
 
The vast majority of studies of intestinal mφ have focused on adult mice and 
little is known about these cells during development in early life. Given the 
recent interest in how the intestinal microbiota can influence immune 
responses and the fact that it becomes established soon after birth, it would 
seem important to know how the local mφ population behaves during this 
period. One study has suggested anti-inflammatory mφ are already present in 
human foetal intestine, but this has not been examined in mice (Maheshwari 
et al., 2011). Recent work in other tissues in mice has lead to the idea that 
there are two mutually exclusive mφ populations with distinct origins. The 
majority comprise “resident” mφ, which populate target tissues very early 
during development, self-renew after birth and are derived from prenatal 
precursors either in the yolk sac (YS) or foetal liver (FL) (Ginhoux et al., 
2010; Schulz et al., 2012). A second pool of “inflammatory” mφ derived from 
BM monocytes may be recruited into tissues in response to infection or tissue 
damage (Geissmann et al., 2010). None of these studies defining the prenatal 
origin of mφ had examined the gastrointestinal compartment, and as 
discussed earlier, work going on in the lab when I started my project was 
suggesting that BM monocytes made a major contribution to the intestinal mφ 
pool, even in steady state. Therefore I designed a series of experiments 
aimed at exploring mφ ontogeny and behaviour early in life. In the first 
experiments, I examined if mφ were already present in the newborn intestine 
and investigated how the populations changed during the process of natural 
colonisation with microbiota after birth and through weaning. I then went on 
to study directly the possibility that YS and/or FL derived precursors might 
contribute to the intestinal mφ pool. When I began this work no methods 
were available to isolate and characterise intestinal mφ in neonatal mice and 
therefore, in the first experiments, I had to optimise protocols for obtaining 
sufficient cells to do this reproducibly. 
 
3.2 Intestinal mφ populations can be found from before birth onwards 
 
Because of the size of the neonatal mice and their colons (Figure 3.1), I had 
to adapt the isolation technique used in adults in terms of general tissue 
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handling, as well as the volumes and concentrations of reagents used. Having 
done this, I then combined the gating strategy routinely used in our 
laboratory (Bain et al., 2013) with one reported previously (Schulz et al., 
2012), in which mφ of YS or FL origin can be discriminated on the basis of 
their F4/80 and CD11b expression. 
Newborn 
Adult 
Figure 3.1. Representative appearance of newborn and adult mice 
(top panels), together with their large intestines (bottom panels). 
Newborn 
Adult 
73 
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First, using adult mice, I set out to establish the procedures. I selected single 
cells, followed by identification of live (7-AAD-) CD45+ leukocytes, and then 
excluded Ly6G+ neutrophils Siglec F+ eosinophils and F4/80lo CD11c+ DCs 
(Figure 3.2 A). This allowed me to identify two distinct populations of CD11b+ 
putative mφ lineage cells: F4/80hi CD11bint and F4/80lo CD11b+ (Figure 3.2 B). 
Consistent with previous work in our lab (Bain et al., 2013), the F4/80hi 
CD11bint populations in adults was homogenously Ly6C- MHC II+, whereas the 
F4/80lo CD11b+ population was made up of 3 subpopulations: Ly6Chi MHC II-, 
Ly6Chi MHC II+ and Ly6C- MHC II+, referred to as P1, P2 and P3 respectively 
(Figure 3.2 C). By using CX3CR1GFP/GFP mice, I could show that the F4/80hi 
CD11bint cells also expressed uniformly high levels of CX3CR1, consistent with 
them being mature mφ, while F4/80lo CD11b+ were mostly CX3CR1int, 
consistent with them being maturing monocytes/mφ (Bain et al., 2013). 
There was also a small number of CX3CR1- cells whose nature is unclear 
(Figure 3.2 D). 
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Figure 3.2. Characterisation of colonic macrophages in adult mice. 
A) Colonic lamina propria cells were isolated from the colon of 
CX3CR1GFP/+ mice and single viable leukocytes (7-AAD- CD45+) were 
identified. After excluding granulocytes (Ly6G+ neutrophils and Siglec 
F+ eosinophils) and F4/80lo/- CD11c+ DCs, CD11b+ cells could be 
separated into F4/80hi CD11bint and F4/80lo CD11b+ subsets (B). (C) 
Expression of Ly6C and MHC II by F4/80lo (blue arrow) and F4/80hi cells 
(red arrow). (D) In CX3CR1GFP/+ mice, the F4/80hi CD11bint cells were 
mostly CX3CR1hi (red), while the F4/80lo cells were predominantly 
CX3CR1int, plus a few CX3CR1- cells.  
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3.3 Detailed comparison of adult and newborn colonic mφ subsets 
 
Having shown that I could define appropriate subsets of monocytes and mφ in 
the adult intestine, I went on to analyse neonatal mice. I obtained an 
average of just over 1 million cells per gut from 1 day old (D1) CX3CR1GFP/+ 
mice and as expected, the absolute numbers of leukocytes were considerably 
lower than in adults, and these made up a much lower frequency of the total 
yield. It was immediately obvious that the F4/80hi CD11bint and F4/80lo 
CD11b+ subsets were much more distinct than in the adult, mainly due to the 
appearance of a clear population of F4/80hi cells expressing intermediate 
levels of CD11b (Figure 3.3 A). As in the adult, the F4/80hi cells were all 
CX3CR1hi, while the F4/80lo CD11b+ cells were mostly CX3CR1int and again, 
this marker revealed a more clearly defined population in the neonate 
(Figure 3.3 C). However, unlike the adult intestine, ~70% of the neonatal 
F4/80hi CD11bint cells were MHC II-, although they were mostly Ly6Clo/-. A 
further major difference from the adult was that the F4/80lo CD11b+ subset 
contained lower proportions of the Ly6Chi MHC II+ and Ly6C- MHC II+ subsets, 
while in parallel there were more Ly6Chi MHC II- and Ly6C- MHC II- amongst 
the F4/80lo population in the neonate (Figure 3.3 B). Interestingly some of 
these subsets were present before birth, as shown by the analysis of 18.5-day 
foetal intestine, where there was already a small population of MHC II+ 
F4/80hi mφ (Figure 3.4). Thus cells with the phenotype of mφ are present in 
the intestine even at birth, but they have some differences compared to 
what is seen in adults, such as a relative absence of MHC II and a population 
with lower levels of CD11b. Therefore I went on to explore when these cells 
acquired the adult characteristics. 
0 102 103 104 105
0
102
103
104
105 39.3
6.34
Ly
6C
 
Ly
6C
 
Figure 3.3. Characterisation of colonic macrophages in newborn 
mice. A) Colonic lamina propria cells were isolated from the colon of 
CX3CR1GFP/+ newborn mice and single viable leukocytes (7-AAD- 
CD45+) were identified. After excluding granulocytes (Ly6G+ 
neutrophils and Siglec F+ eosinophils) and F4/80lo/- CD11c+ DCs, 
CD11b+ cells could be separated into F4/80hi CD11bint and F4/80lo 
CD11b+ subsets. (B) Expression of Ly6C and MHC II by F4/80lo (blue 
arrow) and F4/80hi (red arrow) subsets. (C) In newborn CX3CR1GFP/+ 
mice, all the F4/80hi CD11bint cells were CX3CR1hi Ly6C- with 
different levels of MHC II (red), while the F4/80lo cells were 
predominantly CX3CR1int, plus a few CX3CR1- cells. 
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Figure 3.4. Characterisation of colonic macrophages in foetal mice. 
A) Colonic lamina propria cells were isolated from the colon of 
embryonic day 18.5 CX3CR1GFP/+ mice and after selecting single viable 
leukocytes (7-AAD- CD45+) and excluding F4/80lo/- CD11c+ DCs, CD11b+ 
cells were separated into F4/80hi CD11bint and F4/80lo CD11b+ subsets. 
(B) Representative FACS plot showing expression of Ly6C and MHC II by 
F4/80hi cells. (C) Comparison of MHC II expression from F4/80hi 
CD11bint cells from intestine of foetal and adult mice. 
A 
B 
Gated: live CD45+ CD11clo 
0 102 103 104 105
0
102
103
104
105 0.19 0.015
28.271.6
C 
Foetal Adult
0
25
50
75
100
F4/80hi MHC  II+
78 
	   79	  
 
3.4 Development of colonic mφ during the neonatal period 
 
To do this, I carried out an analysis of mφ populations from birth until 
adulthood at 7 weeks of age. Although the total cell numbers I could isolate 
from each sample increased steadily throughout the period of the 
experiment, the proportion of CD45+ leukocytes reached adult levels by 14 
days of age (Figure 3.5 A & B). This translated into there being no major 
changes in the absolute numbers of leukocytes after a progressive increase 
from birth until the 3rd week of life (Figure 3.5 C). On the other hand, while 
the proportions of total Ly6G- Siglec F- CD11b+ cells declined gradually with 
age, the total numbers of these cells increased slightly during the 1st and 
again during the 2nd week of life, before increasing markedly to attain adult 
levels by 21 days of age (Figure 3.5 D & E). As noted earlier, newborn CD11b+ 
cells divided clearly into F4/80hi CD11bint and F4/80lo CD11b+ populations and 
these could be seen until adulthood (Figures 3.6 & 3.7). F4/80hi CD11bint cell 
numbers increased steadily with age, even though their proportions 
fluctuated on each time point (Figure 3.7 A). Notably, the separation 
between F4/80hi CD11bint and F4/80lo CD11b+ populations became less distinct 
by 21 days, at which time the F4/80hi subset had also acquired the higher 
levels of CD11b seen in the adult (Figure 3.6 histogram). The F4/80lo subset 
was also present throughout, but fell in proportions during the 1st and 2nd  
weeks of life, before increasing back to adult proportions on day 21 (Figure 
3.6 & 3.7 B).  
Figure 3.5. Development of leukocytes in colonic lamina propria. 
Total cell numbers (A), frequencies (B) and absolute numbers (C) of 
CD45+ leukocytes from the colonic lamina propria of CX3CR1GFP/+ mice 
of different ages from the day of birth until adulthood (7 weeks). (D) 
Proportions and numbers (E) of CD11b+ cells amongst live leukocytes. 
Results are representative of at least 3 independent experiments. 
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Figure 3.6. Development of macrophages in colonic lamina propria. 
Expression of CD11b and F4/80 by live gated CD45+, excluding F4/80lo/- 
CD11c+ DCs and Ly6G+ Siglec F+ granulocytes from the colon of 
CX3CR1GFP/+ mice at different ages up until adulthood (7 weeks). 
Numbers show proportions of F4/80hi CD11bint and F4/80lo CD11b+ cells 
amongst total CD11b+ cells, while the histogram shows the expression 
of CD11b on the F4/80hi population at different ages. Results are 
representative of at least 3 independent experiments.  
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Figure 3.7. Development of macrophages in colonic lamina propria. 
Proportions (left panels) and absolute numbers (right panels)  of 
F4/80hi CD11bint (A), and F4/80lo CD11b+ (B) cells. Both F4/80 subsets 
were gated from live CD45+ CD11b+, excluding F4/80lo/- CD11c+ DCs 
and Ly6G+ Siglec F+ granulocytes from colonic lamina propria of 
CX3CR1GFP/+ mice of different ages up until adulthood (7 weeks). 
Results are representative of at least 3 independent experiments. 
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Next I assessed the age-related changes in more detail by analysing the mφ 
subsets based on their expression of Ly6C and MHC II. As mentioned earlier, 
at birth the F4/80hi (CX3CR1hi) subset was Ly6Clo/- in newborn mice and only 
~30% were MHC II+. However, the proportion and absolute numbers of MHC II+ 
cells increased gradually from birth onwards and Ly6C expression was lost 
completely (Figure 3.8 and 3.10 D). In parallel, the proportions of Ly6C- 
MHC II- cells amongst this population decreased gradually, although their 
absolute numbers increased until 14 days of age before falling again (Figure 
3.10 E). The F4/80lo CD11b+ CX3CR1int cells were mostly Ly6Chi MHC II-, with 
some Ly6C- MHC II+ cells at birth (Figure 3.9) and there was a sharp drop in 
the proportions of Ly6Chi MHC II- cells at one week of age (Figure 3.10 A left). 
However the proportions of Ly6Chi MHC II+ cells had increased again by 14 
days of age, and reached their highest proportion at 21 days (Figure 3.10 B 
left). The size of the Ly6C- MHC II+ cell subset also fluctuated from week to 
week, but it was the biggest cell fraction amongst F4/80lo cells from the 2nd 
week onwards (Figure 3.9 and 3.10 C left). All the subsets of F4/80lo CD11b+ 
cells showed a peak in their absolute numbers at 21 days of age, before 
falling again by 7 weeks of age (Figure 3.10 B-C right).  
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Figure 3.8. Development of macrophages in colonic lamina 
propria. Expression of Ly6C and MHC II by F4/80hi CD11bint/+ cells 
amongst live CD45+ CD11b+, excluding F4/80lo/- CD11c+ DCs and Ly6G
+ Siglec F+ granulocytes from colonic lamina propria of CX3CR1GFP/+ 
mice of different ages up until adulthood (7 weeks). (A) 
Representative FACS plot from adult CLP.  Numbers in FACS plots are 
the proportion of cells in Ly6Chi MHC II-, Ly6Chi MHC II+, Ly6C- MHC+ 
(P4) and Ly6C- MHC- gates. Histogram shows expression of MHC II in 
the F4/80hi CD11bint subset at different ages. Data are 
representative of at least 3 independent experiments.  
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Figure 3.9. Development of macrophages in colonic lamina 
propria. Expression of Ly6C and MHC II by F4/80lo CD11b+ cells 
amongst live CD45+ CD11b+ excluding F4/80lo/- CD11c+ DCs and Ly6G+ 
Siglec F+ granulocytes from colonic lamina propria of CX3CR1GFP/+ 
mice of different ages up until adulthood (7 weeks). (A) 
Representative FACS plot from adult CLP. (B) Numbers in FACS plots 
are the proportion of cells in Ly6Chi MHC II- (P1), Ly6Chi MHC II+ (P2) 
and Ly6C- MHC+  (P3) gates. Data are representative of at least 3 
independent experiments.  
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Figure 3.10. Development of macrophages in colonic lamina 
propria. Proportions (left panels) and absolute numbers (right panels)  
of Ly6Chi MHC II- (P1, A), Ly6Chi MHC II+ (P2, B) and Ly6C- MHC II+ (P3, 
C) cells within the F4/80lo CD11b+ subset. D, E) Ly6C- MHC II+ (P4) and 
Ly6C- MHC II- cells within the F4/80hi CD11bint population. Both F4/80 
subsets were gated from live CD45+ CD11b+, excluding F4/80lo/- CD11c+ 
DCs and Ly6G+ Siglec F+ granulocytes from colonic lamina propria of 
CX3CR1GFP/+ mice of different ages up until adulthood (7 weeks). 
Results are representative of at least 3 independent experiments. 
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3.5 Contribution of self renewing foetal-derived precursors to the 
intestinal pool of intestinal mφ 
 
These results showed that macrophages were present in the intestine from 
before birth and recent reports suggest that the majority of tissue 
macrophages may be derived from YS and/or FL precursors that seed tissues 
during development and subsequently self-renew locally (Schulz et al., 2012). 
Although none of these studies have examined the intestine, the F4/80hi 
CD11bint and F4/80lo CD11b+ subsets I found in newborn mice are 
phenotypically similar to what has been described for YS and FL derived mφ 
respectively in other tissues. To examine this more directly, we initiated a 
collaboration with Professor Frederic Geissmann to investigate intestinal mφ 
in CSF1Rmer-icre-mer;RosaLSL-YFP mice, in which cells expressing the CSF1R will be 
responsive to tamoxifen due to expression of the mammalian oestrogen 
receptor (mer). The mer in turn is linked to the cre recombinase.  After 
crossing to ROSA reporter mice, in which YFP has been inserted into the ROSA 
locus but expression prevented by an upstream lox P-flanked (floxed) STOP 
codon. Administration of low dose tamoxifen results in deletion of the STOP 
codon and irreversible YFP expression by CSF1R bearing cells in the progeny 
of these mice. In my experiments, pregnant mice were given tamoxifen at 
8.5 days post-coitus (dpc), a time at which the YS is the only source of mφ 
precursors (Figure 3.11 A). At 9 days of age, 2% of the F4/80hi compartment 
of CD11b+ Ly6G- Siglec F- colonic mφ were YFP+, but no YFP+ cells were seen 
amongst the F4/80lo population (Figure 3.11 AB and 3.12 A & B). This could 
be consistent with a YS origin for at least some of the F4/80hi mφ, whereas 
F4/80lo mφ may be derived from FL. I then examined YFP expression by 
colonic mφ from 7-week-old mice. As shown in Figures 3.11 C and 3.12 A & C, 
a very small population of YFP+ F4/80hi cells could be found at this time (0.1-
0.2%). However, this was much lower than the YFP expression amongst 
F4/80hi microglial mφ in the adult brain where ~30% were YFP+, confirming 
the large contribution of YS to this population throughout life (Figure 3.12 B 
& C). As reported by the Geissmann group (Schulz et al., 2012), other tissues 
such as liver, pancreas and epidermis also contained significantly more YFP+ 
F4/80hi mφ than the colon, while kidney mφ were more similar to colon. YFP+ 
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cells were not seen amongst the F4/80lo population in any tissue from adult 
mice, again confirming previous work from the Geissmann lab. 
 
Together these results suggest that although YS derived mφ are present in the 
intestine at birth, these do not make a major contribution to the adult pool. 
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Figure 3.11. Identification of yolk sac-derived macrophages in 
colonic lamina propria. (A) Pregnant CSF1Rmer-icre-mer;RosaLSL-YFP mice 
were injected with tamoxifen at gestational day 8.5 and the colonic 
lamina propria was analysed in pups at 9 days (B) or 7 weeks of age 
(C). The plots show the proportions of CSF1R/YFP+ cells amongst live 
CD45+ F4/80hi CD11bint Ly6G- Siglec F- and F4/80lo CD11b+ Ly6G- Siglec F- 
mφ. Representative FACS plots from 2 experiments with at least 3 
mice/group. 
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Figure 3.12. Identification of yolk sac-derived macrophages in 
colonic lamina propria. A) Pregnant CSF1Rmer-icre-mer;RosaLSL-YFP mice 
were injected with tamoxifen at gestational day 8.5 and the colonic 
lamina propria was analysed for CSF1R/YFP+ cells within F4/80hi 
CD11bint amongst live CD45+ Ly6G- Siglec F- cells in pups at 9 days or 7 
weeks of age. Frequencies of CSF1R/YFP+ cells within F4/80hi CD11bint 
and F4/80lo CD11b+ populations compared with other tissues at 9 days 
(B) and 7 weeks of age (C). Results are means for 3 individual mice/
group +1SD and represent two independent experiments. *p<0.05. 
Student’s t-test. 
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3.6 Contribution of local proliferation to the developing pool of colonic 
mφ 
 
My results show that small numbers of foetal derived mφ are present from 
birth until two weeks of life, but that there is a large expansion in mφ 
numbers around the time of weaning in the 3rd week. I thought it was 
important to explore how this might take place and first I examined whether 
it was due to local expansion of the pre-existing mφ populations. To do this, I 
used Ki67 staining to assess cell division in situ. This showed that ~30% of 
F4/80hi mφ were actively dividing in the colon of newborn and 2 week old 
mice, with slightly fewer in the 3 week old colon, when there was also 
greater variability within the group. In contrast, very few dividing mφ could 
be observed in 5 or 9-week old adult mice. Similar proportions of dividing 
cells were found amongst the F4/80lo subset in newborn intestine, but these 
levels fell progressively thereafter, unlike the F4/80hi mφ, which maintained 
high levels for longer. However, slightly more F4/80lo mφ were Ki67+ than 
their F4/80hi counterparts in the adult intestine (Figure 3.13 A & B and 3.14). 
In contrast to these marked age dependent differences in the mφ 
populations, the F4/80- CD11c+ MHC II+ DC showed high levels of Ki67+ cells 
throughout, consistent with other work in the laboratory which has found 
that a substantial proportion of mature DC in the intestine are dividing in situ 
(Figure 3.13 B) (Scott C, submitted for publication). As a negative control, I 
examined Ki67 expression by eosinophils and these showed little or no 
proliferation at any timepoint (Figure 3.13 C and 3.14). 
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Figure 3.13. In situ proliferation of leukocytes in colonic lamina 
propria. (A) F4/80hi CD11bint and F4/80lo CD11b+ SSClo mφ were 
identified amongst live CD45+ cells, excluding F4/80lo/- CD11c+ DCs and 
Ly6G+ Siglec F+ granulocytes from CX3CR1GFP/+ mice of different ages 
and Ki67 expression was assessed. B, C) Ki67 expression by F4/80- 
CD11c+ MHC II+ DC and F4/80lo SSChi eosinophils (C) from adult colon as 
positive and negative controls respectively. Data are representative of 
2 independent experiments with at least 3 mice. 
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Figure 3.14. In situ proliferation of leukocytes in colonic lamina 
propria. (A) Proportions of Ki67+ cells amongst F4/80hi CD11bint and 
F4/80lo CD11b+ mφ, F4/80- CD11c+ MHC II+ DC and F4/80lo SSChigh 
eosinophils amongst live CD45+ cells, excluding F4/80lo/- CD11c+ DCs 
and Ly6G+ Siglec F+ granulocytes from colonic lamina propria of 
CX3CR1GFP/+ mice at different ages. (B) Time course of Ki67 expression 
by F4/80hi CD11bint and F4/80lo CD11b+ mφ at different ages. Results 
shown are representative of 2 independent experiments. 
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3.7 Generation of intestinal mφ from Flt3 dependent monocytes  
 
My findings of relatively high cell division in neonatal colonic mφ could be 
consistent with those from other tissues, where it is suggested that foetal 
precursor-derived mφ populate the adult pool by self-renewal in situ. 
However, the highest levels of cell division I found occurred some time 
before the large expansion in mφ populations around weaning, and indeed 
were falling by that time, suggesting that the two processes might not be 
linked. As ongoing studies in the lab had suggested that Ly6Chi monocytes 
replenish colonic mφ in adults, I therefore went on to investigate whether an 
influx of monocytes might be responsible for the expansion of mφ around 
weaning. 
 
To do this, I first used Flt3-Cre; Rosa26-YFP mice, again in collaboration with 
Professor Geissmann’s laboratory. In these mice, YFP is expressed 
permanently on all cells which have ever expressed the fms-like tyrosine 
kinase (Flt3) during development, as the active Flt3 promoter drives cre-
recombinase mediated excision of the STOP codon in the ROSA locus (Figure 
3.15 A). As Flt3 is expressed only by hematopoietic progenitors (including 
blood monocytes) but not by foetal mφ precursors, expression of YFP is 
restricted to cells derived from conventional haematopoietic precursors. 
Using this approach, ~50% of Ly6Chi monocytes in the blood of adult mice 
were YFP+, although this was significantly less than the frequency amongst 
the total blood CD45+ leukocyte population (Figure 3.15 A right & B). The 
proportions of YFP+ cells seen amongst both the F4/80lo and F4/80hi 
populations of adult mφ were identical to that seen with blood Ly6Chi 
monocytes, supporting the idea that adult mφ originate from conventional 
monocytes (Figure 3.15 C). 
Figure 3.15. Generation of intestinal macrophages from Flt3 
dependent monocytes. A) Haematopoietic progenitors from Flt3-Cre; 
Rosa26-YFP mice were identified in the blood and (B, C) the 
proportions of Flt3/YFP+ cells amongst blood CD45+ leukocytes, blood 
Ly6Chi monocytes, F4/80hi and F4/80lo subsets amongst live CD45+ 
F4/80hi CD11bint Ly6G- Siglec F- cells in the colon of 8 week old mice.  
Results are means +1 SD for 3 mice/group from a single experiment. 
*p<0.05. Student’s t-test. 
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3.8 Role of CCR2 in mφ accumulation in developing mice 
 
Together these results suggest that although a small number of mφ that are 
derived from foetal precursors are present in the neonatal intestine, this 
population is diluted out considerably around weaning by cells derived from 
conventional Ly6Chi monocytes. These conventional monocytes then appear 
to account for the great majority of adult mφ. To test this hypothesis further, 
I examined the development of mφ in CCR2 deficient mice, which lack Ly6Chi 
monocytes in blood and other tissues due to a block in their egress from BM 
(Bain et al., 2013; Kurihara et al., 1997; Serbina and Pamer, 2006). 
 
As I found previously, the total cell number in the colon of the CX3CR1GFP/+ 
mice (that were used as WT controls in this experiment) increased in a 
stepwise fashion from birth up to D14, followed by a slight decrease at D18, 
after which adult levels were attained (Figure 3.16 A). Similar patterns of 
total cell number were seen in CCR2 null mice, although these mice had a 
significantly smaller number of total cells than in controls at 3 weeks of age. 
Although the proportions of CD45+ leukocytes were more variable in the WT 
mice of different ages, their absolute numbers increased gradually in the first 
3 weeks of life, followed by a much more marked increase at 3 weeks of age. 
The proportions and numbers of CD45+ in CCR2 null mice were generally 
similar to those in the control colon, apart from an unexplained significant 
increase in the proportion above controls on day 18 (Figure 3.16 B & C). 
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Figure 3.16. Role of CCR2 in development of intestinal 
macrophages. Colonic lamina propria cells were isolated from age 
matched CX3CR1GFP/+ (open bars) and CCR2 null (black bars) mice at 
different ages up until adulthood (6 weeks). (A) Total number of 
cells/colon, B) proportions and (C) total numbers of live CD45+ 
leukocytes/colon. Results are means +1 SD for 3 mice/group and are 
representative of at least 3 independent experiments. *p<0.05, 
***p<0.001 vs CX3CR1GFP/+. Two way ANOVA followed by Bonferroni’s 
post-test. 
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When the different populations F4/80+ cells were analysed, I found that the 
frequencies of F4/80lo mφ were very variable in each timepoint, however 
they remained relatively similar in CX3CR1GFP/+ and CCR2 null colon 
throughout, apart from a slight deficiency in CCR2 null colon at 18 days 
(Figure 3.17 A left). On the other hand, F4/80lo mφ numbers from CX3CR1GFP/+ 
mice showed little increase in the first two weeks of life, followed by highly 
variable numbers, showing an apparent drop at 18 days, a massive expansion 
by 3 weeks and a final decrease by half at 6 weeks of age. Importantly, CCR2 
null mice showed significantly fewer cells at 3 and 6 weeks of age (Figure 
3.17 A right). 
 
In both strains, the proportion of Ly6Chi MHC II- monocytes (P1) within the 
F4/80lo population changed at every timepoint. This population decreased 
from birth to 3 days and apart from a transient increase at day 7, fell 
gradually thereafter, until increasing to adult levels at 3 and 6 weeks. A 
similar pattern was seen for the proportions of Ly6Chi MHC II- cells amongst 
the F4/80lo population in CCR2 null mice up to 3 weeks of age, but their 
proportions did not recover at later times (Figure 3.17 B left). These changes 
were mirrored by a marked expansion in the absolute numbers of this subset 
in CX3CR1GFP/+ mice, which were less marked than in CCR2 null mice (and 
somewhat more variable) at 3 and 6 weeks of age (Figure 3.16 B right). At 
most timepoints the proportion of Ly6Chi MHC II+ cells (P2) were lower in 
CCR2 null colon but there was an expansion in their numbers at 3 weeks. 
However from this age and by 6 weeks of age, the number of Ly6Chi MHC II+ 
cells was much lower than in WT colon, paralleling the behaviour of Ly6Chi 
MHC II- cells at these time points (Figure 3.17 C). The frequency of Ly6C- MHC 
II+ cells was much more variable in WT colon, but again there was an increase 
after 2 weeks of age, which was reflected by a large expansion in numbers at 
3 weeks of age. In comparison, although the proportions of Ly6C- MHC II+ 
F4/80lo cells increased normally at the later timepoints and although this 
population expanded after 3 weeks of age, this was significantly less than 
seen in WT colon at the same times (Figure 3.17 D).  
A  
Figure 3.17. Role of CCR2 in development of intestinal 
macrophages. Colonic lamina propria cells were isolated from age 
matched CX3CR1GFP/+ (open bars) and CCR2 null (black bars) mice at 
different ages up until adulthood (6 weeks). A) Proportions (left 
panels) and absolute numbers (right panels) of F4/80lo CD11b+, 
Ly6Chi MHC II- (P1, B), Ly6Chi MHC II+ (P2, C) and Ly6C- MHC II+ (P3, D) 
cells amongst amongst live CD45+ CD11b+ cells excluding F4/80lo/- 
CD11c+ DCs and Ly6G+ Siglec F+ granulocytes. Results are means +1 
SD for 3 mice/group and are representative of at least 3 
independent experiments.  *p<0.05, **p<0.01 ***p<0.001 vs 
CX3CR1GFP/+. Two way ANOVA followed by Bonferroni’s post-test.  
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As expected from my previous experiments, the proportions of F4/80hi cells in 
WT colon showed discrete changes throughout the experiment, and both 
strains showed a similar pattern to that seen in the CCR2 null colon, with a 
significant decrease by 6 weeks (Figure 3.18 A). There was a progressive 
increase in the proportion of F4/80hi cells expressing MHC II (P4) after birth 
until virtually all were MHC II+ by 3 weeks of age in both strains (Figure 3.18 
B). Again the absolute numbers of F4/80hi MHC II+ mφ were increased most 
dramatically at 3 weeks and this was identical in WT and CCR2 null colon. 
However by 6 weeks of age, a large defect had appeared in CCR2 null mice. 
This was not simply due to a failure of cells to express MHC II, as MHC II- 
F4/80hi cells were virtually absent in both strains of mice at 6 weeks of age 
(Figure 3.18 C). 
 
Thus, this set of results suggests that there may be a number of Ly6Chi 
monocytes early in life. This population is CCR2 independent and slowly 
disappears to be replaced by BM derived monocytes which take over as the 
exclusive haematopoietic organ by 3 weeks of age onwards. This may be the 
reason CCR2 null mice show a significant cell defect as they approach 
adulthood. 
Figure 3.18. Role of CCR2 in development of intestinal 
macrophages. Colonic lamina propria cells were isolated from age 
matched CX3CR1GFP/+ (open bars) and CCR2 null (black bars) mice at 
different ages up until adulthood (6 weeks). A) Proportions (left 
panels) and absolute numbers (right panels) of F4/80hi CD11bint,  Ly6C- 
MHC II+ (P4, B) and Ly6C- MHC II- (C) cells amongst live CD45+ CD11b+ 
cells excluding F4/80lo/- CD11c+ DCs and Ly6G+ Siglec F+ granulocytes. 
Results are means +1 SD for 3 mice/group and are representative of at 
least 3 independent experiments.  ***p<0.001 vs CX3CR1GFP/+. Two way 
ANOVA followed by Bonferroni’s post-test. 
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3.9 Functional comparison of adult and newborn colonic mφ 
 
I also investigated whether newborn mφ had similar functions to their adult 
counterparts. I started by assessing their phagocytic ability, which is a 
characteristic property of mature resident mφ. To do this I used the pHrodo 
assay, in which pH-sensitive E. coli particles fluoresce after uptake into 
acidified vesicles. F4/80hi mφ from adult colon showed high activity in this 
assay, as did their counterparts in newborn mice (Figure 3.19). However 
although F4/80lo mφ from adult mice had similar levels of phagocytic activity 
to F4/80hi mφ, neonatal F4/80lo mφ had little or no ability to phagocytose E. 
coli particles.  
 
Among the other characteristic functions of adult mature mφ are the 
constitutive production of IL10, low but significant constitutive TNFα 
production and expression of scavenger receptors such as CD163 (Bain et al., 
2013). To assess these parameters in neonatal mice, I sorted F4/80hi CD11bint 
mφ from newborn and adult CX3CR1GFP/+ mice (Figure 3.20 A). qPCR analysis 
showed that, as expected, F4/80hi mφ from adult colon expressed greater 
amounts of mRNA for IL10, CD163 and TNFα than the CSF1 generated BM mφ, 
which were used as controls. Identical mRNA levels of TNFα and CD163 were 
found in adult and neonatal F4/80hi CD11bint mφ. Interestingly, there was a 
trend suggesting that adult F4/80hi CD11bint mφ produced more mRNA for IL10 
than their neonatal counterparts (Figure 3.20 B) and this was further 
supported by an apparently lower IL10 production by neonatal CX3CR1hi mφ, 
shown by intracellular staining (Figure 3.21).  
 
Finally I wanted to assess the responsiveness of neonatal mφ to LPS 
stimulation. This was with the purpose of comparing them with adult colonic 
mφ, which are known for being hyporesponsive. My results show that whilst 
none of the adult or neonatal F4/80hi CD11bint mφ produced extra TNFα after 
LPS stimulation, there was a significantly higher proportion of neonatal 
F4/80hi mφ producing TNFα during steady state (Figure 3.22 A & B left). In 
contrast, the F4/80lo CD11b+ mφ from both age groups were fully responsive 
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to LPS stimulation, although no significant differences were found during 
steady state (Figure 3.22 A & B right). 
 
Thus intestinal mφ from newborn mice have most of the characteristics of 
their counterparts in adult mice, although they produce more TNFα than 
their adult counterparts at steady state, whilst they may produce less IL10. 
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Figure 3.19. Phagocytic activity of newborn and adult intestinal 
macrophages. Colonic lamina propria cells from the colon of 
newborn and adult CX3CR1GFP/+ mice were incubated with pH-
sensitive (pHrodo) E. Coli at 37ºC for 15 minutes and analysed by 
flow cytometry. Results show the pHrodo fluorescence of live CD45+ 
F4/80hi CD11bint Ly6G- Siglec F- mφ from adult (blue line) or newborn 
mice (red line) compared with staining at 4ºC as a negative control 
(filled grey). Representative FACS plots from at least 2 independent 
experiments with 3 mice/group. 
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Figure 3.20. Expression of functional molecules by neonatal and 
adult mφ. (A, B) F4/80hi CD11bint mφ amongst live CD45+ cells, 
excluding F4/80lo/- CD11c- DCs and Ly6G- Siglec F- eosinophils were 
sorted from 0-2 day old (newborn) and adult CX3CR1GFP/+ mice. (C) 
mRNA from sorted cells was analysed for expression of IL10, TNFα 
and CD163 by Q-PCR with CSF-1 generated BM mφ set to 1. Results 
shown are mean expression relative to cyclophilin A (CPA) using the 
2-ΔC(t) method. The mean was obtained from (3-4) pooled pups and 
individual adults with 3 biological replicates. Data are representative 
of at least 3 independent experiments. 
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Figure 3.21. IL10 production by intestinal macrophages. Live CD45+ 
CD3- CD19- CD8α- cells from adult and newborn CX3CR1GFP/+ colon were 
analysed for expression of CX3CR1 and CD11b. Intracellular IL10 
production by CX3CR1hi cells was then analysed by intracellular 
staining. Data shown are pooled results from two experiments using 2 
adults and one sample of pooled cells from at least 8 neonates/
experiment. 
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Figure 3.22. TNFα production by intestinal macrophages after LPS 
stimulation. A & B) F4/80hi CD11bint and F4/80lo CD11b+ cells from 
adult and 2-day-old CX3CR1GFP/+ colon were stimulated with 100ng/
ml LPS in presence of brefeldin A and monensin for 4.5 hours, 
followed by analysis for expression of intracellular TNFα production. 
Both mφ subsets were selected amongst live CD45+ cells, excluding 
F4/80lo/- CD11c+ DCs and SSChi cells. Results are means for individual 
adult mice/group and 2-3 pooled pups and are representative of two 
independent experiments. *p<0.05, **p<0.01. Student’s t-test. 
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3.10 Summary 
 
In this chapter, I explored intestinal mφ development from late foetal life up 
to adults of 6-7 weeks. My results show that colonic mφ can be reliably 
isolated even from late foetal life and that two clearly defined populations of 
F4/80hi CD11bint and F4/80lo CD11b+ mφ can be identified. However these 
merge gradually from the 3rd week onwards. In early life, the majority of 
F4/80hi mφ do not express MHC II, but acquire it progressively as mice 
mature. As I found that the resident mφ were proliferating actively in the 
first 2 weeks of life, I tested the hypothesis that self-renewal of a foetal 
derived precursor could account for this increase in mφ at weaning. The 
F4/80hi and CD11bhi populations seemed to correspond to YS and FL derived 
mφ in other tissues and fate mapping studies showed the presence of some YS 
derived mφ in 2 week old intestine. However, there were very few of these in 
the adult intestine, and the in situ proliferation I observed did not correlate 
with the expression at weaning. Rather, this phenomenon was associated 
with an influx of Ly6Chi monocytes, which could be shown to express the 
haematopoietic growth factor receptor Flt3. Unlike the adult mφ pool, this 
influx of monocytes at weaning was not entirely CCR2 dependent, indicating 
that other mechanisms may be involved in recruiting these cells at different 
ages. However my results show clearly that the vast majority of intestinal mφ 
are monocyte-derived from weaning onwards, and non-haematopoietic 
precursors made little or no contribution. Interestingly despite their different 
origins, newborn mφ share many of the functional properties of adult mφ, 
including phagocytic activity, expression of scavenger receptor and 
hyporesponsiveness to LPS stimulation. However, cytokine production shows 
that TNFα is remarkably high in the newborn intestine, whereas IL10 appears 
to be lower than in adults. 
 
  
 
 
 
 
 
 
 
Chapter 4 
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4.1 Introduction 
 
Reports suggesting an important influence of the microbiota on the intestinal 
physiology and structure date back to the late 1960’s (Savage and Dubos, 
1968; Savage and McAllister, 1971) and its effects on general immune 
function are also well characterised. However in recent years, more detailed, 
immunologically-focused work has highlighted how commensal microbes play 
an important role in tuning individual aspects of intestinal immune responses. 
The presence of certain Clostridium species and B. fragilis-derived 
polysaccharide A have been shown to correlate with increased numbers of 
colonic Treg cells (Atarashi et al., 2011; Mazmanian et al., 2008), while 
segmented filamentous bacteria (SFB) drive Th17 responses in the ileum 
(Denning et al., 2011; Fagundes et al., 2011; Ivanov et al., 2009; Ivanov et 
al., 2008; Ostman et al., 2006). Given these intricate relationships and the 
age-related changes I observed in my experiments using neonatal mice, I next 
sought to investigate whether the intestinal microbiota would affect colonic 
mφ distribution in the lamina propria. The initial experiments in this chapter 
evaluated the effects of treating adult mice with two different gut-sterilising 
antibiotic schedules whilst the second part involved analysing colonic 
macrophage populations under germ-free conditions. 
 
4.2 Analysis of colonic mφ in CX3CR1GFP/+ mice 
 
In the previous chapter, I analysed mφ populations based on their expression 
of F4/80 and CD11b. However as mentioned in that chapter, much of the 
other work ongoing in our laboratory used CX3CR1GFP/+ mice to analyse mφ 
populations and I was able to use them for the experiments assessing 
antibiotic treatment. The advantage of this mouse strain over non-GFP 
animals is that it allows a much clearer discrimination between mφ subsets 
and the gating strategy used in these mice is depicted in figure 4.1. After 
discarding doublet cells, 7-AAD- CD45+ cells are selected, followed by 
selection of total CD11b+ cells, in which 3 main populations can be identified 
on the basis of their CX3CR1 expression. First, there is a CX3CR1- population, 
composed mainly of eosinophils and a few neutrophils (Bain et al., 2013), 
which I did not analyse any further. The remaining 2 subsets consist of a 
dominant CD11b+ CX3CR1hi population that is also homogenously Ly6C- MHC II+ 
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and has been shown previously to represent a population of mature resident 
mφ (designated P4) (Bain et al., 2013). Finally, there is a less numerous 
CD11b+ CX3CR1int population, which is heterogeneous in terms of Ly6C, MHC 
II, F4/80 and CD11c expression, identifying the Ly6Chi MHC II- (P1) and Ly6Chi 
MHC II+ (P2) subsets of monocytes as well as a Ly6C- MHC II+ subset that can 
be split up further into a subset of semi-mature F4/80hi Ly6C- MHC II+ 
CX3CR1int mφ (P3) and some F4/80- CD11c+ MHC II+ DCs (P5) (Bain et al., 
2013). 
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Figure 4.1. Gating strategy for evaluating the effect of antibiotic 
treatment on colonic lamina propria macrophages. After pre-gating 
single 7-AAD- CD45+ cells from CX3CR1GFP/+ adult mice, 3 CD11b+ 
populations could be found: CD11b+ CX3CR1-, composed mainly of 
Siglec F+ eosinophils; a CD11b+ CX3CR1int subset composed of Ly6Chi 
MHC II- (P1), Ly6C+ MHC II+ (P2) and Ly6C- MHC II+ cells. The CX3CR1int 
Ly6C- MHC II+ cells can be subdivided into F4/80+ CD11c- mφ (P3) and 
F4/80- CD11c+ DCs (P5). The large population of CX3CR1hi Ly6C- MHC II
+ F4/80+ cells is a homogeneous group of mature mφ (P4).	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4.3 Effects of antibiotics on intestinal macrophages 
 
In the first experiment I used these indices mentioned above to assess the 
effects of a relatively simple mixture of antibiotics (ABX) in the drinking 
water, which was 50mg/kg meropenem and vancomycin. After 22 days of 
treatment, I analysed the colonic mφ subsets. This antibiotic regime was 
adapted from previous published work where imipenem and vancomycin were 
used to reduce colitis in HLA-B27 transgenic rats as well as BALB/c mice (Rath 
et al., 2001). There were few clear effects of our regime on the subsets of 
colonic mφ in CX3CR1-GFP mice, with no additional changes to the 
frequencies or absolute numbers of viable leukocytes, total CD11b+ cells, or 
granulocytes (Figure 4.2). Although there was a significant increase in the 
frequency of CX3CR1hi mφ in ABX treated mice, this was extremely small and 
there was no significant difference in the number of these cells (Figure 4.2 
D). I then examined the individual populations within the CX3CR1int subset 
(Figure 4.3 A-C), as well as the CX3CR1hi fraction (Figure 4.3 D). Again the 
proportions and absolute numbers of all these subsets were not affected by 
the antibiotic treatment.  
 
It occurred to us that intestinal mφ, especially the CX3CR1hi subset, may have 
a lifespan longer than the duration of the ABX treatment. Thus even if 
cellular changes had started to take place, these might be at a more subtle 
level that could be detected by enumerating cells by flow cytometry. To 
explore this possibility, I reduced the ABX treatment to 10 days and looked 
for changes in intracellular production of IL10 and TNFα by CX3CR1hi mφ 
(Figure 4.4), together with qPCR analysis for IL10, TNFα and CD163 
expression by FACS sorted CX3CR1int and CX3CR1hi populations. However, 
none of these parameters were affected by the ABX treatment (Figure 4.5). 
 
As I thought this lack of effect might be due to the antibiotics I used, I 
decided to investigate whether a broader spectrum antibiotic cocktail might 
reveal more significant effects. 
Figure 4.2. Effects of antibiotic treatment on intestinal 
macrophages. Frequencies (left) and absolute numbers (right) of 
(A) viable CD45+ leukocytes, (B) CD11b+ CX3CR1int cells (C), CD11b+ 
CX3CR1hi cells (D) and granulocytes (E) in colon of adult CX3CR1GFP/+ 
mice receiving 50mg/kg vancomycin and 50mg/kg meropenem in 
drinking water for 22 days and the controls receiving sweetened 
water. The data shown are from 5 individual mice/group and are 
representative of 2 independent experiments.  
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Figure 4.3. Effects of antibiotic treatment on intestinal 
macrophages. Frequencies (left) and absolute numbers (right) of  
CX3CR1int Ly6Chi MHC II- (P1, A), CX3CR1int Ly6Chi MHC II+ (P2, B), 
CX3CR1int Ly6C- MHC II+ F4/80+ CD11c- (P3, C) and CX3CR1hi Ly6C- 
MHC II+ (P4, D) subsets after receiving 50mg/kg vancomycin and 
50mg/kg meropenem in drinking water for 22 days. The data shown 
are from 5 individual mice/group and are representative of 2 
independent experiments.  
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Figure 4.4. Effects of antibiotic treatment on cytokine production 
by intestinal macrophages. Intracellular IL10 (A) and TNFα (B) 
expression by CX3CR1hi mφ from mice receiving 50mg/kg vancomycin 
and 50mg/kg meropenem in drinking water for 10 days. Results 
shown are % of CX3CR1hi cells expressing each cytokine after 4.5 
hour culture with brefeldin A and monensin. The data shown are 
from at least 4 individual mice/group and are representative of one 
experiment.  
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Figure 4.5. Effects of antibiotic treatment on intestinal 
macrophages. CX3CR1int and CX3CR1hi mφ amongst live CD45+ Ly6G- 
Siglec F- cells were sorted from mice treated with 50mg/kg 
vancomycin and 50mg/kg meropenem for 10 days and from 
sweetened water-fed controls. mRNA from sorted cells was analysed 
for expression of IL10 (A), TNFα (B) and CD163 (C) by qPCR. Results 
shown are mean expression relative to cyclophilin A (CPA) using the 
2-ΔC(t) method. The mean was obtained from 2-3 pooled samples with 
technical replicates. Data are representative of one experiment. 
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4.4 Effects of broad spectrum antibiotic treatment on intestinal 
macrophages 
 
Based on work by Abt and colleagues, which had shown marked effects on 
intestinal immune responses, I switched to a cocktail containing ampicillin, 
gentamicin, metronidazole, neomycin and vancomycin administered for 21 
days in the drinking water (Abt et al., 2012). This regime would act on 
Gram+ve, Gram-ve, aerobic and anaerobic bacteria, and is also poorly 
absorbed from the intestine, maximising its effects on local bacteria. This 
regime produced small, but significant increases in the frequency and number 
of total CD11b+ cells and a higher number of granulocytes compared with 
controls (Figure 4.6 B & E). However the frequencies and absolute numbers of 
viable leukocytes, total CX3CR1int and CX3CR1hi mφ were not altered by the 
ABX (Figure 4.6 A, C & D). Although there was a decrease in the proportion of 
Ly6Chi MHC II- (P1) cells amongst the CX3CR1int population, together with a 
significant increase in the number of Ly6C- MHC II+ CX3CR1int mφ in ABX 
treated mice (Figure 4.7 A & C), these changes were generally small and of 
unclear significance (Figure 4.7). Finally I measured mRNA levels for IL10 and 
TNFα in CX3CR1hi mφ sorted from ABX treated and control colon. This 
experiment detected few differences apart from a trend towards higher 
expression of TNFα by CX3CR1hi cells from ABX treated mice (Figure 4.8), 
which interestingly was similar to what I found using the simple ABX regime 
(Figure 4.5 B). 
 
As these findings revealed few consistent effects, I decided not to pursue any 
further experiments involving antibiotic manipulation of the intestinal 
environment. 
Figure 4.6. Effects of broad spectrum antibiotics on intestinal 
macrophages. Frequencies (left) and absolute numbers (right) of (A) 
viable leukocytes, (B) CD11b+ cells, (C) CX3CR1int, (D) CX3CR1hi mφ 
and granulocytes (E) in colon of adult CX3CR1GFP/+ mice after 
receiving ampicillin, neomycin, gentamycin, metronidazole and 
vancomycin in drinking water for 21 days. Data shown are from 5 
individual mice/group and are representative of at least 2 
independent experiments. *p<0.05. Student’s t test. 
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Figure 4.7. Effects of broad spectrum antibiotics on intestinal 
macrophages. Frequencies (left) and absolute numbers (right) of 
CX3CR1int Ly6Chi MHC II- (P1, A), CX3CR1int Ly6Chi MHC II+ (P2, B), 
CX3CR1int Ly6C- MHC II+ F4/80+ CD11c- (P3, C) and CX3CR1hi Ly6C- 
MHC II+ (P4, D) subsets after receiving ampicillin, neomycin, 
gentamycin, metronidazole and vancomycin in drinking water for 21 
days. Data shown are from 5 individual mice/group and are 
representative of at least 2 independent experiments. *p<0.05. 
Student’s t test. *p<0.05, **p<0.01. Student’s t test. 
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Figure 4.8. Effects of broad spectrum antibiotics on intestinal 
macrophages. F4/80hi CD11bint mφ amongst live CD45+ Ly6G- Siglec 
F- CD11clo cells were sorted from CX3CR1GFP/+ mice receiving 
ampicillin, neomycin, gentamycin, metronidazole and vancomycin in 
drinking water for 21 days. mRNA from sorted cells was analysed for 
expression of IL10 and TNFα by qPCR. Results shown are mean 
expression relative to cyclophilin A (CPA) using the 2-ΔC(t) method. 
The mean was obtained from 2-3 pooled samples with biological 
replicates for the ABX treated group. Data are from one experiment. 
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4.5 Development of intestinal macrophage populations in germ free 
mice 
 
Because the effects of antibiotic treatment were small and inconsistent, I 
decided to use a more definitive approach, in which all microbiota were 
absent. Thanks to collaboration with Dr David Artis, I was able to visit his 
laboratory in the University of Pennsylvania, to study mice in his germ-free 
(GF) facility. There I compared the mφ populations present in the colon of GF 
mice with those from age-matched conventionally raised (CNV) animals at 
three different time points: 7-days-old, 3-weeks-old and 12-week-old adults.  
 
4.5.1 Adult germ free mice 
 
First I analysed adult mice and found that these mice had markedly enlarged 
caeca compared with CNV mice (Figures 4.9 A & B), together with a modest 
but significant increase colon length, thus confirming their GF status (Figures 
4.7 B & C). However this was not reflected in a difference in the total 
number of cells obtained following enzymatic digestion of the colon (Figure 
4.9 D). 
 
For flow cytometric analysis, I used the same gating strategy I developed for 
identification of mφ subsets in non-CX3CRGFP/+ mice described in Chapter 3. 
Thus, total CD11b+ cells were identified amongst 7-AAD- CD45+ Siglec F- Ly6G- 
CD11clo cells and separated into F4/80hi and F4/80lo subsets for assessment of 
their expression of Ly6C and MHC II (Figure 4.10 A). This revealed a trend 
towards reduced proportions and a significantly reduced absolute number of 
F4/80hi cells in GF colon compared with CNV colon (Figure 4.10 B). 
Interestingly, when I looked in more detail within the F4/80hi population I 
found that the lack of microbiota had significant effects on the proportions 
and absolute numbers of cells expressing MHC II in this subset (Figures 4.10 C 
& D). Thus, whereas virtually all F4/80hi mφ in CNV colon were Ly6C- MHC II+ 
there were many more Ly6C- MHC II- cells within this population in GF mice. 
 
In parallel there was a trend towards an increased frequency of F4/80lo cells 
in GF colon. Although their absolute numbers showed a trend towards being 
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lower than in CNV intestine (Figures 4.11 A & B), the proportions and 
numbers of Ly6Chi MHC II- (P1) and Ly6Chi MHC II+ (P2) cells were significantly 
reduced in the GF colon (Figure 4.11 C & D). The more mature subset of 
Ly6C- MHC II+ (P3-P4) did not exhibit any significant difference between GF 
and CNV mice (Figure 4.11 E). Thus these cell subsets appear to be show 
generalised reduction in the proportions and number of mφ in the adult GF 
colon, which affects the early stages of monocyte development acquisition of 
MHC II. 
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Figure 4.9. Effects of the germ free state on the large intestine. 
Adult germ-free (GF) mice have a much larger caecum than 
conventional (CNV) mice (A & B, arrows), as well as increased colon 
length (B & C). D) Total cells per colon from 12 week old GF and CNV 
mice. Data shown from 5 mice/group and are representative of two 
independent experiments. *p<0.05. Student’s t test.  
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Figure 4.10. Effects of germ free state on intestinal macrophages 
in adult mice. Colonic LP cells were isolated from 12 week old GF or 
CNV B6 mice and live CD45+ Siglec F- Ly6G- CD11b+ CD11clo cells were 
analysed. F4/80hi CD11bint mφ were assessed for expression of Ly6C 
and MHC II (A). Proportions (left) and absolute numbers (right) of 
F4/80hi CD11bint mφ (B) Ly6C- MHC II+ (P4, C) and Ly6C- MHC II- (D) 
cells within this population. Data are pooled from two independent 
experiments with 5 mice/group/experiment. *p<0.05, ***p<0.001. 
Student’s t test.  
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Figure 4.11. Effects of germ free state on intestinal macrophages 
in adult mice. Colonic LP cells were isolated from 12 week old GF or 
CNV B6 mice and live CD45+ Siglec F- Ly6G- CD11b+ CD11clo cells were 
analysed for F4/80lo CD11b+ mφ and their expression of Ly6C and 
MHC II (A). Proportions (left) and absolute numbers (right) of F4/80lo 
CD11b+ mφ (B), Ly6Chi MHC II- (P1, C), Ly6Chi MHC II+ (P2, D) and 
Ly6C- MHC II+ (P3, E) cells amongst F4/80lo CD11b+ mφ. Data are 
pooled from two independent experiments with 5 mice/group/
experiment. *p<0.05, **p<0.01. Student’s t test.  
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4.5.2 3 week old germ free mice 
 
As results in my previous chapter indicated that a large influx of mφ around 
the time of weaning might be involved in establishing the adult pool, I 
thought it was important to determine if this process was dependent on the 
presence of the microbiota. To do this I compared GF and CNV mice at 21 
days of age, around the time when the weaning-related influx occurred. As I 
found in the previous chapter, there was a much better defined population of 
F4/80lo cells in CNV mice at this age (Figure 4.12 A left). Although the total 
numbers of F4/80hi cells were not different between GF and CNV mice, GF 
mice had significantly higher proportions (Figure 4.12 A & B). Both 
proportions and numbers of Ly6C- MHC II+ cells were significantly reduced in 
GF mice together with parallel increased proportions and numbers of Ly6C- 
MHC II- cells (Figure 4.12 C & D). Interestingly, these changes appeared 
despite the fact that the total numbers of F4/80hi mφ were similar between 
groups and GF mice had a significantly higher proportion of F4/80hi cells in 
comparison to their CNV counterparts (Figure 4.12 A & B) and this probably 
reflected the fact that these GF mice had fewer F4/80lo cells than the 
controls (Figure 4.13 A left & B). The most dramatic difference with this 
population was seen in regards to the Ly6Chi MHC II+ subset (P2), which was 
virtually absent in GF mice (Figure 4.13 A right & D). Additionally, the 
proportions and numbers of Ly6Chi MHC II- monocytes (P1) were also 
significantly reduced in GF mice (Figure 4.13 A right & C). Finally, the 
proportions of Ly6C- MHC II+ (P3) cells amongst the F4/80lo subset were 
significantly increased in GF mice, but these numbers tended to be lower 
than the CNV colons (Figure 4.13 E). Thus there appears to be a pronounced 
defect in the recruitment of mφ precursors in GF mice at weaning. 
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Figure 4.12. Effects of germ free state on intestinal macrophages 
in 3 week old mice. Colonic LP cells were isolated from 3 week old 
GF or CNV B6 mice and live CD45+ Siglec F- Ly6G- CD11b+ CD11clo cells 
were analysed. F4/80hi CD11bint mφ were assessed for expression of 
Ly6C and MHC II (A). Proportions (left) and absolute numbers (right) 
of F4/80hi CD11bint mφ (B) Ly6C- MHC II+ (P4, C) and Ly6C- MHC II- (D) 
cells within this population. Data are from 1 experiment with 3 
mice/group. *p<0.05, **p<0.01, ***p<0.01. Student’s t test.  
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Figure 4.13. Effects of germ free state on intestinal macrophages 
in 3 week old mice. Colonic LP cells were isolated from 3 week old 
GF or CNV B6 mice and live CD45+ Siglec F- Ly6G- CD11b+ CD11clo cells 
were analysed for F4/80lo CD11b+ mφ and their expression of Ly6C 
and MHC II (A). Proportions (left) and absolute numbers (right) of 
F4/80lo CD11b+ mφ (B), Ly6Chi MHC II- (P1, C), Ly6Chi MHC II+ (P2, D) 
and Ly6C- MHC II+ (P3, E) cells amongst F4/80lo CD11b+ mφ. Data are 
from 1 experiment with 3 mice/group. *p<0.05, **p<0.01, ***p<0.001. 
Student’s t test.  
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4.5.3 7 day old germ free mice 
 
Finally, I compared 7 day old GF and CNV mice to gain some insight into how 
early mφ development might be altered in GF conditions at the time when 
the microbiota would normally begin to establish. As expected, there was a 
clear distinction between F4/80hi and F4/80lo subsets at this time and this 
was not dependent on the presence of the microbiota (Figure 4.14 A). Similar 
to adult mice, there were significant reductions in the frequency and 
absolute number of F4/80hi cells in GF mice (Figure 4.14 B) and this appeared 
to be due to a reduced number Ly6C- MHC II- cells (Figure 4.14 A right, C & 
D). 
 
No differences were seen in the number or frequency of the entire F4/80lo 
subset between GF and CNV intestine (Figure 4.15 A left & B). However as I 
found in older mice, 7 day old GF had a very marked reduction in numbers 
and proportions of the Ly6Chi MHC II+ (P2) cells in this subset (Figure 4.15 A 
right & D). There was also a trend towards fewer Ly6C- MHC II+ F4/80lo cells in 
GF mice (P3) (Figure 4.15 E), also consistent with what I found at previous 
age time points (Figures 4.13 E & 4.11 E). 
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Figure 4.14. Effects of germ free state on intestinal macrophages 
in 7 day old mice. Colonic LP cells were isolated from 7 day old GF 
or CNV B6 mice and live CD45+ Siglec F- Ly6G- CD11b+ CD11clo cells 
were analysed. F4/80hi CD11bint mφ were assessed for expression of 
Ly6C and MHC II (A). Proportions (left) and absolute numbers (right) 
of F4/80hi CD11bint mφ (B) Ly6C- MHC II+ (P4, C) and Ly6C- MHC II- (D) 
cells within this population. Data are from 1 experiment with 3 sets 
of 2 pooled mice/group. *p<0.05. Student’s t test.  
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Figure 4.15. Effects of germ free state on intestinal macrophages 
in 7 day old mice. Colonic LP cells were isolated from 7 day old GF 
or CNV B6 mice and live CD45+ Siglec F- Ly6G- CD11b+ CD11clo cells 
were analysed for F4/80lo CD11b+ mφ and their expression of Ly6C 
and MHC II (A). Proportions (left) and absolute numbers (right) of 
F4/80lo CD11b+ mφ (B), Ly6Chi MHC II- (P1, C), Ly6Chi MHC II+ (P2, D) 
and Ly6C- MHC II+ (P3, E) cells amongst F4/80lo CD11b+ mφ. Data are 
from 1 experiment with 3 sets of 2 pooled mice/group. *p<0.05, 
**p<0.01. Student’s t test.  
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4.6 Summary 
 
In this chapter I examined the role of the commensal microbiota on the 
development of colonic mφ. To do this, I first tried to decrease the bacterial 
load using two different oral antibiotic regimes. My results suggest that short 
term administration of broad-spectrum antibiotics may not be sufficient to 
generate significant changes in colonic mφ in terms of numbers, cell surface 
markers, intracellular cytokine production or mRNA expression from FACS-
purified cells. 
 
Because these studies were unsuccessful, I went on to compare colonic 
lamina propria mφ populations in GF and SPF mice at 7 days of age, weaning 
and adulthood. Interestingly, at 7 days of age GF mice had a defect in the 
frequency and numbers of the F4/80hi mφ, thought to be derived from foetal 
YS precursors, principally affecting the Ly6C- MHC II- subset. This could 
suggest a crucial role for commensal microbiota in driving the recruitment of 
primitive mφ precursors into the developing colonic lamina propria. At 3 
weeks of age, GF mice showed a dramatic decrease in the frequency and 
absolute numbers of the Ly6Chi MHC II- and Ly6Chi MHC II+ subsets of F4/80lo 
cells that represent monocytes and immature mφ respectively. There was 
also a relative increase in the number of the Ly6C- MHC II- subset of F4/80hi 
mφ in GF mice. Together these results suggest there may be deficient 
recruitment of monocytes into the GF intestine, as well as delayed 
maturation with respect to MHC II expression. Although adult GF mice also 
had fewer F4/80hi cells and decreased numbers of Ly6Chi MHC II-, Ly6Chi MHC 
II+ and Ly6C- MHC II+ cells in addition to a higher proportion of Ly6C- MHC II- 
cells compared with CNV controls, these changes were generally less marked 
than at weaning, suggesting that although the microbiota play a prominent 
role in the recruitment and maturation of monocytes at weaning, these 
defects can be overcome by other mechanisms later in life. 
 
  
 
 
 
 
 
 
 
Chapter 5 
Role of the CX3CL1-CX3CR1 axis in 
macrophage function in vitro  
and in vivo 
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5.1 Introduction 
 
The final aim of my thesis was to explore the role of the CX3CL1-CX3CR1 axis 
in the development and function of intestinal macrophages. As I have shown 
in the previous chapters, resident intestinal mφ express very high levels of 
CX3CR1 and its ligand CX3CL1 is produced by intestinal epithelial cells (Kim, 
2011). Additionally, a significant increase in CX3CL1 mRNA expression in 
inflamed lesions from the intestine of patients with Crohn’s disease 
compared with non-inflamed colonic mucosa has been reported. 
Furthermore, CX3CR1 deficient mice have been reported to have a defect in 
mononuclear phagocyte uptake of bacteria from the intestinal lumen 
(D'Haese et al., 2010; Niess et al., 2005), be resistant to experimental colitis 
(Kostadinova et al., 2010) and have a defect in oral tolerance induced by 
feeding protein antigen (Hadis et al., 2011). Taken together, these findings 
suggest that the CX3CR1-CX3CL1 axis may play an important role in driving 
active immunity in the intestine (Blaschke et al., 2003; Durkan et al., 2007; 
Kasama et al., 2010; Lesnik et al., 2003; Staniland et al., 2010; Suzuki et al., 
2005). However, contrary to the above there are some reports that actually 
suggest an anti-inflammatory role for CX3CR1, including models of 
autoimmune uveitis and DSS colitis (Dagkalis et al., 2009; Medina-Contreras 
et al., 2011). As high levels of CX3CR1 characterise intestinal mφ from 
embryonic life, I thought it would be important to define how CX3CR1 and 
CX3CL1 might regulate intestinal mφ populations in steady state and during 
inflammation. I then went on to investigate the role of CX3CR1 in priming of 
mice by feeding ovalbumin together with a mucosal adjuvant. Finally, I 
examined the role of this interaction in the activation of bone marrow-
derived macrophages by the TLR agonist LPS in vitro. 
 
5.2 Role of the CX3CR1-CX3CL1 axis in DSS colitis 
 
To examine how the lack of CX3CR1 might affect intestinal inflammation, I 
used a model in which CX3CR1GFP/GFP (KO) mice received 2% DSS in their 
drinking water for 8 days. In the first experiment, C57/Bl6 (WT) mice were 
used as controls and as expected, they showed progressive weight loss from 
day 5 onwards, which was accompanied by colon shortening and signs of 
clinical disease such as rectal bleeding and diarrhoea (Figure 5.1 A). In this 
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experiment, the CX3CR1 KO mice showed protection from disease, with no 
significant weight loss or clinical disease and much less colon shortening than 
WT mice, confirming previous studies in this model (Brand et al., 2006; 
Kostadinova et al., 2010; Nishimura et al., 2009). However, this protective 
effect was not seen consistently when I repeated the experiment. Thus when 
CX3CR1 KO mice were compared with B6 WT mice on a second occasion, both 
strains lost weight, had colon shortening and developed clinical disease, with 
only a small degree of protection being seen for the clinical scores in KO mice 
compared with WT (Figure 5.1 B). In the last experiment, I used CX3CR1GFP/+ 
mice as controls and on this occasion both strains developed equivalent 
disease as assessed by all the parameters (Figure 5.1 C). 
A 
B 
Figure 5.1. Role of CX3CR1 in DSS colitis. CX3CR1GFP/GFP (KO) and 
C57Bl/6 (WT) mice were given drinking water containing 2% DSS for 
7-8 days and the progress of disease monitored by (A) percentage of 
the original weight loss, (B) colon shortening and clinical score (C). 
Results shown are the means ± 1 SD for three independent 
experiments with 3 mice/group. *p<0.05; ***p<0.001 WT or 
CX3CR1GFP/+ vs KO; ¶p<0.001, WT D0 vs D8 DSS; #p<0.05, KO D0 vs 
DSS. Two-way ANOVA followed by Bonferroni’s post-test.  
C 
137 
0 1 2 3 4 5 6 7 8
70
80
90
100
110
WT
CX3CR1 KO
Days after DSS feeding
0 1 2 3 4 5 6 7 8
0.0
2.5
5.0
7.5
10.0
***
Days after DSS feeding
D0 D4 D8
0.0
2.5
5.0
7.5
10.0
*
Days after DSS feeding feeding
#
¶
	   138	  
 
5.3 CX3CR1+ cell distribution in bone marrow, blood and colon in steady 
state and inflammation 
 
To examine whether the CX3CL1-CX3CR1 axis might be having more subtle 
effects on colitis, I went on to compare the inflammatory infiltrates in the 
colon, blood and BM of CX3CR1GFP/+ (het) and CX3CR1GFP/GFP (KO) mice with 
DSS colitis. This also allowed me to determine if these various myeloid cell 
populations were altered by the absence of CX3CR1 in the steady state and 
during acute inflammation. Under resting conditions, both strains 
demonstrated the expected populations of CX3CR1hi, CX3CR1int and CX3CR1- 
cells amongst the CD11b+ cells, with the CX3CR1hi cells being in the majority 
(Figure 5.2 A & B top panels). As shown previously in the lab (Bain et al., 
2013), after 4 days on DSS there was a substantial increase in the proportions 
of CX3CR1int of cells in CX3CR1GFP/+ mice (Figure 5.2 B bottom panels). 
Although these subsets were significantly higher as a proportion of total 
CD45+ leukocytes in CX3CR1 deficient mice compared with CX3CR1GFP/+ mice 
with colitis, there were no differences between the strains in terms of 
absolute numbers (Figure 5.3). As expected from an acute inflammatory 
process, the frequency and absolute numbers of neutrophils increased in 
CX3CR1GFP/+ mice with colitis, whereas only the numbers of neutrophils were 
significantly increased in CX3CR1 deficient mice with colitis (Figure 5.3 A & 
B). The numbers of CX3CR1hi cells also increased, although their proportions 
decreased in parallel with marked rise in CX3CR1int cells (Figure 5.3 E & F). 
Regardless of all these changes in cell distribution, no consistent differences 
between strains were seen during inflammation and therefore I did not 
analyse the CX3CR1-expressing populations further in terms of Ly6C or MHC II 
expression to identify the P1, P2, and P3 subsets described in earlier 
chapters. 
 
To investigate if there were any intrinsic differences in the production of 
myeloid cells in CX3CR1 KO mice and to explore if they might be mobilised 
differently during inflammation, I examined the numbers of monocytes and 
granulocytes in BM and blood of CX3CR1GFP/+ and KO mice in the resting state 
and in DSS colitis. Three populations of CD45+ CD11b+ cells were found in the 
BM, the largest of which was Ly6Cint CX3CR1-, representing granulocytes. The 
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next biggest group comprised Ly6Chi CX3CR1int monocytes and there was a 
less well-defined group of Ly6Clo CX3CR1+ monocytes (Figure 5.4 A). Steady 
state CX3CR1 deficient mice had a significantly lower proportion of 
granulocytes in the BM compared with resting CX3CR1GFP/+ controls. However 
during DSS colitis the proportions of granulocytes in CX3CR1 KO BM rose to 
match the levels in CX3CR1GFP/+ mice, which did not alter in colitis. (Figure 
5.4 B). Concomitant with the changes in granulocytes, the proportion of 
Ly6Chi monocytes was higher in steady state CX3CR1 KO mice compared with 
heterozygous controls but this decreased during inflammation, whilst again 
there was no change in this population in CX3CR1GFP/+ mice during colitis 
(Figure 5.4 C). The low proportion of Ly6Clo monocytes in CX3CR1GFP/+ 
controls increased significantly during inflammation, while these were found 
at significantly higher levels in resting CX3CR1 KO BM, and did not change in 
colitis (Figure 5.4 D).  
 
As expected, blood contained the same subsets of myeloid cells found in BM 
and there were no differences in the proportions of granulocytes between the 
strains in either steady state or during DSS colitis (Figure 5.5 A & B). However 
after 4 days on DSS the proportion of Ly6Chi blood monocytes in CX3CR1 KO 
mice decreased, whereas they remained at the steady state level in 
CX3CR1GFP/+ mice (Figure 5.5 C). Finally, the proportions of Ly6Clo blood 
monocytes were higher in steady state CX3CR1 KO than in CX3CR1GFP/+ 
controls, but this difference was not observed during DSS colitis (Figure 5.5 
D).  
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Figure 5.2. Role of CX3CR1 in leukocyte populations in colonic 
lamina propria of during steady state and in inflammation. (A) 
Gating strategy for the identification of colonic mφ. (B) CD11b and 
CX3CR1 expression by live gated CD45+ Siglec F- cells from the colon 
of CX3CR1GFP/+ (left) and CX3CR1GFP/GFP mice. Numbers represent the 
proportion of cells within each marked gate. Data are representative 
of two independent experiments. 
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Figure 5.3. Role of CX3CR1 in leukocyte populations in colonic 
lamina propria of during steady state and in inflammation. 
Proportions (left panels) and absolute numbers (right panels) of 
neutrophils (A & B), CX3CR1int (C & D) and CX3CR1hi (E & F) cells 
amongst total live gated CD45+ Siglec F- cells from the colon of 
CX3CR1GFP/+ (het) and CX3CR1GFP/GFP mice. Data are representative of 
two independent experiments. *p<0.05, **p<0.01 CX3CR1GFP/+ vs KO; 
¶p<0.05, ¶¶p<0.01, ¶¶¶p<0.001 steady state vs inflammation. 
Student’s t test.  
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Figure 5.4. Role of CX3CR1 in leukocyte development in bone 
marrow during steady state and inflammation. (A) Expression of 
Ly6C and CX3CR1 by live gated CD45+ CD11b+ cells from BM of 
CX3CR1GFP/+ (Het, left) and CX3CR1GFP/GFP (KO, right) mice showing 
granulocytes (Ly6C+ CX3CR1-), Ly6Chi monocytes (Ly6Chi CX3CR1lo) and 
Ly6Clo monocytes (Ly6Clo CX3CR1+). Frequencies of granulocytes (B), 
Ly6Chi (C) and Ly6Clo (D) monocytes. Data are representative of two 
independent experiments. *p<0.05, ***p<0.001 CX3CR1GFP/+ vs KO; 
¶p<0.05, ¶¶p<0.01, ¶¶¶p<0.001 steady vs inflammation. Student’s t 
test. 
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Figure 5.5. Leukocyte populations in blood of CX3CR1 KO and Het 
mice during steady state and inflammation. (A) Expression of Ly6C 
and CX3CR1 by live gated CD45+ CD11b+ cells from blood of 
CX3CR1GFP/+ (left) and CX3CR1GFP/GFP (KO, right) mice showing 
granulocytes (Ly6C+ CX3CR1-), Ly6Chi monocytes (Ly6Chi CX3CR1lo) and 
Ly6Clo monocytes (Ly6Clo CX3CR1+). Frequencies of granulocytes (B), 
Ly6Chi (C) and Ly6Clo (D) monocytes. Data are representative of two 
independent experiments. *p<0.05, **p<0.01 CX3CR1GFP/+ vs KO; 
¶¶p<0.01 steady vs inflammation. Student’s t test. 
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5.4 Oral priming in CX3CR1 deficient mice 
 
To assess further the role of the CX3CL1-CX3CR1 axis in active immune 
responses in the intestine, I examined whether the reported defect in oral 
tolerance in CX3CR1GFP/GFP mice might have consequences for their 
susceptibility to be primed by this route. To do this, B6 WT and CX3CR1GFP/GFP 
animals were primed by oral gavage with either OVA and cholera toxin (CT), 
OVA alone or PBS, every 7 days for 3 weeks. Primary antigen-specific immune 
responses were then assessed by measuring the proliferative responses of 
MLN and splenic cells after restimulation with OVA in vitro and by measuring 
OVA-specific antibodies in serum and faeces (Figure 5.6 A). 
 
As expected, splenocytes from WT mice that had been primed with OVA and 
CT showed significant proliferative responses when restimulated with OVA in 
vitro compared with PBS-fed control cells (Figure 5.6 B). In contrast 
splenocytes from WT mice fed OVA alone showed no increase in proliferation, 
confirming the need for CT as an adjuvant to induce priming. Splenocytes 
from CX3CR1 KO mice fed OVA+CT also had increased proliferative responses 
compared with PBS-fed controls after restimulation with OVA in vitro. 
However these responses were significantly lower than those of the primed 
WT spleen cells (Figure 5.6 B). Interestingly, CX3CR1 KO mice fed OVA alone 
also had significant proliferative responses in the spleen, perhaps consistent 
with their resistance to being tolerised by feeding antigen alone. This may 
also explain why MLN cells from CX3CR1 KO mice fed OVA+CT or OVA alone 
both showed equivalent and significant proliferative responses to stimulation 
in vitro, whereas no responses above the PBS fed background were found by 
MLN cells from the other groups of mice (Figure 5.6 C). 
 
OVA-specific IgG1 responses were found in the serum of all WT and KO mice 
fed OVA, either alone or with CT, although these were highest in WT mice 
fed OVA+CT (Figure 5.7 A). WT mice fed OVA+CT were also the only group to 
show OVA-specific serum IgG2a antibodies above background (Figure 5.7 B). 
No OVA-specific IgA antibodies could be detected in either serum of faeces 
compared with WT mice (Figure 5.7 C, E). However there was an apparent 
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trend towards increased total IgA level in the faeces of CX3CR1 KO mice 
compared with WT controls (Figure 5.7 D). 
 
Together these results suggest that in the absence of CX3CR1 oral priming 
may be partially impaired, from point of view of systemic immunity, as shown 
by the lack of T-cell proliferation in spleen but not in MLN. Moreover, this 
may be mirrored by the lower levels of OVA-specific IgG1 and IgG2a 
antibodies in CX3CR1 deficient mice, even in the presence of adjuvant. 
B 
C 
Figure 5.6. Role of CX3CR1 in OVA-specific oral priming. (A) 
C57Bl/6 (WT) and CX3CR1 KO mice were gavaged every 7 days for 3 
weeks with 10mg OVA with or without 10µg cholera toxin as an 
adjuvant. At day 21, spleen, MLN, sera and faeces were collected. 
Spleen (B) and MLN cells (C) were restimulated with 500µg/ml OVA in 
vitro and proliferation assessed by measuring thymidine uptake after 
3 days of culture. The data shown are means +1 SD from 6 individual 
mice/group. *p<0.05, **p<0.01, ***p<0.001 OVA vs OVA+CT vs PBS; 
¶¶¶p<0.001 WT vs KO. One-way ANOVA followed by Bonferroni’s post-
test. 
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Figure 5.7. Role of CX3CR1 in OVA-specific oral priming. Serum 
OVA-specific IgG1, IgG2a and IgA antibodies (A-C). Total intestinal IgA 
(D) and OVA-specific IgA antibodies in faeces (E) assessed by ELISA 
were measured 7 days after the last of 3 feeds of OVA±CT and in PBS 
fed controls. The data shown are OD450 of 6 individual mice/group 
+1SD. *p<0.05, **p<0.01 and ***p<0.001 WT+CT vs KO+CT. Student’s t 
test. 
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5.5 Effects of CX3CL1 on activation of macrophages in vitro 
 
Together, although the results of my in vivo experiments were inconsistent, 
they did produce some evidence that intestinal immune responses may be 
dysregulated in the absence of CX3CR1. As previous studies had suggested 
this reflects abnormal mφ function (Hadis et al., 2011), I decided to explore 
how the CX3CR1-CX3CL1 axis might influence mφ activation, using TLR 
stimulation of bone marrow mφ BMM in vitro as a model. First I determined 
the optimal concentration of LPS required for activating BMM. BMM from 
CX3CR1GFP/+ mice were harvested after 6 days culture with M-CSF and 
stimulated overnight with increasing concentrations of LPS ranging from 
100pg/ml to 1µg/ml (Figure 5.8). Mφ activation was assessed by measuring 
the production of TNFα and IL6 using ELISA, while expression of MHC II and 
the costimulatory molecules CD40, CD80 and CD86 were assessed by flow 
cytometry. LPS stimulation caused a clear dose-dependent increase in IL6 
production which was greatest using 1µg/ml LPS, while TNFα production 
reached a maximum at 100ng/ml LPS and above (Figure 5.8 F & G). LPS also 
led to increased expression of CD40 and CD86, with a similar dose effect to 
that seen with TNFα production (Figure 5.8 B & D). In contrast, LPS actually 
led to a dose dependent decrease in CD80 and MHC II expression (Figure 5.8 C 
& E). Importantly, the higher doses of LPS were associated with reduced 
viability of BMM as assessed by exclusion of 7-AAD+ cells (Figure 5.8 A) and on 
that basis, I decided to use 100ng/ml LPS for future experiments. 
 
To explore the role of the CX3CL1-CX3CR1 axis, I first examined whether pre-
incubation overnight with rCX3CL1 affected the response of WT BMM to LPS 
stimulation, using 3 different concentrations of rCX3CL1 which had been 
reported in a previous study (Mizutani et al., 2007). As before, stimulation 
with 100ng/ml LPS alone led to increased production of IL6 and TNFα by 
BMM, together with increased expression of CD40 and CD80, but had no 
effects on MHC II expression or viability (Figure 5.9 B). Pre-incubation with 
rCX3CL1 alone had no effects on any parameter at any concentration and had 
no effects on the stimulatory ability of LPS, apart from a small but significant 
decrease in LPS-induced CD80 expression after addition of 300ng/ml rCX3CL1. 
Significant decreases in viability were also seen when 3 or 300ng/ml rCX3CL1 
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was added to LPS. Due to the lack of a clear pattern in these experiments, I 
decided to rely on the middle dose reported in previous work. 
Figure 5.8. Dose dependent effects of LPS on BM macrophage 
activation. BMM from CX3CR1GFP/+ mice were cultured for 6 days in M-
CSF, harvested and cultured for a further 24h with increasing 
concentrations of LPS. Viability (A),  CD40 (B), CD80 (C), CD86 (D) 
and MHC II (E) expression by F4/80+ BMM were assessed by flow 
cytometry, while IL6 (F) and TNFα (G) production were measured by 
ELISA. Data shown are expressed as pg/ml for cytokine production 
and MFI for surface markers and are means for 3 individual mice/
group +1SD and are representative of at least 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001 vs unstimulated control. 
Student’s t test.  
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Figure 5.9. Effects of rCX3CL1 on LPS-induced activation of BM 
macrophages. BMM from CX3CR1GFP/+ mice were cultured for 6 days in 
M-CSF, harvested and cultured for a further 24h with different amounts 
of rCX3CL1 (3, 30 and 300ng/ml) and 100ng/ml LPS. Viability (A), CD40 
(B), CD80 (C), and MHC II (D) expression by F4/80+ BMM were assessed 
by flow cytometry, while IL6 (E) and TNFα (F) production were 
measured by ELISA. Data shown are expressed as pg/ml for cytokine 
production and MFI for surface markers and are means for 3 individual 
mice/group +1SD and are representative of at least 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001 vs LPS stimulated in 
absence of rCX3CL1; ¶p<0.05 vs unstimulated BMM . Student’s t test.  
Viability
0
25
50
75
100
3ng 30ng 300ng
rCX3CL1
* **
CD40
0
2000
4000
6000
3ng 30ng 300ng
rCX3CL1
***
*** ***
***
¶
CD80
1000
3000
5000
3ng 30ng 300ng
rCX3CL1
¶
** ** **
MHC II
0
500
1000
3ng 30ng 300ng
rCX3CL1
*
IL6
0
6000
12000
18000
3ng 30ng 300ng
rCX3CL1
** * *
TNF!
500
1500
2500
3ng 30ng 300ng
rCX3CL1
* **
151 
	   152	  
 
5.6 Effect of rCX3CL1 on CX3CR1 het and CX3CR1 KO BM macrophages 
 
Next, I decided to repeat and extend the previous experiments using 
interferon gamma (IFNγ) as an additional stimulus for mφ and also compared 
BMM from CX3CR1GFP/+ and CX3CR1GFP/GFP (KO) mice. This was partly to 
examine how the lack of CX3CR1 might affect LPS responsiveness and partly 
to test if the effects of CX3CL1 I observed were truly CX3CR1 mediated. 
 
As before, treatment of CX3CR1GFP/+ BMM with 100ng/LPS induced increased 
production of IL6 and TNFα, as well as enhanced expression of CD40 and 
CD80. In this experiment CD86 expression was also increased by LPS (Figure 
5.8). IFNγ alone had similar effects on all these parameters, except for IL6 
production and also induced increased expression of MHC II (Figure 5.10). 
Stimulation with both IFNγ and LPS enhanced the production of IL6 and TNFα 
above that with either stimulus alone, but otherwise had similar or lesser 
effects to LPS alone (Figure 5.10 E, F). As I found previously, addition of 
30ng/ml rCX3CL1 alone had no significant effect on any of these parameters 
using CX3CR1GFP/+ BMM, while CX3CR1GFP/GFP BMM responded to LPS or IFNγ 
alone very similarly to their CX3CR1GFP/+ counterparts, except when LPS+IFNγ 
were used together. Under these conditions, KO BMM expressed significantly 
more CD40 and CD80, but produced less IL6 and TNFα (Figure 5.10 B, C, E & 
F). However as this differential response by CX3CR1 KO BMM appeared to be 
abolished by addition of CX3CL1 despite the absence of its receptor, the 
significance of these results is unclear. None of the conditions had a 
significant effect on the viability of either het or KO BMM, although there was 
a trend towards lower viability when LPS+IFNγ were used together with both 
cell types (Figure 5.10 A). Overall, my results suggest that there are no 
consistent effects of deleting CX3CR1 or its ligand on mφ responsiveness in 
vitro.  
Figure 5.10. Effects of recombinant CX3CL1 on activation of BM 
macrophages. BMM from CX3CR1GFP/+ and  CX3CR1GFP/GFP mice were 
cultured for 6 days in M-CSF, harvested and cultured overnight with or 
without 30 ng/ml rCX3CL1 before being stimulated with 100ng/ml LPS 
± 500ng/ml IFNγ for a further 24h Viability (A), CD40 (B), CD80 (C) and 
MHC II (D) expression were measured by flow cytometry, while IL6 (E) 
and TNFα (F) production were measured by ELISA. Data shown are 
expressed as pg/ml for cytokine production and MFI for surface 
markers and are means for 3 individual mice/group +1SD and are 
representative of at least 3 independent experiments. *p<0.05, 
**p<0.01, ***p<0.001 CX3CR1+/GFP vs  CX3CR1GFP/GFP, Two-way ANOVA 
followed by Bonferroni’s post-test.  ¶p<0.05, ¶¶p<0.01, ¶¶¶p<0.001, vs 
unstimulated CX3CR1GFP/+ BMM; #p<0.05, ##p<0.01, ###p<0.001 vs 
CX3CR1GFP/GFP BMM; §p<0.05 vs CX3CR1GFP/GFP+LPS+IFN in absence of 
rCX3CL1; •p<0.05 vs CX3CR1GFP/++LPS+IFN in absence of rCX3CL1. 
Student’s t test. 
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5.7 Effect of CX3CL1-expressing epithelial cells on activation of BM 
macrophages  
 
As these studies using soluble rCX3CL1 had not generated consistent results 
and CX3CL1 is expressed as a membrane bound protein in vivo (Bazan et al., 
1997), I next attempted to mimic the natural environment of intestinal mφ 
more closely by using human epithelial kidney cells (HEK293) that had been 
modified to express either membrane-bound (MB) or soluble (sol) CX3CL1. 
Untransfected HEK cells were used as control group, as well as BM mφ alone, 
which were used as control for each condition. First I examined the effects of 
the different HEK cells by co-culturing them at a 1:1 ratio with BMM from WT 
B6, CX3CR1GFP/+ and CX3CR1GFP/GFP mice for 24 hours before adding 100ng/ml 
LPS. Survival of BMM in the absence of LPS was generally low and only showed 
a significant increase when co-cultured with soluble CX3CL1 (Figure 5.11). 
Co-culture of BMM with HEK cells decreased expression of CD86 and MHC II 
(Figures 5.13 & 5.14) whilst it showed no significant effect on CD40 
expression and IL6 and TNFα production (Figures 5.12, 5.15 & 5.16). As 
expected, addition of LPS to WT BMM induced the expression of CD40 (Figure 
5.12), CD86 (Figure 5.13) and MHC II (Figure 5.14), as well as increased 
production of IL6 and TNFα (Figure 5.15 and 5.16) independently of the type 
of HEK cells used. Interestingly, CX3CR1 KO BMM cultured in presence of 
soluble CX3CL1 showed a significantly lower expression of CD40 (Figure 
5.12C), CD86 (Figure 5.13C) and IL6 (Figure 5.14C), when compared to their 
WT BMM counterparts, however this results were the only clear indicators of 
an effect of the absence of CX3CR1 on BMM. 
 
The effects of adding the epithelial cells on the individual parameters of 
activation were quite variable, but in general, the responses to LPS by all 
types of BMM were significantly inhibited in presence of HEK cells, 
irrespective of whether they expressed CX3CL1 or not. The only exception to 
this was TNFα production by most BMM types, where no significant 
differences were seen. 
 
These effects could not be explained by differences in the viability of the 
different BMM cells co-cultured with the various HEK cells, as although there 
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was substantial variation in viability, no consistent patterns could be 
observed (Figures 5.11). It should also be noted that overall viability in this 
experiment was considerably lower than in my previous studies, perhaps 
reflecting the fact that these BMM cells were used after 8 days of culture in 
M-CSF, as opposed to 6 days previously. 
 
Therefore, due to the lack of a clear or consistent pattern of results that 
could be attributed to the presence/absence of CX3CR1, I did not take these 
experiments further. 
Figure 5.11. Effects of CX3CL1 expressing epithelial cells on 
viability by activated BM macrophages. BMM from C57Bl/6 (WT), 
CX3CR1GFP/+ or CX3CR1GFP/GFP (KO) mice were cultured in M-CSF for 6 
days, followed by 24 hours at a 1:1 ratio with control HEK293 cells (A) 
or HEK cells expressing membrane bound (MB) (B) or (C)) soluble 
CX3CL1 (sol) before 100ng/ml LPS was added for a further 24 hours. 
Viability was measured by flow cytometry. Data shown are expressed 
as frequency of viable (7-AAD-) cells and shown as mean +1SD from 3 
individual mice/group. Data are representative of at least 3 
independent experiments. *p<0.05, unstimulated vs LPS-stimulated 
BMM; ¶p<0.05 vs unstimulated BMM alone; #p<0.05 vs LPS-stimulated 
BMM alone; §p<0.05 vs LPS-stimulated WT BMM. Student’s t test. 
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Figure 5.12. Effects of CX3CL1 expressing epithelial cells on CD40 
expression by activated BM macrophages. BMM from C57Bl/6 (WT), 
CX3CR1GFP/+ or CX3CR1GFP/GFP (KO) mice were cultured in M-CSF for 6 
days, followed by 24 hours at a 1:1 ratio with control HEK293 cells (A) 
or HEK cells expressing membrane bound (MB) (B) or (C)) soluble 
CX3CL1 (sol) before 100ng/ml LPS was added for a further 24 hours. 
Viability was measured by flow cytometry. Data shown are expressed 
as frequency of viable (7-AAD-) cells and shown as mean +1SD from 3 
individual mice/group. Data are representative of at least 3 
independent experiments. *p<0.05, **p<0.01, ***p<0.001 unstimulated 
vs LPS-stimulated BMM; ¶p<0.05, ¶¶p<0.01 vs unstimulated BMM alone; 
#p<0.05 vs LPS-stimulated BMM alone; §p<0.05 vs LPS-stimulated WT 
BMM. Student’s t test. 
A B 
C 
157 
HEK 293 cells
0
750
1500
**
***
** **
¶¶ ¶¶
3000
4000
5000
#
# #
MB CX3CL1
0
750
1500
3000
4000
5000 **
****
*# #
#
Soluble CX3CL1
0
1000
2000
3000
4000
5000 **
*** **
#
§
A B 
C 
Figure 5.13. Effects of CX3CL1 expressing epithelial cells on CD86 
expression by activated BM macrophages. BMM from C57Bl/6 (WT), 
CX3CR1GFP/+ or CX3CR1GFP/GFP (KO) mice were cultured in M-CSF for 6 
days, followed by 24 hours at a 1:1 ratio with control HEK293 cells 
(A) or HEK cells expressing membrane bound (MB) (B) or (C)) soluble 
CX3CL1 (sol) before 100ng/ml LPS was added for a further 24 hours. 
Viability was measured by flow cytometry. Data shown are expressed 
as frequency of viable (7-AAD-) cells and shown as mean +1SD from 3 
individual mice/group. Data are representative of at least 3 
independent experiments. *p<0.05, **p<0.01, ***p<0.001 
unstimulated vs LPS-stimulated BMM; ¶p<0.05, ¶¶p<0.01 vs 
unstimulated BMM alone; #p<0.05 vs LPS-stimulated BMM alone; 
^p<0.05 vs unstimulated WT BMM. Student’s t test. 
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Figure 5.14. Effects of CX3CL1 expressing epithelial cells on MHC 
II expression by activated BM macrophages. BMM from C57Bl/6 
(WT), CX3CR1GFP/+ or CX3CR1GFP/GFP (KO) mice were cultured in M-CSF 
for 6 days, followed by 24 hours at a 1:1 ratio with control HEK293 
cells (A) or HEK cells expressing membrane bound (MB) (B) or (C)) 
soluble CX3CL1 (sol) before 100ng/ml LPS was added for a further 24 
hours. Viability was measured by flow cytometry. Data shown are 
expressed as frequency of viable (7-AAD-) cells and shown as mean 
+1SD from 3 individual mice/group. Data are representative of at 
least 3 independent experiments. *p<0.05, **p<0.01, unstimulated vs 
LPS-stimulated BMM; ¶p<0.05, ¶¶p<0.01 vs unstimulated BMM alone; 
#p<0.05, ##p<0.01 vs LPS-stimulated BMM alone; ^p<0.05, ^^p<0.01 
vs unstimulated WT BMM; §p<0.05, §§p<0.01 vs LPS-stimulated WT 
BMM. Student’s t test. 
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Figure 5.15. Effects of CX3CL1 expressing epithelial cells on IL6 
production by activated BM macrophages. BMM from C57Bl/6 (WT), 
CX3CR1GFP/+ or CX3CR1GFP/GFP (KO) mice were cultured in M-CSF for 6 
days, followed by 24 hours at a 1:1 ratio with control HEK293 cells (A) 
or HEK cells expressing membrane bound (MB) (B) or (C)) soluble 
CX3CL1 (sol) before 100ng/ml LPS was added for a further 24 hours. 
Viability was measured by flow cytometry. Data shown are expressed 
as frequency of viable (7-AAD-) cells and shown as mean +1SD from 3 
individual mice/group. Data are representative of at least 3 
independent experiments.**p<0.01, ***p<0.001 unstimulated vs LPS-
stimulated BMM; ##p<0.01, ###p<0.001 vs LPS-stimulated BMM alone; 
§p<0.05, §§§p<0.01 vs LPS-stimulated WT BMM. Student’s t test. 
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Figure 5.16. Effects of CX3CL1 expressing epithelial cells on 
TNFα production by activated BM macrophages. BMM from C57Bl/
6 (WT), CX3CR1GFP/+ or CX3CR1GFP/GFP (KO) mice were cultured in M-
CSF for 6 days, followed by 24 hours at a 1:1 ratio with control 
HEK293 cells (A) or HEK cells expressing membrane bound (MB) (B) 
or (C)) soluble CX3CL1 (sol) before 100ng/ml LPS was added for a 
further 24 hours. Viability was measured by flow cytometry. Data 
shown are expressed as frequency of viable (7-AAD-) cells and shown 
as mean +1SD from 3 individual mice/group. Data are 
representative of at least 3 independent experiments. *p<0.05, 
**p<0.01, ***p<0.001 unstimulated vs LPS-stimulated BMM; §§p<0.01 
vs LPS-stimulated WT BMM. Student’s t test. 
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5.8 Summary 
 
The experiments in this chapter were designed to investigate the role of the 
CX3CL1-CX3CR1 axis on active intestinal immunity in vivo and on mφ 
activation in vitro.  
 
The results showed few consistent effects. Although my initial experiments 
seemed to support previous findings that CX3CR1 KO mice were partially 
protected from DSS colitis compared with B6 WT mice, this could not be 
reproduced in two repeat experiments using either B6 or CX3CR1GFP/+ mice as 
controls. This applied to both systemic effects of DSS such as weight loss and 
myeloid cell recruitment, as well as inflammatory infiltrates of colon and 
colon shortening. 
 
I did obtain some evidence that there may be intrinsic differences in the 
production of granulocytes and monocytes in the absence of CX3CR1, with an 
apparent reduction in granulocyte numbers. In addition, the proportions of 
Ly6Clo monocytes were increased in the BM and bloodstream of CX3CR1 KO 
mice, perhaps reflecting decreased production. However these differences 
were overcome in colitis, consistent with normal recruitment to inflamed 
colon. 
 
I next attempted to induce antigen specific immune responses in the 
intestine of WT and CX3CR1 KO mice by immunising orally with OVA together 
with CT as an adjuvant. These experiments revealed that there appeared to 
be a defect in systemic priming in KO mice as assessed by spleen cell 
responses to OVA restimulation in vitro and by serum IgG1 and IgG2a 
antibodies in vivo. In contrast I obtained some evidence to suggest that KO 
mice may be more susceptible to priming of local immune responses, even in 
the absence of adjuvant, as indicated by an increase in proliferative 
responses in the MLN. Total IgA levels also showed a trend towards being 
higher in KO intestine and together, these results could support previous 
findings of a defect in ability of CX3CR1 KO mice to be tolerised by feeding 
soluble protein (Hadis et al., 2011). However it is important to note that the 
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results of my experiments were very variable and I did not have sufficient 
time to repeat them. 
 
My experiments on BMM in vitro showed no overall effect of the CX3CL1-
CX3CR1 axis on mφ activation. Although some effects of adding recombinant 
CX3CL1 on the responses of BMM to LPS and or IFNγ were observed, the 
results were not consistent between different parameters of activation and 
were not dependent on expression of CX3CR1 by the BMM. Similarly there 
were no consistent differences between the responses of CX3CR1 KO BMM 
from WT or het BMM. Finally, I examined the effects of co-culturing BMM with 
epithelial cells expressing soluble or membrane-bound CX3CR1. 
Unfortunately, all epithelial cells lines were found to typically inhibit the 
activation of BMM, irrespective of whether they expressed CX3CL1 or not. 
However there was some evidence that expression of soluble CX3CL1 could 
overcome some of these inhibitory effects in a CX3CR1 dependent manner, 
indicating that further experiments on this system might be interesting, but 
perhaps with a more physiologically relevant epithelial cell line. 
 
  
 
 
 
 
 
 
 
Chapter 6 
General discussion 
	   165	  
6.1 Introduction 
 
From the moment of birth, the intestinal tract is in perpetual contact with a 
wide range of antigens. In order to preserve homeostasis, the intestinal 
immune system has to identify and act against potentially dangerous 
microbes and substances, whilst tolerating the harmless materials that are 
beneficial to the host, such as commensal organisms and food proteins 
(Mowat, 2003). Macrophages play crucial roles in these processes and 
understanding their development and function was the principal aim of this 
project. 
 
When I began my project, work in the lab had already developed rigorous 
multiparametric flow cytometry-based methods to analyse mφ and DCs in 
adult mouse intestine and had described a number of subsets based on the 
expression of CX3CR1 and other markers. The majority of mφ in healthy colon 
express high levels of CX3CR1 and are also F4/80hi MHC II+. Functionally, 
these cells have been shown to be hyporesponsive to TLR stimulation, 
produce copious amount of IL-10 and have high phagocytic activity (Bain et 
al., 2013). In addition to this subset, the steady state colon contains 3 
transitional stages of macrophages, all of which are CX3CR1int, but which can 
be distinguished from each other based on their expression of Ly6C and MHC 
II. These subsets represent sequential maturation stages between pro-
inflammatory Ly6Chi monocytes and resident mature mφ. Further work has 
shown that these cells are replenished constantly by blood monocytes whose 
development into resident mφ is driven by the local environment in the 
intestine. In my project I adopted the strategies developed in the earlier 
studies to explore how intestinal mφ development was influenced by age, the 
microbiota and the CX3CR1 chemokine receptor. 
 
6.2 Intestinal macrophages in early life 
 
Although there has been a considerable amount of work exploring the 
development of the immune system in the neonate (Cope and Dilly, 1990; 
Haverson et al., 2007; Inman et al., 2010a; Maheshwari et al., 2011; Mulder 
et al., 2011; Schmidt et al., 2011; Stokes, 2004), there are only a limited 
number of studies focussing on intestinal antigen presenting cells under these 
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conditions, mainly dealing with DCs but not intestinal mφ (Inman et al., 2012; 
Inman et al., 2010b). Therefore, my first experiments aimed to examine 
whether colonic mφ in newborn mice have different phenotypic and 
functional characteristics to those in fully-grown animals. 
 
For all the comparisons between adult mice and newborn I measured cell 
numbers as well as cell proportions. The importance of doing this is that even 
as the mouse grows it may be that the cell proportions do not vary very 
much, however the cell numbers may be increasing greatly, for instance at 3 
weeks of age. A good example of this is the F4/80hi CD11bint cell population. 
In newborn mice, the proportion of these cells is the largest, although their 
numbers are small, whereas adult mice have a much larger number of F4/80hi 
CD11bint whilst their proportions are much smaller. Finally, for future 
experiments that may involve cell imaging, it would be important to quantify 
the mφ expansion in the whole colon and compare it with the expansion of 
the rest of the cells that constitute the intestine. This may provide a very 
informative perspective to the phenomenon of mφ expansion during 
development. 
 
When I isolated LP cells from the colon of newborn mice and gated out 
granulocytes and DCs, it was immediately apparent that cells with the 
phenotypic features of resident intestinal mφ were already present. Thus, I 
could identify significant numbers of cells expressing F4/80 and CD11b 
amongst CD45+ leukocytes, with the majority being F4/80hi CD11bint. This 
population was also CX3CR1hi, as seen with their adult counterparts, but 
unlike adult intestine, only a small proportion of CX3CR1hi F4/80hi mφ 
expressed MHC II at birth. Interestingly however, these neonatal cells 
expressed comparable levels of scavenger receptor and had similar 
phagocytic activity in adult and neonatal intestine. This is consistent with 
previous reports showing similar levels of phagocytosis and TLR 
hyporesponsiveness by CD14+ blood cells from human newborns and healthy 
adults (Gille et al., 2006). Thus these functions are important for processes 
that are common to the developing and mature intestine, such as 
phagocytosis of apoptotic cells (Wynn et al., 2013). On the other hand, my 
results showed that neonatal F4/80hi mφ produced higher amounts of TNFα 
constitutively than their adult counterparts, while their production of IL10 
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was lower, indicating that these properties may be defined by the nature of 
the local environment.  
 
In our laboratory, phenotypical analysis of mφ relied on the expression of 
CX3CR1, which allowed us to find clear mφ subsets according to their 
maturation state. This characterisation approach has to be modified when 
identifying intestinal mφ in non-CX3CR1-GFP mice. Therefore I decided that 
for most of this thesis I would define intestinal mφ based on their expression 
of F4/80 and CD11b, with F4/80hi CD11bint being mostly equivalent to 
CX3CR1hi cells and representing the fully mature mφ subset. Conversely, 
F4/80lo CD11b+ cells were mostly CX3CR1int, similar to what is seen with the 
intermediary stages in adults.  
 
One difference between the adult and neonatal intestine was that the F4/80lo 
and F4/80hi subsets were much more discrete in newborn mice. Additionally, 
the F4/80lo numbers varied markedly at different times after birth, especially 
around the age of weaning. When the F4/80lo subset was divided on the basis 
of Ly6C and MHC II, I found that at birth, the Ly6Chi MHC II- (P1) cells were 
the largest subset, but they quickly dropped to half after only 7 days. 
Interestingly Ly6Chi MHC II+ (P2) cells were almost absent at birth and only 
started being clearly noticeable, in both proportions and numbers, after 14 
days of life. Finally, Ly6C- MHC II+ (P3) cells started with a low proportion 
that reached stable levels after 7 days of life, although in terms of absolute 
numbers they also showed their highest peak at 21 days of age. Thus I 
hypothesised that in newborn mice, the large number of Ly6Chi MHC II- 
monocyte-like cells, which are rare in adult intestine, could represent mφ 
precursors derived from foetal liver. This would be consistent with other 
recent work suggesting that the FL is a major haematopoietic site at this age 
and that the progeny are F4/80lo CD11b+ (Hoeffel et al., 2012). In contrast 
the numbers of Ly6Chi MHC II+ cells were very low amongst F4/80lo cells in 
newborn compared with adult intestine, while there were also reduced 
numbers of Ly6C- MHC II+ thought to be the next stage in the differentiation 
continuum (Bain et al., 2013). Together these results could indicate that the 
normal maturation processes in the mφ lineage have not yet begun at this 
early stage of life. Alternatively, the assumption that these phenotypic 
groups represent differentiation stages within the same lineage may not be 
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relevant in the newborn intestine and each population may actually be from 
distinct origins. 
 
Interestingly, I detected a very small proportion of CX3CR1- cells within the 
F4/80lo CD11b+ subset of myeloid cells that could not be found in adult mice. 
I considered the possibility that these might be granulocytes contaminating 
the macrophage population in the neonate mice. Indeed, granulocytes such 
as eosinophils and neutrophils have been shown to express low levels of 
F4/80 (Narni-Mancinelli et al., 2011; Taylor et al., 2006). However these 
were excluded from my CD11b+ CX3CR1- fraction of cells based on their 
expression of Siglec F and Ly6G. I have not found literature reporting any 
neonatal cell population with such characteristics. A final possibility is that 
they could be intestinal DC and if sufficient could be sorted, this could be 
tested by examining their expression of DCs-specific transcription factors, 
such as Zbtb46 (Meredith et al., 2012; Satpathy et al., 2012). 
 
Unlike in adults, only a small proportion of the F4/80hi CD11bint CX3CR1hi 
subset expressed MHC II at birth and this increased gradually with time. The 
lack of expression of MHC II on newborn intestinal mφ is similar to what is 
seen with mature mφ in other anatomical sites such as the peritoneum and 
spleen. However an important difference between these tissues and the 
maturing intestine is the increasing microbial colonisation of the gut. That 
this may play a major role in induction of MHC II was supported by my 
subsequent experiments in GF mice, where even adult mφ showed delayed 
acquisition of MHC II. In addition, global gene analysis has shown that MHC 
expression decreases in small intestine and colon after treatment with broad-
spectrum spectrum antibiotics (Schumann et al., 2005). Nevertheless it is 
clear that the microbiota are not entirely responsible for the expression of 
MHC II on intestinal mφ. It has been reported that interaction with vascular 
endothelial cells may be sufficient to induce MHC II expression on blood 
monocytes as they enter tissues (Jakubzick et al., 2013).  However this would 
not explain why the phenomenon is selective for the intestine, unless the 
vascular endothelium is different in this tissue. Ongoing studies in the lab 
have attempted to identify factors that might explain MHC II expression on 
intestinal mφ and have excluded factors such as IFNγ, T cells, B cells and 
CSF2 (Bain, unpublished data). 
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Because of the gradual changes in MHC II expression after birth and the fact 
that the numbers of mφ did not alter markedly until the 3rd week of life, it 
seems likely that these early changes reflected in situ differentiation of the 
cells that were already present. However I could not exclude the possibility 
that the increased numbers of MHC II- mφ reflected the arrival and 
maturation of small numbers of new monocyte-derived mφ, as occurs in 
adults (Bain et al., 2013). However this would not be consistent with my 
findings that Ly6Chi MHC II+ F4/80lo cell numbers were very low until weaning. 
 
6.3 Origin and expansion of colonic macrophages after birth 
 
The most dramatic feature of my studies of neonatal intestine was the large 
expansion in mφ numbers around the time of weaning and I used a number of 
approaches to explore the reasons for this. An idea which was put forward 
during my project was that tissue resident mφ might be derived from 
embryonic precursors in the YS or FL which self-renew throughout later life 
(Huber et al., 2004; Schulz et al., 2012). This was shown to be the case for 
alveolar mφ, microglia, some splenic mφ, liver Kupffer cells, pancreatic mφ 
and Langerhans cell in the epidermis (Ginhoux et al., 2010; Lichanska and 
Hume, 2000; Naito et al., 1996; Schulz et al., 2012), but never explored in 
the intestine. 
 
Therefore I thought it was important to examine this possibility, as the 
F4/80hi CD11bint and the F4/80lo CD11b+ populations I found in neonatal 
intestine were phenotypically similar to the YS and FL derived subsets found 
in other tissues (Orkin and Zon, 2008; Schulz et al., 2012). To study this I 
visited Professor Frederic Geissmann’s laboratory, where I used the reporter 
gene system he had developed to identify YS derived mφ. Using this 
approach, I found CSF1-YFP+ mφ in 9 day old colon and these were uniformly 
F4/80hi CD11bint, consistent with YS derived mφ in other tissues. However, the 
frequency of CSF1-YFP+ in the intestine was low compared with that in other 
tissues such as the brain (2% vs ~30%). Moreover, it has to be noted that even 
in tissues thought to be seeded exclusively from the YS, this system is not 
100% efficient, meaning that the true level of YS derived intestinal mφ may 
actually be higher. The reasons for this relative inefficiency are not known, 
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but may reflect the fact that the experiment involves a single pulse with 
tamoxifen to the pregnant dam at 8.5 of gestation, meaning that only a 
relatively small fraction of progenitors may be labelled in such a short 
period. It has also been suggested by others that the YS actually contributes 
little to tissue mφ development and that even the F4/80hi cells may be 
derived from FL (Ginhoux et al., 2010). However the authors of this paper 
only showed that there may be a later seeding of Langerhans cells precursors, 
but did not use any FL-specific marker to directly claim FL involvement in the 
process (Ginhoux et al., 2010). This lack of a reliable FL marker made 
impossible for me to replicate this approach and so I was unable to address 
the contribution of FL to the mφ pool in neonatal mice. However its role in 
the postnatal accumulation and maturation of intestinal mφ is likely to be 
limited, given that the BM takes over haematopoiesis soon after birth (Orkin 
and Zon, 2008), long before I found the most marked changes in the 
population to occur. 
 
Throughout my experiments, a high variability between was noticed with 
each repeat. It was explained that due the low number of cells that can be 
isolated from young mice, and that for practical reasons, some experiments 
analysed mφ from the same litter at different ages, whilst some other 
experiments used pups of different ages (consequently different litters) on 
the same day. An interesting observation suggested that by keeping track of 
the origin of the mφ for each experiment could have showed a pattern 
regarding the high variability of the results, thus being able to control or 
reduce the variability between experiments. Indeed, this suggestion may be 
key and definitely will be considered for future experiments. Unfortunately 
for this thesis, the records I kept from the mice I used did not take this into 
consideration and are not useful for the data I present here.  
 
The idea that self-renewal might contribute to the increasing number of mφ 
in the first weeks of life was initially supported by my findings that a high 
percentage of F4/80hi mφ were dividing actively in neonatal mice. However 
this was most marked up to 2 weeks of life, when the population was not 
increasing greatly in size and it was already decreasing by 3 weeks of age, 
when the most dramatic accumulation of mφ was seen. These findings suggest 
that the expansion of the intestinal mφ pool is not due to the local 
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proliferation of existing cells, as it was previously thought (Chorro et al., 
2009). Interestingly, the F4/80lo CD11b+ monocyte-like cells were also Ki67+ 
when at various timepoints, suggesting that they are in active cell division 
throughout development. One explanation for this could be that monocytes 
recently released from the bone marrow and newly arrived in the tissue 
might carry residual levels of Ki67. 
 
The lack of contribution of local self renewal to the intestinal mφ is 
supported by the fact that the proportion of CSF1R-YFP+ cells amongst F4/80hi 
mφ was greatly decreased in adult intestine and indeed, the absolute 
numbers had also fallen. This contrasted markedly with other tissues such as 
the brain, skin and liver, where foetal precursor-derived cells remained 
present in approximately equal numbers (Schulz et al., 2012). Thus the 
intestine appears to be an exception to the new paradigm that all resident 
mφ are derived from foetal progenitors. One additional finding that arose 
from my studies was that the relative expression of F4/80 and CD11b became 
increasingly unreliable as a means of defining the origin of mφ in the 
intestine, as the F4/80hi and F4/80lo subsets were not as distinct in aged 
mice. This appeared to reflect the increased expression of both markers, so 
that most adult mφ were F4/80hi CD11bhi. These results emphasise the 
difference between the intestine and other tissues and indicate that more 
definitive approaches are needed to identify the origins of gut mφ.  
 
Monocyte release from the BM is CCR2 dependent (Kurihara et al., 1997; 
Kuziel et al., 1997; Serbina and Pamer, 2006; Si et al., 2010; Tsou et al., 
2007) and previous work in the lab had indicated that intestinal mφ were at 
least partly deficient in adult CCR2 null mice (Bain et al., 2013). My results 
showed that this phenotype only became apparent after weaning and as I was 
writing up, subsequent studies revealed that the defect developed 
progressively until aged mice showed almost complete absence of mφ 
(unpublished data). Despite considerable variability between individual mice 
and in the separate experiments I performed on weaning mice, it was evident 
that CCR2 null mice did not show the same degree of expansion in mφ 
population as the wild type controls. This affected the F4/80lo CD11b+ subset 
predominantly, whereas the F4/80hi CD11bint subset remained mostly intact.  
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The partial preservation of monocyte recruitment in CCR2 null mice at 
weaning raises questions about whether CCR2 is the only monocyte 
recruitment mechanism. Other possible chemokines involved could be CCR1 
and CCR5, which are known to be involved in monocyte migration during 
inflammatory conditions such as arthritis, as well as in in vitro assays (Gouwy 
et al., 2013; Lebre et al., 2011). Finally, other mechanisms apart from 
chemokines have been reported to regulate monocyte migration to the LP 
including TGFβ and IL8 (Smythies et al., 2006), which can be produced by 
intestinal epithelial cells and mast cells. 
 
An additional possibility is that the other subset of Ly6Clo monocytes may play 
a role at weaning and not in adult intestine. Although it has been proven 
difficult to find evidence for these monocytes entering tissues and previous 
work in the laboratory could not find progeny of adoptively transferred Ly6Clo 
monocytes in adult colon (Bain et al., 2013), their function has not been 
examined in early life. Thus it would be important to compare formally the 
mechanisms that might be involved in the recruitment of monocytes and mφ 
in mice of different ages, perhaps by using mice deficient for other cytokine 
receptors such as CCR1 and CCR5. 
 
It was clear from my experiments that the intestinal mφ pool is relatively 
stable for the first 2 weeks of life and that dramatic changes occurred during 
the third week of life. This is the time of weaning in mice (and other 
species), when there are known to be major changes in intestinal physiology, 
cell populations and immune function (Bailey et al., 1992; Manzano et al., 
2002). As well as the exposure to new food antigens, a novel range of 
bacterial strains appears, adding to the commensals that begin to colonise at 
birth (Bailey et al., 2005). In addition, withdrawal of maternal milk leads to 
the lack of exposure to immunomodulatory factors such as TGFβ (Maheshwari 
et al., 2011; Oddy and Rosales, 2010). In all my experiments, considerable 
variability was found when I examined mφ numbers and subsets around the 
time of weaning, possibly because I usually used a fixed time point, whereas 
individual mice probably begin to sample solid food at different ages and in a 
continuous process. During my experiments, weaning was considered as the 
age when mice start eating solid food (day 14 onwards) rather than their 
withdrawal from the dam’s milk, therefore I was not able to carry out 
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experiments in which the exact time of weaning was tightly controlled. It 
would important to do this for future experiments to prove that the rapid 
changes in mφ populations are truly due to the effects of weaning, or simply 
reflect age-dependent alterations in e.g., haematopoiesis, mucosal 
physiology or monocyte development.  
 
6.4 Functions of neonatal intestinal macrophages 
 
The low number of mφ obtainable from newborn mice meant that I could only 
perform limited functional studies. Nevertheless, I was able to show that 
F4/80hi CD11bint mφ from neonates were fully capable of phagocytosis and 
expressed comparable levels of scavenger receptor CD163 to that found in 
their adult counterparts. Given the fact that the microbiota is virtually 
absent at this time, these features may indicate that the main role of 
intestinal mφ in newborns is to participate in tissue remodelling process at 
the stage of intestinal development. Indeed, F4/80+ mφ have been shown to 
participate in phagocytic clearing of naturally occurring programmed cell 
death in the remodelling interdigital zones of the developing limb buds 
(Hopkinson-Woolley et al., 1994). Thus by the time of birth mφ are already 
well prepared to deal with removing apoptotic tissue (Hart et al., 2008; 
Mantovani et al., 2013; Schulz et al., 2012). Neonatal F4/80hi CD11bint mφ 
were also already refractory to TLR4 ligation and failed to increase 
production of TNFa after LPS stimulation despite their constitutive 
production of this cytokine. In a similar fashion, albeit not to such an extent, 
F4/80hi CD11bint mφ from adults showed an impaired responsiveness to LPS 
stimulation. These results are consistent with previously published findings 
that TLR unresponsiveness of human and mouse intestinal mφ is already 
established in foetal life and is secondary to production of TGFβ by local 
stromal cells (Lotz et al., 2006; Maheshwari et al., 2011). An alternative 
source could be from the phagocytosis of apoptotic cells as this is known to 
drive TGFβ production (Henson and Bratton, 2013). This inertia contrasts with 
the similar TLR tolerance found in intestinal epithelial cells which involves 
exposure to microbial products during the birth process. 
 
The inability of intestinal macrophages to mount inflammatory responses 
after LPS stimulation is in a stark contrast to blood monocytes that react 
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vigorously to TLR ligands. This inability of human and mouse intestinal 
macrophages to respond to LPS was explained by the apparent absence of the 
LPS receptor CD14 on their cell surface (Smythies et al., 2005) or markedly 
down-regulated adapter proteins MyD88 and TRIF (Smythies et al., 2010). 
Interestingly, greater susceptibility to infections in early life correlates with 
changes in innate TLR responses (Kollmann et al., 2012). Even though 
monocytes from neonates are capable, like adults, of recognising the 
presence of pathogens through TLR, several of their functions are impaired, 
including an inability to secrete cytokines or differentiate into macrophages 
(Dasari et al., 2011; Velilla et al., 2006). 
 
Despite the similarities between newborn and adult intestinal macrophages, I 
also noted some important age-related differences. Namely, F4/80hi CD11bint 
mφ from newborn intestine had lower levels of IL10 mRNA and intracellular 
cytokine compared with adult F4/80hi CD11bint mφ, although these were still 
clearly higher than BMM used as a control for RNA expression. These findings 
are consistent with other reports that microbiota may be important in driving 
the high constitutive production of IL10 by resident intestinal mφ (Rivollier et 
al., 2012). That the developing intestine itself can have significant effects on 
the maturation of intestinal mφ is supported by the fact that F4/80hi CD11bint 
mφ from newborn intestine also showed the constitutive production of 
significant amounts of TNFα seen in adult mφ. Together with the high 
expression of CX3CR1 and some MHC II on the neonatal mφ, these findings 
indicate that neonatal mucosa contains factors capable of conditioning the 
unique properties of intestinal mφ, although these are still to be identified. 
 
6.5 Effects of the microbiota on intestinal mφ development 
 
Although there is a considerable amount known about the effects of the 
microbiota on immune function (Atarashi et al., 2011; Cummins and 
Thompson, 2002), relatively few studies have examined intestinal mφ 
specifically and none have investigated this in early life. Moreover, because 
of the dramatic changes I observed in gut mφ populations in developing mice, 
particularly at weaning, I decided to investigate if the microbiota was 
involved in this phenomenon. 
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My first approach was to administer broad-spectrum antibiotics to adult mice, 
using regimes shown previously to modify innate immune responses in vivo 
(Abt et al., 2012; Rath et al., 2001). Initially I treated mice for 21 days with a 
mixture of meropenem and vancomycin, but the only effect I observed was a 
marginal increase in the frequency of CX3CR1hi mφ in the ABX treated 
animals, perhaps consequent on the parallel decrease in CX3CR1int cells. The 
numbers of granulocytes, total leukocytes and CX3CR1int mφ were not altered 
by the ABX regime. There was a trend towards higher TNFα mRNA expression 
by ABX treated CX3CR1hi cells, but a shorter regime had no effect on 
intracellular TNFα or IL10 production. The reasons for the apparent increase 
in CX3CR1hi (F4/80hi) mφ are unknown, particularly in view of the lack of any 
overall effect of this regime, which contrasted with an earlier report using 
this cocktail to protect mice from intestinal inflammation (Rath et al., 2001). 
Although it has to be noted that I used C57Bl/6 mice, whereas Rath et al. 
used rats and BALB/c mice, there are no reports supporting strain or species 
differences in the efficacy of these particular antibiotics. Therefore I decided 
to try an alternative regime that contained a cocktail of ampicillin, 
gentamicin, metronidazole, neomycin and vancomycin that had been shown 
to reduce innate and adaptive immune responses to lymphocytic 
choriomeningitis virus (LCMV), including decreased TNFα production by 
peritoneal and splenic mφ (Abt et al., 2012). In my hands, this regime had an 
obvious effect that was evident to the naked eye, with treated mice 
developing an enlarged caecum similar to what I found subsequently in GF 
mice. Despite this, there were few cellular changes amongst the colonic mφ 
populations, apart from modest increases in total CD11b+ cells and 
granulocytes. There were no significant changes in the various populations of 
F4/80lo or F4/80hi mφ, including Ly6Chi monocytes, consistent with the 
findings of Abt and colleagues, who found no effects of this regime on the 
phenotype of splenic and peritoneal mφ. However, in contrast to their 
studies, I did not find a decrease in TNFα mRNA expression by F4/80hi 
CD11bint mφ from ABX treated intestine. In fact, there was a trend towards 
increased TNFα expression in these cells, similar to what I found with 
CX3CR1hi cells in the first experiments. Unfortunately, I was unable to FACS 
purify enough F4/80lo cells in this second series of experiments to obtain 
good quality RNA for analysis of cytokine gene expression. 
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The lack of effects of these antibiotic regimes on mφ seemed surprising in 
view of the previous reports that similar regimes can prevent colitis, 
downregulate MHC II gene expression, and alter the balance between Th17 
and Treg in LP (Ivanov et al., 2008; Lamouse-Smith et al., 2011; Schumann et 
al., 2005; Videla et al., 1994), especially in view of the clear effects of the 
second regime on caecal size. However, it should be noted that earlier work 
suggested that this phenomenon was due to direct effects of penicillin-
related compounds on tissue osmolarity (Savage and Dubos, 1968; Savage and 
McAllister, 1971), rather than to changes in bacteria composition. In this 
regard, it is important to note that I was unable to carry out analysis of the 
microbiota to confirm directly what effects the antibiotic regimes had had. 
Nevertheless, other work going on in the lab while I was working showed that 
the same cocktail of ampicillin, gentamicin, neomycin, vancomycin and 
metronidazole reduced the frequency of Th17 cells in the small intestine 
(Scott C, unpublished data), suggesting that this regime was capable of 
modulating function in the intestine. One explanation for these discrepant 
findings could be that the short term treatment we used may be insufficient 
to influence the behaviour of longer lived cells such as intestinal mφ, which 
are thought to have a lifespan of several weeks (Zigmond and Jung, 2013). 
Furthermore, work in our lab and others indicate that these cells are unable 
to change their functions once fully mature (Bain et al., 2013; Zigmond and 
Jung, 2013). However, as these cells appear to be replenished continuously 
from monocytes in a process that takes a week or less (Bain et al., 2013), it is 
surprising that the earliest stages of differentiation continuum were not 
affected by my antibiotic treatment. Unfortunately, I was unable to study the 
function of the various stages of differentiation directly using CX3CR1GFP/+ 
mice, as the permeabilisation and fixation needed to assess intracellular 
cytokine staining alters GFP in such way that its fluorescence activity 
reduces, meaning that the CX3CR1int populations become more difficult to 
define accurately (Kusser and Randall, 2003). Thus, in order to get a deeper 
insight to the effects of antibiotics it would be interesting to study their 
effect on each monocyte/mφ populations by other methods such as qPCR or 
microarray analysis of sorted cells. It has been shown that a discrete but 
significant decrease in type I interferon expression can be elicited by 
antibiotic treatment (Abt et al., 2012; Ganal et al., 2012). This strategy 
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might be worth considering because it would provide a more focused and 
sensitive observation of the cell subsets involved and therefore, any subtle 
change could be easier to detect.  
 
Finally, my results may suggest that antibiotic regimes have a minimal effect 
on the mφ populations in the colon. A reason for this could be that the mφ 
populations of conventional mice have already been conditioned by previous 
exposure to commensals and therefore their response to antibiotics is more 
difficult to quantify. In order to overcome this, it might be feasible to use a 
more intensive antibiotic regime such as that in which pregnant mice are 
given antibiotics and their pups continued on this after birth. This has been 
shown to modify antibody responses and tolerance to orally administered 
antigens (Kusser and Randall, 2003; Lamouse-Smith et al., 2011) and it might 
show a clearer effect of the antibiotics treatment. 
 
6.6 Macrophage populations in germ free mice 
 
As the experiments using antibiotics were inconclusive, I took the opportunity 
to visit Dr David Artis’s laboratory in Philadelphia to study GF mice, which are 
known to have profound differences in immune functions (Eberl and Lochner, 
2009; Ivanov and Honda, 2012; Kosiewicz et al., 2011; Molloy et al., 2012; 
Reading and Kasper, 2011; Round and Mazmanian, 2009). 
 
The effects of the GF condition were shown clearly by the slightly longer 
colon and considerably larger caecum, confirming earlier findings (Savage and 
McAllister, 1971). In addition, adult GF mice had fewer F4/80hi Ly6C- mφ 
compared with the conventionally reared controls, as well as reduced 
expression of MHC II by these cells, similar to the absence of MHC II on the 
F4/80hi cells in neonatal intestine. These differences were even more 
pronounced in 3 week old GF mice, despite the fact that the total numbers of 
these cells were normal at this time. Interestingly however, F4/80hi CD11bint 
mφ from 7 day old GF mice had equivalent levels of MHC II to their 
conventional counterparts, confirming my initial conclusions that a significant 
amount of mφ differentiation in the early neonatal period is independent of 
the microbiota. However, the total numbers of F4/80hi CD11bint mφ were also 
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lower in 7 days old GF pups, perhaps suggesting that primitive precursors of 
these early mφ may be dependent on the presence of the microbiota. 
 
As these experiments were carried out in non CX3CR1-GFP mice, I had to use 
the F4/80lo population as a surrogate for analysing how monocytes and the 
intermediary subsets behaved in GF mice. Using this approach, I found that 
the total number of F4/80lo cells only showed a significant difference 
between GF and CNV mice at 3 weeks of age, when they were decreased in 
GF colon. However, more detailed analysis of this population showed that the 
Ly6Chi MHC II- subset was significantly decreased in both 3 week old and in 
adult GF mice, while the Ly6Chi MHC II+ (P2) subset was reduced in GF mice 
regardless of their age. 
 
Together these results could support the idea that in the first week of life, 
the majority of intestinal mφ is derived from foetal precursors, whose 
recruitment is mostly independent of the microbiota (Orkin and Zon, 2008). 
Moreover, my findings could suggest that while some myelopoiesis in the YS 
may be influenced by microbial colonisation, YS derived mφ develop 
independently of the microbiota once they have arrived in the mucosa 
(Maheshwari et al., 2011). The normal numbers of Ly6Chi MHC II- monocytes in 
7 day old GF mice may support the idea that these are FL derived at this 
time, although to my knowledge, the expression of Ly6C by FL monocytes has 
not been explored. The decreased numbers of Ly6Chi MHC II+ (P2) in neonatal 
GF intestine and delayed acquisition of MHC II and upregulation of F4/80 in 
GF mice indicate these processes are dependent on the microbiota. Studying 
the ontogeny of intestinal mφ in GF lineage tracker mice and/or developing 
adoptive transfer techniques for use in neonatal animals may allow these 
ideas to be explored directly. 
 
At weaning, both the recruitment and maturation of BM derived Ly6Chi 
monocytes become highly dependent on the microbiota and this defective 
recruitment and maturation persist into adult life. The fact that the 
differences between GF and CNV mice become so marked at this time 
emphasises what a crucial role weaning plays in the development of the 
intestinal mφ pool (Mulder et al., 2011; Russell et al., 2013). Despite these 
effects on monocyte recruitment, it is interesting to note that substantial 
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numbers of mφ were present in adult GF mice, indicating that factors other 
than the microbiota such as dietary components may be able to compensate 
for some of the effects normally provided by the microbiota. Previous studies 
of the effects of the microbiota on intestinal mφ populations have produced 
conflicting results, with some suggesting that their numbers are reduced in 
GF intestine (Atarashi et al., 2008; Niess and Adler, 2010), while others have 
reported no difference (Rivollier et al., 2012). Although my results support 
the idea of a defect in the total mφ pool in GF mice, they also show that the 
exact nature of this abnormality may depend on the stage of differentiation 
within the monocyte-mφ continuum, as well as the age of the animal and the 
origin of the mφ precursors. In this respect, it is important to note that none 
of the previous studies of intestinal mφ in GF mice analysed neonatal and 
adult mφ. A further factor which needs to be taken into account is that 
whereas there is contradictory evidence on the number of mφ in GF intestine, 
there has been consensus on the fact that functions such as IL10 production 
may depend on the presence of microbiota (Kayama et al., 2012; Rivollier et 
al., 2012). Unfortunately, there were insufficient mice available for me to 
carry out direct functional analyses of GF mice during my visit to 
Philadelphia. Although I did isolate mRNA from F4/80hi mφ I sorted from these 
mice with the aim of performing microarray analysis, no meaningful results 
were obtained due to poor cell yield and low RNA quality. Therefore further 
experiments are now planned to correlate alterations in the mφ subsets I 
observed in GF mice with functional indices. 
 
6.7 Regulation of macrophage function by CX3CR1 
 
One of the most characteristic features of resident intestinal mφ is the 
acquisition of high levels of the CX3CR1 chemokine receptor during their 
differentiation from CX3CR1lo/int monocytes (Bain et al., 2013). One 
possibility raised by these findings is that CX3CR1 may play a role in 
controlling the differentiation or function of the mature mφ via its ligand 
CX3CL1 that is expressed by epithelial cells and vascular endothelial cells in 
the intestine (D'Haese et al., 2010; Kim, 2011; Umehara et al., 2004). 
However, previous studies had produced contradictory results on the 
immunoregulatory effects of the CX3CL1-CX3CR1 axis. Although it has been 
suggested that CX3CL1 promotes intestinal inflammation, as shown by 
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increased CX3CL1 production in cases of Crohn’s disease (D'Haese et al., 
2010), and less severe DSS and T cell dependent colitis in CX3CR1 deficient 
mice (Kim, 2011; Kostadinova et al., 2010; Niess and Adler, 2010), others 
have reported anti-inflammatory effects. Indeed, CX3CR1 may be required 
for oral tolerance via the production of IL10 by intestinal mφ (Dagkalis et al., 
2009; Hadis et al., 2011). Therefore I decided to explore further the role of 
CX3CR1 in intestinal mφ function. 
 
First I examined the outcome of DSS colitis in CX3CR1GFP/GFP (KO) mice, but 
obtained inconsistent results, ranging from reduced susceptibility to a 
complete lack of effect. An example of this situation was noticed on one 
occasion, which suggested that the absence of CX3CR1 actually had a 
protective role, a trend could be observed in the 2nd and 3rd time I performed 
this experiment. During the discussion of results, it was suggested to pool the 
results from the three repeats and to perform a repeated-measures general 
linear model test, in order to increase the statistical power of the analysis. 
This analysis was not possible due to the lack of an even number of mice 
assessed at each timepoint, therefore it was substituted with a two way 
ANOVA. As expected, after pooling the experiments, a more robust data set is 
generated, however this was enough only to show significant differences in 
colon length and clinical score after 8 days on colitis. 
 
 The reasons for this high variability and for the discrepancy with the 
previous reports are unclear. However, as noted above, it is not the first time 
that opposing results have been published regarding the proinflammatory 
versus anti-inflammatory role of the CX3CL1-CX3CR1 axis (D'Haese et al., 
2012; Kayama et al., 2012; Medina-Contreras et al., 2011; Niess and Adler, 
2010). One possibility could be that the model of DSS colitis I used was too 
severe to be modified by the absence of CX3CR1 and that differences in the 
microbiota between different laboratories might determine the CX3CR1 
dependency of colitis, which is known to be driven by local bacteria (Denning 
et al., 2011; Elsheikh et al., 2012; Ivanov et al., 2009; Wu et al., 2010). If 
correct, these findings indicate that CX3CR1 is not absolutely required for 
intestinal inflammation, but may only modulate certain aspects and/or 
forms.  
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Despite the fact that CX3CR1 is known to influence monocyte recruitment to 
tissues (Ancuta et al., 2003; Aspinall et al., 2010; Fong et al., 1998; Imaizumi 
et al., 2004), I could not find any difference in the numbers or proportions of 
myeloid subsets in steady state or inflamed intestine from CX3CR1 KO mice. 
These results suggest that this receptor is not required for the entry, 
maturation or survival of any of the CX3CR1+ mφ and DCs in the mucosa. 
Whether it controls the anatomical location of these cells once in the 
intestine, as might be suggested by the inability of CX3CR1 KO mφ to form 
TEDs (Niess et al., 2005), remains to be determined using immunohistology.  
 
CX3CR1GFP/GFP mice did show some subtle differences in myeloid cell 
populations in the BM and bloodstream. Thus the BM of CX3CR1GFP/GFP mice 
had higher frequencies of Ly6Chi and Ly6Clo monocytes with a concomitant 
decrease in granulocytes compared with CX3CR1GFP/+ controls. During DSS 
colitis, there was a decrease in the frequency of Ly6Chi monocytes in CX3CR1 
KO BM which did not occur in control mice, suggesting that CX3CR1 may 
normally act to inhibit release of monocytes from BM. Alternatively, as the 
frequency of Ly6Chi monocytes were also decreased in the blood of CX3CR1 
KO mice with colitis, it could be that there is actually enhanced recruitment 
of these cells to the inflamed mucosa in the KO mice. However, this would 
not be consistent with the lack of effect of CX3CR1 on the inflammatory 
infiltrate of the mucosa itself. A very recent study has shown that there are 
enhanced migration of Ly6Chi monocytes into the spleen of CX3CR1 KO mice 
after chemotherapeutic ablation in vivo which was associated with reduced 
numbers (Jacquelin et al., 2013), similar to my findings in mice with DSS 
colitis. Although I found no difference in Ly6Chi monocytes in the blood of 
steady state CX3CR1GFP/GFP mice, the proportions of Ly6Clo monocytes were 
increased in these animals, which would appear to contradict a recent 
suggestion that soluble CX3CL1 is needed for the intravascular survival of 
these cells (Kim, 2011). As Ly6Clo monocytes are now thought to be the 
progeny of Ly6Chi monocytes (Ramachandran et al., 2012)), together these 
findings indicate that further studies are warranted to explore the role of 
CX3CR1 in the homeostasis of monocytes in steady state and inflammation. 
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6.8 CX3CL1-CX3CR1 axis in oral priming 
 
Oral tolerance has been extensively studied in laboratory rodents, but also in 
several other species such as pigs and dogs (Deplazes et al., 1995; Miller et 
al., 1984; Stokes, 1987; Stokes et al., 1987). The phenomenon of oral 
tolerance can be defined as a state of immunological unresponsiveness to 
antigens that can be induced by oral administration of non-invasive antigen 
such as proteins. Intestinal mφ are considered to be key in the regulation of 
mucosal immunity and their remarkable expression of CX3CR1 has been 
described by our group and others (Bain et al., 2013; Kayama et al., 2012; 
Zigmond and Jung, 2013), however no investigations have been conducted in 
order to define the role of this chemokine receptor in oral tolerance.  
 
A recent report has shown that intestinal mφ from CX3CR1 deficient mice had 
defective production of IL10, leading to reduced expansion of Foxp3+ Treg 
cells in the LP and a subsequent defect in systemic tolerance induced by 
feeding ovalbumin (Hadis et al., 2011). To explore if this reflected a wider 
role for CX3CR1 in regulating all aspects of adaptive immunity in the 
intestine, I primed mice by feeding them OVA with or without cholera toxin 
as an adjuvant. After feeding OVA alone, CX3CR1 deficient, but not WT mice 
showed evidence of T cell priming in the MLN. In parallel, oral administration 
of CT adjuvant had a greater ability to enhance T cell responses in CX3CR1 
deficient MLN compared with WT MLN, while CX3CR1GFP/GFP mice had 
increased total IgA levels in faecal extracts. Although it should be noted that 
the differences I found were modest and therefore need confirmation, they 
could indicate that local tolerance mechanisms may indeed be impaired by 
the absence of CX3CR1. This would be consistent with the lack of IL10 
production by intestinal mφ in CX3CR1GFP/GFP mice (Hadis et al., 2011). 
Although the IL10 producing cells studied in this and other laboratories have 
found there is also a bona fide population of CX3CR1int DCs, which could be 
implicated in these processes (Cerovic et al., 2013; Zigmond and Jung, 2013), 
cell specific KO mice could help resolve these issues.  
 
I also found a rather different pattern of systemic immune responses in 
CX3CR1GFP/GFP mice, as these animals had lower T cell priming in the spleen 
and lower serum antibodies after feeding OVA+CT than WT mice. No 
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differences were observed in the very limited responses seen after feeding 
OVA alone. Again these results need to be confirmed, especially as they 
appear to conflict with the earlier report of defective systemic consequences 
of OVA-specific oral tolerance in CX3CR1GFP/GFP mice (Hadis et al., 2011). 
However my results could indicate that CX3CR1 may play distinct roles in 
determining whether tolerance or active immunity are generated in the 
mucosal and systemic immune systems. Alternatively it may have a role in 
controlling the systemic dissemination of whatever response is initiated in 
the intestine, be it tolerance or priming. Again the cells involved and exact 
consequences need to be explored. For instance it would be of interest to 
examine whether the absence of CX3CR1 alters the migration of DCs from LP 
to MLN, the cellular process that is central to the induction of oral tolerance 
(Worbs et al., 2006). 
 
Finally, it is known that defects in oral tolerance are more common during 
infancy and weaning. Reports have shown that animals which received 
antigen during the first 1 or 2 days of life showed systemic priming when 
challenged parenterally as adults (Peng et al., 1989; Strobel and Ferguson, 
1984), and interestingly this has been shown not only in neonate mice, but 
also in piglets (Miller et al., 1984; Stokes et al., 1987). Thus, even though the 
evidence from my oral priming experiments was not robust, it would be 
interesting to compare the efficiency to develop oral priming by CX3CR1 
deficient mice at early age. 
 
6.9 Role of the CX3CL1-CX3CR1 axis in macrophage function in vitro 
 
My final experiments investigated how CX3CL1 might influence mφ function 
directly and my initial plan was to study intestinal mφ in vitro. However this 
proved impossible due to the poor viability of the mature CX3CR1hi mφ that 
could be purified from the intestine, while only low numbers of the 
intermediary CX3CR1int subsets could be obtained. Therefore I decided to use 
BM-derived mφ as a means of establishing the system, with the intention of 
moving on to intestinal mφ once the technical issues had been overcome.  
 
First I compared cytokine release and co-stimulatory molecule expression of 
CX3CR1 KO and WT BMM that had been stimulated with IFNγ or LPS+IFNγ in 
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the presence or absence of recombinant CX3CL1. As expected, WT BMM 
responded to LPS stimulation by upregulating the costimulatory molecules 
CD40 and CD80, together with increased production of TNFα and IL6. 
Although addition of recombinant CX3CL1 seemed to enhance the production 
of TNFα by CX3CR1GFP/+ BMM, this had no consistent effect on costimulatory 
molecule expression. In general, CX3CR1 KO BMM responded equivalently, 
except for some increase in CD40 and CD80 and lower production of IL6 and 
TNFα when stimulated with LPS+IFNγ. However these effects were modest 
and inconsistent. 
 
As the effects of recombinant CX3CL1 were inconclusive, I acquired epithelial 
cell lines expressing either the soluble or membrane bound forms of CX3CL1, 
in the hope this would mimic the physiological situation more accurately, 
where the transmembrane form is expressed by epithelial cells and 
endothelial cells (Andrzejewski et al., 2010). Again, the results were mostly 
inconclusive, with only modest effects of the soluble CX3CL1-expressing HEK 
cells on the viability and expression of costimulatory molecules by LPS 
stimulated CX3CR1 KO BMM when compared with their WT and CX3CR1GFP/+ 
counterparts. On the other hand, the effects of HEK cells expressing 
membrane bound CX3CL1 were almost identical to those found using by 
untransfected HEK cells. Interestingly, there were some differences between 
WT and CX3CR1 KO BMM in certain parameters such as costimulatory 
molecules when cultured with soluble CX3CL1, however due to the lack of a 
clear pattern, these differences could not be related to the 
presence/absence of CX3CR1. Previously, these CX3CL1-expressing HEK cells 
had only be used to analyse structural properties of CX3CL1 (Andrzejewski et 
al., 2010) and not in cellular co-cultures in vitro. Therefore it seems that 
more work will be required to optimise this model. Furthermore it may be 
necessary to develop the method to use monocytes with the capacity for 
plasticity, or tissue mφ that express more CX3CR1 than BMM.  
 
Together my results suggest that there may be a role for the CX3CL1-CX3CR1 
axis in modulating the balance between the local and systemic effects of 
mucosal immune responses in vivo. However the results from my in vitro 
experiments were not consistent enough to dissect the cellular mechanisms 
involved. 
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6.10 Concluding remarks 
 
The results presented here show that although mφ derived from primitive 
precursors are present in the colon before birth and can self renew for 1-2 
weeks, they are replaced by an influx of conventional monocytes around the 
time of weaning. As described in other tissues, both YS and FL appear to 
contribute to the mφ present in early neonatal intestine (Figure 6.1). The 
recruitment of monocytes at weaning is highly dependent on CCR2 and 
constant replenishment by CCR2-dependent monocytes then becomes the 
only source of mφ in adult intestine. The recruitment of monocytes is only 
partly dependent on the microbiota and interestingly, the mφ present at birth 
already have many characteristics of the fully mature mφ found in adult 
intestine, including the expression of high levels of CX3CR1 and scavenger 
receptors, phagocytic activity and hyporesponsiveness to TLR ligation, 
together with some constitutive production of IL10 and TNFα. However the 
full expression of MHC II and production of IL10 are not acquired until adult 
life and may be driven by the microbiota.  
 
These findings indicate that factors other than the commensal bacteria can 
contribute to the tissue specific maturation of monocytes after their arrival 
in the mucosa, but their identity remains to be determined. The mechanisms 
involved in the recruitment at weaning are also poorly defined. Although I 
attempted to explore the role of the CX3CL1-CX3CR1 axis in intestinal mφ 
function, my experiments were not conclusive and more work is needed to 
identify these mechanisms. 
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Figure 6.1. Development of the intestinal mφ pool in mice. In early 
embryonic life (E8.5), yolk sac (YS) generates mφ precursors before being 
superadded by the foetal liver (FL) around E10.5. Production of bone 
marrow (BM) monocytes begins becoming the exclusive source of 
monocytes around 3 weeks of age. 
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